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Abstract 
Secondary-active trans-membrane transporters couple the ‘downhill’ 
movement of ions with the ‘uphill’ movement of essential substrates, such as 
neurotransmitters or metabolites, across the cell membrane. Disruption of 
these vital processes is linked to some severe diseases in humans, for 
example Parkinson’s disease. The aim of this project is to investigate the 
structural basis of the transport mechanism of secondary-active 
transporters, using the bacterial sodium-hydantoin transporter Mhp1 as a 
model system, with a combination of X-ray crystallography and small-angle 
X-ray scattering (SAXS).  
A wide variety of strategies have been applied and optimised in the 
crystallisation, harvesting and cryo-protection steps to improve the data 
obtained from Mhp1 crystals. These include modifications to the crystal drop 
morphology to improve crystal size and quality, as well as on-line crystal 
dehydration and contact-less harvesting by photoablation to minimise 
damage during cryo-protection and harvesting. This has enabled the 
determination of several novel crystal structures of Mhp1 mutants in 
complex with various ligands.  
SAXS experiments have been used to obtain information about the overall 
shape and detergent organisation around the purified protein, in order to 
gain insight into crystallisation propensity and detergent packing in 
membrane protein crystals. The challenges imposed by the presence of the 
detergent molecules have been overcome by combining SAXS with size-
exclusion chromatography.  
The results obtained in this Thesis suggest that the altered ligand binding in 
the Mhp1 mutants studied in this work is a result of an altered protein 
conformational landscape, rather than loss of specific protein-ligand 
interactions. They have also shown that conformational selection during 
crystallisation can stabilise ligand binding states that are not strongly 
favoured in solution. Whilst this provides useful detail on ligand binding, it 
also highlights that a combination of biochemical, biophysical and structural 
data are required to understand how mutations perturb membrane protein 
function. 
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Chapter 1: Introduction 
1.1 Membrane transport  
1.1.1 Introduction 
The membranes surrounding living cells are composed of phospholipid 
bilayers, which act as protective barriers between the exterior and interior of 
the cells. Through these membranes, which have a hydrophobic interior, 
only a few small molecules can passively diffuse at a slow rate. In order to 
maintain homeostasis, membrane-embedded transport proteins aid the 
translocation of ions and metabolites through the hydrophobic interior of cell 
membranes. Membrane transport proteins can be divided into two major 
classes; channels and transporters, which carry out facilitated diffusion, 
group translocation, primary or secondary active transport. This section will 
give an overview of bacterial cell membranes, membrane transport proteins 
and their role in living organisms.  
 
1.1.2 Bacterial cell membranes 
Bacterial cells can be distinguished as Gram-positive or Gram-negative, 
depending on the structure of their cell membranes. The names stem from 
the ability of the bacterial cells to be stained by Gram’s stain, which was 
developed in 1884 for the detection of bacteria and infection (Brock, 1961; 
Austrian, 1960).  
Membrane transport proteins are embedded in the so-called cytoplasmic 
membrane, which separates the inside of the cells (the cytoplasm) from the 
exterior. In Gram-negative bacteria, an approximately 100 Å wide 
periplasmic space separates the cytoplasmic membrane from a 
peptidoglycan layer and an outer membrane that contains porins and is 
coated with a layer of lipopolysaccharides (see Figure 1.1) (Nicholls & 
Ferguson, 2014). In Gram-positive bacteria there is no periplasmic space, 
and the cytoplasmic membrane is in direct contact with a thick peptidoglycan 
layer. 
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Figure 1.1 The structure of a Gram-negative bacterial cell membrane. 
The membrane layers surrounding Gram-negative bacteria that separates the 
cytoplasm from the outside of the cell are composed of a cytoplasmic membrane 
and a peptidoglycan layer which are covered by an outer membrane. The 
cytoplasmic membrane holds integral membrane proteins, such as various 
transport proteins that carry out facilitated diffusion, group translocation, primary or 
secondary-active transport. Figure from Campbell Biology © Pearson Education, 
2011. 
 
1.1.3 Membrane proteins  
Integral membrane proteins residing in the bacterial cytoplasmic membrane 
are responsible for the translocation of ions, metabolites and compounds 
involved in signalling pathways between the cytoplasm and the outside of 
the bacterial cell. Membrane proteins can be divided into groups that carry 
out passive diffusion, facilitated diffusion, group translocation, primary or 
secondary active transport and these will be discussed further in this section. 
 
1.1.3.1 Passive diffusion 
Typically, small and neutral molecules that are soluble in a hydrophobic 
environment, such as O2, CO2, NH3, HCO2H or glycerol, are able to diffuse 
freely across the phospholipid membrane (Henderson, 2012). This is termed 
passive diffusion, and occurs down the concentration gradients of the 
molecules without the aid of transport proteins. 
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1.1.3.2 Facilitated diffusion 
Facilitated diffusion by transport proteins is required to transport hydrophilic 
and/or larger substrate molecules across the hydrophobic membrane, or for 
rapid responses to changes in the concentration of water or ions. As for 
passive diffusion, this occurs down the concentration gradient of the 
substrate molecules.  
Channels facilitate the diffusion of molecules and ions across the membrane 
by forming pathways through the membrane, with a selectivity filter for the 
substrate molecule. Substrate molecules can approach openings of the 
channel from either side of the membrane but will only flow down their 
concentration gradient (Figure 1.2). Channels can be permanent pores 
through the membrane, as for example aquaporins in the case of water 
molecules (King et al, 2004). Channels may also be regulated, as for 
example the voltage-gated K+-channels, where the pore is opened or closed 
in response to changes in the membrane potential (Sigworth, 1994). 
Similarly to channels, there are also facilitated diffusion transporters (also 
termed uniporters) that also move substrates across the cell membrane 
down their concentration gradients but in a different fashion and at a slower 
rate (Figure 1.2) (Gadsby, 2009).  
 
 
Figure 1.2 Illustration of facilitated diffusion carried out by a channel 
and a transporter. 
(a) A channel forms a pore through the membrane, allowing substrate molecules to 
flow through down their concentration gradients (indicated by the grey triangles) 
when the pore is open. (b) In contrast, a transporter undergoes conformational 
changes instead, transporting one substrate molecule at a time across the 
membrane.  
(a) 
(b) 
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Instead of providing a continuous pathway through the membrane, 
transporters undergo substantial conformational changes which arise from 
binding of the substrate molecules at their binding sites. Transporters 
therefore translocate one substrate molecule per turnover cycle (together 
with co-transported molecules or ions), making the rate of transport slower 
than through channels. 
 
1.1.3.3 Group translocation  
Group translocation, or the phosphotransferase system (PTS), is another 
type of active transport system in bacteria that uses phosphoenolpyruvole 
(PEP), an intermediate in glycolysis and gluconeogenesis, as an energy 
source to transport sugar molecules into the cytoplasm of bacterial cells 
(Figure 1.3). This transport system is a multi-enzyme complex that transfers 
sugars such as glucose, mannose or mannitol to the inside of the cells. This 
is driven by the transfer of a high-energy phosphate group from PEP to 
members of the multi-enzyme complex of the PTS, to finally end up on the 
transported sugar molecule (Bramley & Kornberg, 1987).  
 
1.1.3.4 Primary active transport 
As opposed to facilitated diffusion, primary active transporters use energy to  
transport substrate molecules across cell membranes against their 
concentration gradients. One example of primary active transporters are 
those involved in photosynthesis or respiration. In photosynthesis, proteins 
of the photosynthetic electron transport chain use light as their source of 
energy. The light initiates transport of electrons through the proteins, which 
in turn drives the pumping of protons across the thylakoid membrane of plant 
cells or the cell membrane of photosynthetic bacteria (Figure 1.3) (Raven et 
al, 2005; Bryant & Frigaard, 2006).  
Respiration in aerobic prokaryotes and eukaryotes is driven by redox energy 
in the form of electrons stored in electron donors such as NADH. In these 
cases, proteins of the electron transport chain pump protons across the cell 
membrane of prokaryotes, or across the inner membrane of mitochondria in 
eukaryotes, while electrons obtained from NADH are incorporated into 
electron acceptors such as O2 (Gautheron, 1984).  
Consequently, photosynthesis and respiration creates a proton gradient 
across cell membranes in prokaryotes or inner mitochondrial membranes in 
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eukaryotes. The proton gradient drives ATP synthase to produce ATP, which 
is another primary energy source. ATP-driven primary active transporters, 
such as ATP-dependent synthases (Lodish et al, 2000) or ABC uptake/efflux 
systems (Reyes et al, 2006) couple the energy obtained by hydrolysing ATP 
into ADP and Pi to drive the movement of ions, nutrients or toxins against 
their concentration gradients (Figure 1.3). 
   
 
 
Figure 1.3 Summary of the different bacterial membrane transport 
proteins. 
The yellow oval represents the cytoplasmic membrane of a bacterial cell. Primary 
active transport involves photosynthetic or respiratory proteins (blue oval), which 
use light or electron donors as an energy source to create a proton gradient across 
the membrane. The proton gradient drives the production of ATP by ATP synthase 
(pink), which in turn fuels ATP-driven ABC uptake or efflux systems (purple and red, 
respectively). The proton gradient is also a driving force for some secondary active 
transporters, which co-transport substrates with protons or ions. Secondary active 
transporters can carry out translocation of the proton/ion and the co-transported 
substrate to the same side of the membrane (symporter, green circle) or to opposite 
sides of the membrane (antiporter, red circles). Group translocation is carried out by 
phosphotransferase systems, which utilise the energy released during the transfer 
of phosphate groups to translocate sugar molecules into the cytoplasm (brown 
oval). Facilitated diffusion does not use any energy, and only transports substrates 
down their concentration gradients (grey circle). 
 
1.1.3.5 Secondary active transport 
When performing their action, some primary active transporters generate an 
electrochemical gradient across membranes. For example, the ATP-driven 
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Na+/K+-pumps maintain ion gradients of higher extra- and intracellular 
concentrations of sodium and potassium, respectively (Gadsby et al, 2012). 
Meanwhile, photosynthetic and respiratory chain proteins in the prokaryote 
cell membrane generate a proton gradient by pumping protons across the 
membrane during electron transport (Bryant & Frigaard, 2006). A different 
family of transporters, termed secondary active transporters, utilise the 
energy stored in these electrochemical gradients for co-transport of 
substrates across the membrane (Figure 1.4) (Forrest et al, 2011).  
 
1.2 Secondary active membrane transporter proteins 
1.2.1 Introduction 
Secondary active transporters constitute a very important class of proteins 
found in bacteria, archaea, yeast, fungi, plants and animals. This type of 
transporters utilise the energy stored in membrane proton or ion gradients 
generated by primary active transporters. The energy stored in these 
concentration gradients is used to drive the co-transport of a second 
substrate, such as vitamins, neurotransmitters or metabolites.  
Secondary active transporters are classified into antiporters, symporters and 
uniporters. Anti- and symporters couple the energy obtained by moving ions 
down their concentration gradient to the co-transport of another substrate 
against its concentration gradient, i.e. they translocate two or more 
molecules across the membrane in each transport cycle. Uniporters on the 
other hand transport only one substrate molecule, and are believed to have 
lost their coupling ability through evolution.   
The transport is proposed to occur through a so-called alternating access 
mechanism. The alternating access mechanism was originally suggested in 
the 1960s (Jardetzky, 1966) and has been supported by subsequent 
biochemical and structural studies (Forrest et al, 2011). The transport model 
involves the protein alternating between two main conformational states, 
where the substrate binding site is accessible to the solvent on either the 
extra- or intracellular side of the membrane for release or uptake of 
substrates. The transition between these two states is thought to occur 
through an occluded state, where the substrates are shielded from either 
side of the membrane. Some important superfamilies of secondary active 
transport proteins include the major facilitator superfamily (MFS) and the 
LeuT superfamily, discussed in more detail below.  
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1.2.2 Major facilitator superfamily 
The major facilitator superfamily (MFS) is present in all kingdoms of life and 
includes physiologically very important proteins. Previous crystal structures 
of MFS superfamily members include a broad repertoire of bacterial 
transporters, such as the lactose:H+ symporter LacY (Abramson et al, 2003; 
Guan et al, 2007), the glycerol-3-phosphate:phosphate antiporter GlpT 
(Huang et al, 2003) and the D-xylose:H+ symporter XylE (Sun et al, 2012). 
This superfamily also includes the eukaryotic glucose transporters GLUT1-4, 
which are of great medical significance for humans. Until recently, there 
were no crystal structures available of any eukaryotic GLUT transporter. The 
structure of GLUT1, the dysfunction or overexpression of which leads to 
GLUT1 deficiency syndrome or cancer (Seidner et al, 1998) was recently 
reported (Seidner et al, 1998; Deng et al, 2014).  
 
1.2.3  LeuT superfamily 
An important group of secondary active transporters is the LeuT transporter 
superfamily, also interchangeably termed the 5-helix inverted repeat (5-
HIRT) transporter superfamily (Krishnamurthy et al, 2009; Adelman et al, 
2011).  
The LeuT superfamily includes the nucleobase-cation symporter (NCS-1) 
family, solute-sodium symporter (SSS) family and neurotransmitter-sodium 
symporter (NSS). In addition, it also includes the more distantly related 
betaine/carnitine/choline transporter (BCCT) family and the amino acid-
polyamine-organocation (APC) family (Figure 1.4).  
 
1.2.3.1 Structural fold of LeuT superfamily members 
Rather than being related by sequence identity or common function, the 
members of the LeuT superfamily are related by a common structural fold – 
a 5-helix inverted repeat (Figure 1.5). This fold comprises ten trans-
membrane helices (TMHs), which are arranged as two inverted repeats of 
five TMHs each (helices 1-5 and 6-10, respectively). TMH1 and TMH6 
consist of two half-helices, and the middle-region between them provides the 
site of substrate binding. The two repeats are related to each other by a 180° 
rotation in the putative plane of the membrane.  
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Figure 1.4 The secondary-active transporters belonging to the LeuT 
superfamily. 
The green circles represent members of the NCS-1 family, with the chemical 
structure of their respective substrates drawn in the middle of the yellow oval (which 
represents the cytoplasmic membrane of a bacterial cell). The blue circles 
represent members of other families;  including the APC, BCCT, SSS and NSS 
families (initial figure provided by Peter Henderson). 
 
Crystal structures of proteins belonging to the LeuT superfamily that have 
previously been determined include, for example, the sodium-leucine 
transporter LeuT, a member of the NSS family (Yamashita et al, 2005). LeuT 
is a bacterial homologue of the mammalian sodium-serotonin transporter, 
which has been implicated in depressive disorders (Murphy et al, 2004). 
LeuT has subsequently been a target for rational design of anti-depressant 
compounds (Zhou et al, 2009). Another example is the homologue of the 
mammalian sodium-glucose transporter; vSGLT from V. parahaemolyticus, a 
member of the SSS family (Faham et al, 2008), which has been implicated in 
kidney disorders (Wright et al, 2007). Other examples include the betaine 
transporter BetP, which belongs to the BCCT family (Ressl et al, 2009), and 
the arginine-agmatine antiporter from E. coli, a member of the APC family 
(Fang et al, 2009). The LeuT superfamily also includes the bacterial sodium-
hydantoin transporter Mhp1, a member of the NCS-1 family, which is the 
focus of this Thesis and will be described in more detail further into this 
Chapter.  
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Figure 1.5 Illustration of the overall fold of LeuT superfamily members. 
Illustration of the LeuT fold, with two inverted segments of five TMHs (helices 1-5, 
and 6-10) that are related to each other by a 180° rotation in the plane of the 
membrane. TMH1 and TMH6 (grey) consist of two half-helices, between which 
substrate binding occurs. The figure is adapted from Shi et al. 2013. 
 
Overall, the LeuT superfamily includes proteins that play an important role in 
health and disease in humans, but there is as yet no crystal structure 
available of any of the eukaryotic members of this superfamily. The already 
available crystal structures of the bacterial transporters have been 
determined in various intermediate states along the proposed common 
alternating access transport mechanism. The conformations observed are 
consistent with the conformational states discussed in 1.2.1 (outward-open, 
occluded and inward-open) and have helped to further understand the 
molecular basis behind the alternating access mechanism in secondary 
active transport proteins (Forrest et al, 2011; Krishnamurthy et al, 2009; Shi, 
2013). LeuT has been crystallised in an occluded form with leucine bound 
(Yamashita et al, 2005), and has also been trapped in the outward-open and 
inward-open substrate-free forms in complex with Fab fragment 
(Krishnamurthy & Gouaux, 2012). vSGLT has been crystallised in an inward-
open conformation, with and without galactose bound (Faham et al, 2008; 
Watanabe et al, 2011). More recently, crystal strctures of BetP in an 
outward-open state both in the presence and absence of betaine (Perez et 
al, 2013), as well as the inward-open form have been obtained (Koshy et al, 
2013). Mhp1, which is the focus of this Thesis, was the first protein for which 
crystal structures were obtained in all three conformational states (Weyand 
et al, 2008; Shimamura et al, 2010) and these will be described in more 
detail in 1.3.2.  
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1.2.4 The nucleobase-cation-symporter 1 family 
The secondary-active symporter Mhp1 from Microbacterium liquefaciens. 
Mhp1 belongs to the NCS-1 family, which includes approximately 1000 
proteins found in bacteria, archaea, fungi and plants. The members of the 
NSC-1 family and their respective substrates are outlined in Figure 1.4, and 
carry out the following general symport mechanism across the membrane: 
 
Nucleobase/vitamin (out) + cation (out) → Nucleobase/vitamin (in) + cation (in) 
 
Essentially, the role of NCS-1 transporters is the uptake of organic 
molecules such as allantoin, hydantoin compounds, cytosine, uracil or 
thiamine (see Figure 1.4) into the cytoplasm of the cells. The organic 
substrates are transported by NCS-1 members to the cytoplasm together 
with either sodium ions or protons (Weyand et al, 2006). The transported 
compounds then act as precursors in nucleotide or amino acid salvage 
pathways, where, for example, nucleotides are used as precursors in the 
synthesis of DNA, RNA, ATP, GTP and NAD+ inside the cells, and may also 
act as nitrogen sources in bacteria and fungi (de Koning & Diallinas, 2000).  
1.3 The bacterial sodium-hydantoin transporter Mhp1 
1.3.1 Introduction 
The bacterial symporter Mhp1 from Microbacterium liquefaciens couples the 
transport of sodium ions down their concentration gradients with the symport 
of 5-substituted hydantoin compounds to the cytoplasm of bacterial cells. 
Inside the cells, the hydantoin compounds are hydrolysed and converted into 
optically pure amino acids (Figure 1.6) (Suzuki & Henderson, 2006).  
Mhp1 was originally discovered as part of the so-called hyu gene cluster, 
which also includes enzymes that participate in the production of optically 
pure amino acids (Suzuki & Henderson, 2006). Optically pure amino acids 
are of great interest in industrial applications, where they are used as 
precursors for the production of, for example, antibiotics, pesticides, 
pharmaceuticals and food additives (Suzuki & Henderson, 2006; Clemente-
Jiménez et al, 2008), which is what initially generated interest in studying the 
hyu gene cluster, containing the Mhp1 protein. 
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Figure 1.6 Conversion of hydantoin compounds to optically pure amino 
acids by the gene cluster containing the Mhp1 gene. 
Mhp1 transports hydantoin compounds into the cytoplasm of bacterial cells, where 
the they are broken down into L-amino acids by other members of the hyu gene 
cluster. Figure adapted from Suzuki and Henderson, 2006. 
 
1.3.2  Previously published crystal structures of the Mhp1 protein  
Mhp1 was the first transporter of the LeuT superfamily for which crystal 
structures were obtained in all the three key states of the proposed 
alternating access mechanism (Weyand et al, 2008; Shimamura et al, 2010; 
Diallinas, 2008). The overall fold is comprised by twelve TMHs, as for other 
LeuT superfamily members. The ligand- and sodium-binding sites are 
nested between two sets of four helices, which are termed the bundle- 
(TMH1, 2, 6 and 7) and hash-motifs (TMH3, 4, 8 and 9). These  two motifs 
are flanked by two mobile helices, TMH5 and TMH10, which undergo 
conformational changes during the transport mechanism (Figure 1.7) 
(Diallinas, 2008; Weyand et al, 2011).   
The outward-open state (numbered III in Figure 1.7) has an intact sodium 
binding site, where a sodium atom can be modelled, and the ligand binding 
site is open to the periplasmic side of the protein, ready to accept hydantoin 
compounds. The occluded state (numbered V in Figure 1.7) also has an 
intact sodium binding site where a sodium atom can be modelled, and L-
benzylhydantoin (L-BH) bound in the ligand binding site.  
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Figure 1.7 The transport mechanism in Mhp1. 
The proposed reaction cycle of Mhp1 (original figure provided by Peter Henderson) 
is illustrated as a simplified cartoon (a). The intermediate states for which crystal 
structures have been obtained are highlighted. In accordance with the alternating 
access model, the protein alternates between an outward-open state (II), where it 
accepts sodium and hydantoin compounds from the extracellular side of the 
membrane (III-IV) and an inward-open state (IX), which is adopted after substrates 
have been released into the inside of the cell (VII-VIII). The transition between 
these two states is thought to go through an occluded state (V-VI), where the bound 
substrates are shielded from both sides of the membrane but with either the 
outward (V) or inward gate (VI) remaining partially open. The three previously 
published crystal structures of Mhp1 in key conformational states (outward-open, III; 
occluded, V; and inward-open, IX) are illustrated with the key α-helices that undergo 
conformational changes highlighted (b). Upon ligand binding during the transition 
between the outward-open to occluded states, TMH10 shifts to close the ligand 
binding site as a lid (arrow 1). Upon the subsequent transition to the inward-open 
state, the hash-motif undergoes a rotation with respect to the bundle-motif (arrows 
2a-b), as well as an opening of the ligand binding cleft by a shift of TMH5 (arrow 3). 
The colour scheme is the same for both panels, representing the bundle- and hash-
motifs (red and yellow, respectively), as well as the flexible TMH5 and TMH10 
(blue). 
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The outward-open (III) and occluded (V) states differ in that in the occluded 
state, TMH10 shifts by approximately 7.5 Å to close up on the entry route to 
the ligand binding site like a lid, shielding the bound ligand from the outside 
of the protein. 
The last key conformational state for which a crystal structure of Mhp1 has 
been obtained is the inward-open state (numbered IX in Figure 1.7). In the 
crystal structure of the inward-open state, no ligands are bound, the sodium 
binding site is no longer intact and the ligand binding site is open to the 
cytoplasmic side of the protein. Going from the occluded form (V) to the 
inward-open form (IX), the hash-motif undergoes an approximately 30° 
rotation with respect to the bundle-motif, as well as a shift of TMH5, opening 
the ligand binding cleft to the intracellular side of the protein. 
The availability of this structural information makes Mhp1 an ideal model 
system for further structural studies to investigate what occurs in the 
transitions between the key states and confirm their sequence. 
A sodium ion can be modelled into the intact sodium-binding site in both the 
structure of Mhp1 in an outward-open (III), as well as in that of the occluded 
state (V) with L-BH bound. The synergistic binding of the sodium and L-BH 
has been demonstrated using a tryptophan fluorescence quenching assay 
(Figure 1.8a) (Weyand et al, 2008). 
 
 
 
Figure 1.8 Sodium-dependent binding in Mhp1 and the ligand-binding 
site in the inward-open form of Mhp1. 
(a) Tryptophan fluorescence quenching data shows that the affinity for L-BH in 
Mhp1 increases with added NaCl. (b) Image of the electron density at 3.8 Å in the 
sodium binding site (2Fobs-Fcalc, coloured blue and contoured at 1σ) in the inward-
open form, with the additional density (Fobs-Fcalc, coloured red contoured at 6σ) 
which has not yet been identified. Figure adapted from Shimamura et al. (2010). 
(a) (b) 
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In contrast, the sodium binding site is not intact in the crystal structure of the 
inward open form, which was determined from crystals of seleno-L-
methionine derivatised Mhp1 (Shimamura et al, 2010). In this crystal 
structure, TM helices 1 and 8 have moved apart, separating the residues 
that bind the sodium ion and thus disrupting its binding site. Molecular 
dynamics simulations have been carried out to investigate whether the 
inward-open form does indeed perturb the sodium binding site or if it is still 
capable of binding sodium in this conformational state. Simulations of the 
three states in a native-like membrane showed that sodium escapes very 
quickly (<2ns) from its binding site in the inward-open form while it remains 
bound in the outward-open and occluded forms (Shimamura et al, 2010). 
However, the ligand binding site in the crystal structure of Mhp1 in the 
inward-open form was found to be occupied by a portion of positive 
difference electron density, indicating that something is bound and it may be 
that this potentially stabilises the protein in the inward-open state (Figure 
1.8b). However, the electron density is not consistent with any components 
of the crystallisation mixture and this putative ligand has not yet been 
identified.  
 
1.3.3 Insights into the ligand-binding step of Mhp1 
Apart from the crystal structures of Mhp1 in the three key conformational 
states discussed in 1.3.2, a number of additional Mhp1-ligand complex 
structures have been published in a recent study, giving further insights into 
substrate recognition and ligand binding in the protein (Simmons et al, 
2014). The additional Mhp1-ligand complex structures include the protein 
with L-indolylmethylhydantoin (L-IMH), bromovinylhydantoin (BVH) and L-
naphthylmethylhydantoin (L-NMH) bound. In addition, a revised structure of 
Mhp1 in complex with L-BH was also published, revealing a new binding 
mode of L-BH. In the previous structure of the Mhp1 protein, in an occluded 
state at 4 Å resolution in complex with L-BH (1.3.2, Weyand et al. 2008), the 
L-BH was modelled in the same conformation as the ligand adopts in 
solution (Delgado et al, 2007). In the new, improved structure of the same 
ligand complex at resolution 3.8 Å, the L-BH was modelled in a more 
extended configuration, which was derived from the structure of Mhp1 in 
complex with L-IMH. The structure of Mhp1 in complex with BVH helped to 
confirm the orientation and binding mode of the hydantoin ligands, as the 
bromine scatters anomalously and could be clearly seen in an anomalous 
map. In the crystal structure of Mhp1 in complex with the Mhp1 inhibitor L-
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NMH, the protein also adopted an occluded conformation but differed from 
the other protein-ligand structures in that TMH10 adopted a conformation 
similar to that in the structure of Mhp1 in its outward-open conformation. It 
appears as if L-NMH prevents TMH10 from closing up around the ligand 
binding site. This suggests that the occlusion of TMH10 is required for the 
protein to turn over the transport of the ligand.  
1.4 Challenges in structural studies of membrane transport 
proteins  
1.4.1 Introduction  
Membrane proteins constitute up to 30% of human genes (Wallin & Heijne, 
1998) and are targeted by more than 50% of commercially available drugs 
(Arinaminpathy et al, 2009; Terstappen & Reggiani, 2001). Membrane 
proteins are subsequently high-priority targets for structural studies. Yet, 
they constitute only 1.9%1 of the structures published in the Protein Data 
Bank (PDB). This stems from the fact that a great portion of the surface area 
of membrane proteins is hydrophobic, as they are embedded in a 
hydrophobic lipid bilayer in the cell. This makes membrane proteins very 
challenging targets to study, as most biochemical and structural assays are 
carried out in an aqueous solution. This requires the presence of, for 
example, detergents in order to solubilise and maintain the fold and function 
of membrane proteins in solution. The work presented in this Thesis was 
carried out on the Mhp1 protein solubilised in detergents. The presence of 
the detergents presented challenges in the experiments carried out, which 
will be discussed in subsequent Chapters. This section will give an 
introduction to the complications and hurdles in structural studies of 
membrane proteins. 
 
1.4.2 Expression of membrane proteins 
The primary problem when working with membrane proteins is to obtain 
sufficient qualities of the protein of interest. Membrane proteins often exist at 
very low levels in their native hosts and therefore strategies for heterologous 
                                            
1 1768 coordinate files of membrane proteins are reported by the Membrane 
Protein Structures Database (http://blanco.biomol.uci.edu/mpstruc/, updated 15th 
September 2015), out of 93594 protein crystal structures in the PDB (19th 
September 2015). 
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expression are required in order to produce sufficient quantities of protein for 
biochemical and structural studies. However, heterologous expression of 
membrane proteins in for example E. coli often causes aggregation of the 
protein in the expression host cytoplasm. In some cases, the expression 
host also lacks the machinery for post-translational modifications required to 
produce the membrane protein of interest in a fully functional state (Drew et 
al, 2003; Wagner et al, 2006).  
 
1.4.3 Solubilisation of membrane proteins 
When sufficient over-expression of the membrane protein of interest has 
been achieved, another major problem arises, which is the requirement of a 
method to extract and contain the intact, folded hydrophobic membrane 
proteins in all steps throughout the purification process and in subsequent 
biochemical and structural studies. There are several strategies for the 
solubilisation of membrane proteins out of their native hydrophobic bilayer, 
and finding the optimal strategy for the protein of interest may require 
extensive trial-and-error screening and optimisation. The development of 
high-throughput screens for the solubility of membrane proteins has made 
this step more efficient (Gutmann et al, 2007; Eshaghi et al, 2005). 
The main strategy of solubilising membrane proteins out of their native lipid 
bilayer is the use of detergents (Seddon et al, 2004; Privé, 2007). 
Detergents are amphiphatic molecules, which means that they have both a 
hydrophilic (a polar head-group) and a hydrophobic part (hydrophobic alkyl 
chain). Every detergent exhibits an individual critical micelle concentration 
(CMC), which depends on structural properties such as the alkyl chain 
length and charge of the head-group. The CMC may in turn also vary with 
pH, ionic strength and temperature of the solution. Below the CMC, the 
detergent molecules exist as monomers. When the concentration is at the 
CMC or above the detergent monomers spontaneously aggregate into 
micelles through the entropy-driven hydrophobic effect (Tanford, 1973). 
Membrane proteins can be extracted from their native membrane 
environment by mixing membrane fragments with a detergent solution where 
the detergent concentration is above its CMC. This results in the formation of 
protein-detergent complexes (PDCs), driven by the hydrophobic effect, as 
well as free micelles and detergent monomers, which is illustrated in Figure 
1.9 (Duquesne & Sturgis, 2010). 
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Figure 1.9 Solubilisation of membrane proteins using detergents. 
Membrane proteins (MP) can be extracted from the lipid bilayer by mixing with 
detergents. Above the CMC of the detergent, protein-detergent complexes (PDCs) 
will form, as well as protein-free detergent micelles. 
 
1.4.4 X-ray crystallographic studies of membrane proteins 
Obtaining a crystal structure using X-ray crystallography may be seen as the 
ultimate experiment in the study of protein structure, as the technique carries 
the potential of yielding structural information at near-atomic resolution. The 
main bottleneck still remains the step of obtaining well-diffracting crystals.  
This process has been accelerated with the development and availability of 
high-throughput screens and screening robots, but there is, as yet, no 
rational method for predicting protein crystallisation conditions. As described 
in section 1.4.3, the hydrophobic nature of membrane proteins requires the 
presence of a solubilising agent, such as detergents. This presents 
additional challenges in the crystallisation of membrane proteins. 
The basic principle of protein crystallisation is to take a protein solution to a 
supersaturated state, where the protein molecules are at a concentration 
that exceeds their solubility limit, while still remaining in solution. The 
supersaturation region in protein crystallisation is divided into three regions; 
the metastable zone, the nucleation zone and the precipitation zone (Figure 
1.10). In a successful crystallisation experiment, the concentrations of 
protein and a precipitating agent are altered to bring the protein into the 
PDC 
Lipid bilayer MP 
Detergent 
micelle 
Detergent 
monomer 
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nucleation zone, where crystal nuclei form that then allow the formation of 
protein crystals (Manuel García-Ruiz, 2003). Precipitating agents, such as 
salts, polymers or organic solvents affect chemical and physical properties of 
the protein and/or solvent, so as to facilitate protein association and 
crystallisation (McPherson, 2011). 
This is achieved by, for example, the vapour-diffusion technique (Sutton & 
Sohi, 1994), dialysis (Fromme, 2003) or micro-batch methods (Loll et al, 
2003; Chayen, 2003). Another technique for protein crystallisation is the use 
of counter-diffusion, which will be further described in section 4.4.1. 
The vapour-diffusion technique involves mixing a droplet of protein with a 
reservoir solution containing precipitating agents. The droplet is suspended 
over the reservoir solution (e.g. in a sitting- or hanging-drop configuration) 
and allowed to equilibrate in a sealed chamber. Since the droplet will contain 
a lower concentration of precipitants than the reservoir solution, net vapour-
diffusion will occur from the droplet to the reservoir until equal vapour-
pressures are obtained. The droplet will therefore slowly 'dry out', leading to 
supersaturation of the protein solution, and bringing the protein into the 
nucleation zone where crystal growth is initiated (Figure 1.10).  
The dialysis method involves dialysing the protein solution against a solution 
containing the precipitant solution. The protein concentration remains the 
same in the dialysis vessel, while the precipitant concentration increases 
through diffusion through the dialysis membrane to mix with the protein 
solution (Figure 1.10). An advantage of this technique is that the 
crystallisation conditions can be continuously varied, but a drawback is that it 
is difficult to assess the outcome of the crystallisation trial. 
A micro-batch experiment involves mixing the protein solution with a 
precipitant solution, at their final concentration, to directly form a 
supersaturated solution (Figure 1.10). Droplets are covered with paraffin oil 
to prevent evaporation. An advantage of the micro-batch method is that a 
wide range of droplet volumes can be used, and it is a relatively simple set-
up to perform, even for initial screening for crystallisation conditions.  
The starting point of the crystallisation process in the phase diagram is tuned 
by changing the protein and precipitant concentrations. Factors affecting the 
equilibration rate and outcome of crystallisation trials are droplet-to-reservoir 
distance, droplet:reservoir volume ratios, temperature and choice of 
precipitating agents (Forsythe et al, 2002). 
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Figure 1.10 The phase diagram in a crystallisation experiment. 
The phase diagram for a protein solution is illustrated. The metastable, nucleation 
and precipitation zones are illustrated in relation to the concentrations of protein 
(vertical axis) and the precipitant (horizontal axis). The blue arrow shows the path of 
a protein solution during crystallisation by dialysis, where the protein concentration 
remains constant in the dialysis vessel (A) while the precipitant concentration 
increases until the protein reaches the nucleation zone (B) from which crystals grow 
until the protein solution reaches its solubility limit (C). The red arrows show the 
path of the protein solution during a vapour-diffusion experiment, where the protein 
and precipitant concentrations (D) are both concentrated through dehydration of the 
crystallisation droplet, bringing the protein into the nucleation zone (E) where 
crystals form and grow (F). The green arrow shows the path of a protein solution in 
a (micro-)batch experiment, where the protein solution is mixed with a precipitant 
solution, producing a supersaturated solution (G), from which crystal growth occurs 
(H).  
 
All these methods can be used with detergent-solubilised membrane 
proteins, and are in these cases termed as in surfo methods. Through in 
surfo methods, “type II” membrane protein crystals are formed from the 
detergent-solubilised protein molecules, where the crystal contacts are made 
by extracellular, polar regions of the proteins, as illustrated in Figure 1.11b 
(Michel, 1991). The disadvantage of this type of crystal is that they possess 
a high solvent-content which is likely to give rise to fragile crystals that 
diffract to a low resolution and are highly sensitive to radiation damage 
(Carpenter et al, 2008). Additionally, crystal formation may be unsuccessful 
if the polar regions are too small and/or the detergent that works best to 
solubilise the protein does not allow for the molecules to come close enough 
to each other to form crystals.  
More recently, new crystallisation methods for membrane proteins have 
been developed that involve the reconstitution of detergent-solubilised 
proteins into a lipidic environment, mimicking their native environment. This 
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includes, for example, the lipidic cubic phase (LCP) and lipidic sponge phase 
(LSP) crystallisation techniques (Landau & Rosenbusch, 1996; Wöhri et al, 
2008). In these techniques, a lipid bilayer matrix is created, into which 
membrane protein molecules are reconstituted (Caffrey & Cherezov, 2009). 
Upon the addition of precipitating agents, a phase change of the cubic phase 
into a lamellar phase is induced, which promotes the association of protein 
molecules and the formation of protein crystals. A drawback of the LCP 
method is that the  phase is very stiff, making handling of it difficult and time-
consuming. 
The principle of the LSP crystallisation method is the same as for the LCP 
technique, where the protein is reconstituted into a lipdic bilayer matrix. 
Upon the addition of agents that destabilise the LCP, for example 
polyethylene glycol (PEG), propylene glycol (PG), dimethyl sulfoxide 
(DMSO), or jeffamine (Wadsten et al, 2006), the LCP “melts” to form a more 
fluid cubic phase. This creates more room for the LSP to accommodate 
extracellular domains, and the more liquid nature of the lipidic phase makes 
the crystallisation experiment much easier, with the phase being adaptable 
to use in crystallisation robots and in conventional vapour-diffusion set-ups. 
Other alternative crystallisation techniques also include using detergent-lipid 
mixtures. This is employed in, for example the bicelle method (Faham & 
Bowie, 2002) or HiLiDe (High Lipid Detergent concentration) methods 
(Gourdon et al, 2011). 
 
 
 
Figure 1.11 “Type I and II” membrane protein crystals. 
Type I membrane protein crystals (a) are comprised of 2D layers of the membrane 
proteins, which rely on hydrophobic contacts between the protein molecules. On the 
contrary, type II membrane protein crystals (b) are stabilised by polar contacts 
between the extracellular portions of the proteins. Membrane proteins are illustrated 
in grey and detergent monomers are illustrated in blue.  
(a) (b) 
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In the case of lipidic phase based crystallisation methods, “type I” membrane 
protein crystals are formed, where the protein molecules are arranged into 
2D layers and rely on hydrophobic contacts between the proteins to stabilise 
the lattice, as shown in Figure 1.11a (Michel, 1991). This results in a greater 
area of the protein molecules stabilising the crystal lattice, but a drawback of 
these techniques, compared to in surfo methods, is that it can be difficult to 
work with lipidic mixtures.  
 
1.4.5 X-ray scattering studies of membrane proteins 
The crystallisation step is a great bottleneck in structural studies of 
(membrane) proteins, and the resulting crystals can also suffer from crystal 
packing effects. Therefore, it is often required to use complementary 
techniques in order to obtain structural information about the protein of 
interest. Small-angle X-ray scattering (SAXS) has emerged as a 
complementary technique in structural biology (Svergun & Koch, 2003; 
Putnam et al, 2007; Pérez & Nishino, 2012). From SAXS data of 
macromolecules in solution, the size and shape of the macromoelcules can 
be determined. Apart from giving basic information about the 
macromolecule, such as the radius of gyration (Rg) or maximum particle 
dimension (Dmax), the SAXS data can also give insights into the ternary and 
quaternary structure through distance distribution functions and the 
generation of low-resolution ab initio models.  
An essential step in SAXS studies is buffer subtraction, as the buffer 
components may contribute to the SAXS signal. As for crystallographic 
studies, the presence of detergents poses problems in SAXS studies, 
especially in the buffer subtraction step. When studying detergent solubilised 
proteins, a detergent concentration is required above its CMC, in order to 
maintain the integrity of the PDCs. This gives rise to the formation of free 
detergent micelles in the solution, which results in strong and characteristic 
scattering patterns (Lipfert et al, 2007; Oliver et al, 2013), as illustrated in 
Figure 1.9. This makes detergent subtraction especially crucial in the study 
of detergent-solubilised membrane proteins using SAXS. However, accurate 
buffer subtraction is difficult to achieve as the concentrations of free micelles 
in the sample and the buffer are difficult to match as the detergents give rise 
to a complicated equilibrium in the presence and absence of membrane 
proteins (Laughlin, 1996).  
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SAXS studies on membrane proteins have been previously performed, 
where the contribution of the SAXS signal can be minimised by choosing 
detergents that do not contribute too much to the scattering signal or by 
subjecting the sample to extensive dialysis (Zimmer et al, 2006). In addition, 
standard ab initio modelling approaches are not applicable on PDCs, as 
these assume a uniform electron density throughout the molecules being 
modelled (Grossmann, 2007). In order to overcome the problem of 
inaccurate buffer subtraction, and make SAXS an universal technique that 
can be applied to any membrane protein system, size-exclusion coupled 
SAXS (SEC-SAXS) was recently proposed as a method to achieve accurate 
buffer subtraction (Berthaud et al, 2012a). In addition, a new modelling 
approach was also presented and applied to initial SEC-SAXS data, allowing 
for the modelling of the detergent corona surrounding a protein (Perez & 
Koutsioubas, 2015).  
 
1.5 Aims and objectives of this Thesis 
As discussed in sections 1.2.3.1 and 1.3.2, a wide range of crystal structures 
of various members of the LeuT superfamily are currently available. These 
have been crystallised in various conformational states along the alternating 
access transport model, giving ample insight into how this important class of 
proteins work. The alternating access transport model for secondary-
transport proteins is now widely accepted in the field, but it has been derived 
from crystal structures of the transport proteins in static states. In addition, 
the range of conformational states observed is limited to a few key states 
and these are most likely to be low-energy conformations of the protein 
along the transport mechanism (Shi, 2013). This has resulted in only limited 
insight into the transitions and dynamics between the low-energy states. 
Therefore, it is still of great interest to investigate the conformational 
landscape of secondary active transport proteins and to attempt to obtain 
crystal structures of the proteins in conformational states not previously 
seen. In addition, there are no crystal structures of any eukaryotic members 
of LeuT superfamily. Additional crystal structures of bacterial LeuT 
superfamily members will provide further insights and serve as homology 
models for related proteins in humans, as well as in plants and fungi. For 
example, Mhp1 was recently used to build a homology model of a plant 
NCS-1 family member (Witz et al, 2014), and using Mhp1 or related proteins 
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as models for fungal homologues could be used in the development of 
antifungals (Pantazopoulou & Diallinas, 2007).  
 
Based on this current state of the field of structural studies of secondary 
active transport proteins, the objectives of this Thesis are two-fold. Firstly, 
the main objective is to obtain more structural information about the Mhp1 
protein in order to gain more insights into the transport mechanism. This will 
be achieved by investigating a range of mutants of Mhp1, which have 
previously been shown to have altered ligand binding and transport 
behaviour (Jackson, 2012). In addition, since the previously published 
structure of Mhp1 in an inward-open state contained an unidentified ligand, 
the reproduction of this structure was also attempted in order to better 
understand this conformational state. This requires the preparation of the 
various mutants and variants to be studied, which is described in Chapter 3. 
Crystal structures of these mutants were determined in order to obtain a 
structural basis for the altered kinetic behaviour, and potentially catch 
additional alternative conformational states that give rise to the altered 
kinetic behaviour. The resulting crystal structures are presented in Chapter 
5. 
The second main objective of this Thesis is to overcome the challenges 
associated with structural studies of membrane proteins and further optimise 
the results in order to be able to obtain structural information beyond what is 
already known about Mhp1, as well as extending the knowledge of how to 
universally apply structural methods on membrane proteins. This was 
achieved by exploring various avenues for studying the structure of 
membrane proteins. Initially, various techniques to improve membrane 
protein crystals and the resulting diffraction data were investigated, which 
was required in order to obtain crystal structures of Mhp1 mutants. The 
crystallisation trials and the subsequent optimisation of these is described in 
Chapter 4. 
The applicability of SAXS was also investigated as an alternative, 
complementary technique to study the structure of the Mhp1 protein (Figure 
1.12). The problem of the presence of detergents was addressed, exploring 
the potential of using SAXS as an alternative structural technique on 
membrane proteins in order to obtain structural information where the X-ray 
crystallographic information is limited. The advantage of SAXS is that it is 
carried out on solution samples, meaning that the protein is not constricted 
by a crystal lattice. This is potentially very useful in the study of secondary 
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active transport proteins, as all previously published structures have all been 
obtained in the same conformational states, suggesting that only a few 
conformational states are crystallisable. 
 
 
Figure 1.12 The complementarity between X-ray crystallography and 
small-angle X-ray scattering in studies of membrane transport 
proteins. 
The figure illustrates how (1) X-ray crystallography and (2) small-angle X-ray 
scattering (SAXS) may complement each other to obtain a full picture of the 
transport mechanism. The two techniques cover a wide resolution range and give 
rise to different types of structural information, with X-ray crystallography yielding 
high-resolution crystal structures while SAXS yields low-resolution molecular 
envelopes. The three structural models at various time points t represent the Mhp1 
in its various conformational states: outward-open form (green), the occluded form 
(pink), inward-open form (yellow). In cases where a certain conformational state or 
transition cannot be obtained due to crystal packing effects, molecular envelopes 
obtained from SAXS data collected on the protein in solution could fill in the gap. 
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Chapter 2: Materials and methods 
2.1 Source of materials 
2.1.1 Protein purification 
Tris base, imidazole, NaCl, glycerol, (Sigma-Aldrich, UK); dithiothreitol (DTT) 
(Fluka Biochemika); Ni2+-NTA resin (Qiagen); Vivaspin 20 and Vivaspin 6 
MWCO 100,000 (Sartorius AG); Econo-Pac® 10DG desalting column, 
Econo-Column® 2.5x10 cm glass column (Bio-Rad Laboratories, Inc.); n-
dodecyl-β-D-maltopyranoside (DDM), n-undecyl-β-D-maltopyranoside (UM), 
n-decyl-β-D-maltopyranoside (DM), n-nonyl-β-D-maltopyranoside (NM), all 
Anagrade (Anatrace). 
 
2.1.2 SDS-PAGE and Western blotting 
Bis-acrylamide (2%), acrylamide (40%) (Bio-Rad Laboratories, Inc.); glacial 
acetic acid, methanol (Fisher Scientific, UK); ammonium persulphate, 
Brilliant Blue R 250, Bromophenol blue, glycine, β-mercaptoethanol, 
TEMED, Tris base, Tween-20, bovine serum albumin (BSA), sodium dodecyl 
sulphate (SDS) (Sigma-Aldrich, UK.); Immobilon-P polyvinylidene fluoride 
transfer membrane (Millipore); HisProbe™-HRP and SuperSignal West 
HisProbe™ kit (Fisher Thermo Scientific). SDS7 and SigmaMarker™ 
molecular weight markers (Sigma-Aldrich); Amersham ECL High-range 
Rainbow Molecular Weight Marker (GE Healthcare). 
 
2.1.3 Protein concentration assay 
BSA, NaOH, naphthol blue black, SDS, trichloroacetate (TCA), 
ethylenediaminetetraacetic acid (EDTA), Tris base (Sigma-Aldrich, UK); 
ethanol, methanol, glacial acetic acid (Fisher Scientific Ltd., UK), MF-
Millipore Membrane Filter, 0.22 µm pore size, 25 mm diameter (Merck 
Millipore). 
 
2.1.4  Ligands used in the experiments 
5-Benzyl-L-hydantoin (L-BH), 5-indolylmethyl-5-hydantoin (L-IMH), 5-(2-
naphthylmethyl)-L-hydantoin (L-NMH) and 5-bromovinylhydantoin (BVH)  
were synthesised and provided by Dr Simon Patching or Dr Katie Simmons, 
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University of Leeds (Simmons et al, 2014). The structures of the ligands are 
shown in Table 2.1. 
Table 2.1 Chemical structures of the ligands used in this Thesis. 
The chemical structures of the ligands outlined in section 2.1.4, used for co-
crystallisation trials in this Thesis. The hydantoin moiety of each ligand is displayed 
in black, while the aryl-substituents are displayed in green. 
 
Compound name Abbr. Structure 
5-Benzyl- 
L-hydantoin 
L-BH 
 
5-Indolylmethyl- 
L-hydantoin 
L-IMH 
 
5-(2-Naphthylmethyl)- 
L-hydantoin 
L-NMH 
 
5-Bromovinyl-
hydantoin 
BVH 
 
 
 
2.1.5  Tryptophan fluorescence spectrophotofluorimetry assay 
Choline chloride, dimethyl sulfoxide (DMSO), NaCl, Tris base (Sigma-
Aldrich, UK); KCl, K2HPO4, KH2PO4 (Fisher Scientific Ltd., UK); DDM, UM, 
DM, NM (Anatrace), DTT (Fluka Biochemika).  
 
2.1.6  Size-exclusion chromatography for small-angle X-ray 
scattering studies 
Superdex™ 200 Increase 3.2/300 column (GE Healthcare), Bio SEC-3 
column (Agilent); MF-Millipore Membrane Filter. 
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2.1.7  Crystallisation 
24-well trays (Greiner Bio-One); 18x18 mm glass coverslips (SLS); Mounted 
CryoLoops™ (Hampton Research); MicroMeshes™, MicroLoops E™, In 
Situ-1™ and CrystalDirect™ crystallisation plates (MiTeGen); polyethylene 
glycol 300 (PEG300), Tris base, NaCl (Sigma-Aldrich, UK); Na2HPO4, 
NaH2PO4, KCl, K2HPO4, KH2PO4 (Fisher Scientific Ltd., UK); DDM, UM, DM, 
NM (Anatrace), DTT (Fluka Biochemika), 0.22 µm Millex ® syringe filter unit, 
33 mm diameter (Merck Millipore). 
2.2 Purification and characterisation of Mhp1 
2.2.1 Purification 
30 or 100 litre fermentations of BL21 (DE3) E. coli cells (Novagen™) 
expressing native or mutant His6-tagged Mhp1 were performed by Mr David 
Sharples. Cell stocks with mutant Mhp1 were previously prepared by Dr 
Scott Jackson (Jackson, 2012) and the mutants used here are outlined in 
Table 2.2. Preparations of inner membranes from the fermentations were 
performed by Mr David Sharples, as previously described (Jackson, 2012) 
and stored at -80 °C. Frozen aliquots of inner membrane preparations were 
thawed and resuspended in solubilisation buffer (20 mM Tris-HCl pH 8.0, 20 
mM imidazole pH 8.0, 300 mM NaCl, 20% v/v glycerol, 1% w/v DDM) to a 
total protein concentration of 1-3 mg/ml. The total protein concentration was 
determined as described in section 2.2.2 on 1:30 dilutions of the inner 
membrane preparations. 1:30 preparations were prepared by, firstly, making 
a 1:1 dilution of the inner membranes to improve sample viscosity followed 
by dilution to a 1:30 ratio. The solubilisation suspension was incubated for 4 
h with stirring at 4 °C. The soluble fraction containing solubilised protein was 
separated from the membranes by centrifugation at 100,000 g (41,000 rpm) 
for 1 h using a Ti-45 rotor (Beckman) in an Avanti Optima L-80 
ultracentrifuge (Beckman). The supernatant was incubated with Ni2+-NTA 
resin, which was pre-equilibrated with wash buffer 1 (10 mM Tris-HCl pH 8, 
20 mM imidazole pH 8, 2.5% v/v glycerol, 0.05% w/v DDM), for 16 h at 4 °C 
with stirring. The Ni2+-NTA resin was washed with 2 column volumes (CV) of 
wash buffer 1 in a Econo-Column® glass column. The His6-tagged Mhp1 
bound to the resin was eluted by applying elution buffer (10 mM Tris-HCl pH 
8, 200 mM imidazole pH 8, 2.5% v/v glycerol, 0.05% w/v DDM). The eluted 
protein was concentrated using a Vivaspin 20 MWCO 100,000 spin 
concentrator at 3000 g, to a volume of approximately 3 ml. The concentrated 
protein solution was applied onto an Econo-pac® 10DG desalting column, 
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which was pre-equilibrated with storage buffer (10 mM Tris-HCl pH 7.6, 
2.5% v/v glycerol, 0.05% w/v DDM). After applying 4 ml of storage buffer 
onto the desalting column, the applied protein fraction was eluted, collected 
and concentrated to a final concentration of 10-20 mg/ml before storage in 
10-20 µl aliquots at -80 °C after flash-freezing in liquid nitrogen. Growth of 
SeMet-derivatised Mhp1 in flasks in minimal media supplemented with 50 
mg/ml seleno-L-methionine, as well as subsequent inner membrane 
preparations were performed and provided by Mr David Sharples. 
 
Table 2.2 List of mutants successfully purified and characterised for 
this project. 
Mutant Site of the mutation  
Gln42Asn Ligand 
Gln121Asn Ligand 
Asn318Gly Ligand 
Ser312Ala Sodium 
Lys110Leu Bundle/hash 
 
SeMet-Mhp1 was purified as native Mhp1, but with all buffers supplemented 
with 10 mM DTT. For crystallisation trials and small-angle X-ray scattering 
(SAXS) studies, an additional wash step was added to the Ni2+-NTA column 
step in order to exchange the detergent. The wash step with wash buffer 1 
was followed by an additional wash of 2 CV with wash buffer 2, containing 
the detergent of interest. The bound protein sample was then eluted with 
elution buffer and exchanged into storage buffer as described above, but 
containing the detergent of interest. Table 2.3 outlines the various 
detergents used and the respective final concentrations (%, w/v) in each 
buffer. The concentrations of the detergents in relation to their CMC were 
the same in each buffer, namely 2.5 CMC for wash buffer 2 and the elution 
buffer and 1.8 CMC for the storage buffer.  
 
2.2.2 Protein concentration assay 
The concentration of protein in inner membrane preparations and of purified 
protein was determined using the Schaffner-Weissman assay (Schaffner & 
Weissmann, 1973). Sample volumes were adjusted to 270 µl with deionised 
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water, to which 30 µl of a solution containing 1 M Tris-HCl pH 7.5, 10% w/v 
SDS and 60 µl of 60% w/v TCA was added. Samples were vortexed and 
transferred drop-wise onto a single spot, marked with a pencil, on a 0.22 µm 
MF-Millipore Membrane Filter under a vacuum manifold. The filter was pre-
soaked in deionised water. The eppendorf tube previously containing the 
sample was rinsed with 200 µl 6% w/v TCA, which was also added onto the 
membrane in the same spot. The whole membranes were rinsed with 2 ml 
6% w/v TCA before being transferred into a petri dish containing staining 
solution (methanol, acetic acid and water in a 45:10:45 v/v ratio with 0.1% 
w/v naphthol blue black) and left for 3 minutes under stirring. Thereafter, the 
membrane filter was transferred for 30 s into deionised water, twice for 1 
minute into destaining solution (methanol, acetic acid and water in a 90:2:8 
v/v ratio) and finally, for 2 minutes into deionised water. Pieces containing 
the stained dots of protein were cut out and transferred into Eppendorf tubes 
containing 1 ml elution buffer (25 mM NaOH, 0.05 mM EDTA, 50% v/v 
ethanol). A blank piece of the same filter paper, of a similar size to the 
sample pieces, was also cut out and transferred into a separate tube 
containing elution buffer. The OD630 of the eluted samples was measured 
using a WPA Biowave II UV/Visible spectrophotometer (Biochrom Ltd.), 
using the sample from the blank membrane filter as the 100% transmission 
reference and concentrations were calculated with reference to a BSA 
standard graph.  
 
Table 2.3 Detergents concentrations used for buffer exchange.  
The concentrations (%, w/v) outlined in the table used for each of the detergents in 
the buffers used for detergent exchange from DDM, which was used to solubilise 
the protein. The concentrations correspond to 2.5 (wash buffer 2 and elution buffer) 
and 1.8 (storage buffer) of the CMC of each detergent.  
Detergent 
Wash buffer 2 
(%, w/v) 
Elution buffer  
(%, w/v) 
Storage buffer 
(%, w/v) 
n-Undecyl-β-D-
maltopyranoside (UM) 
0.07 0.07 0.05 
n-Decyl-β-D-
maltopyranoside (DM) 
0.2 0.2 0.16 
n-Nonyl-β-D-
maltopyranoside (NM) 
0.7 0.7 0.5 
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2.2.3 SDS-PAGE and Western blotting 
The purity of the protein samples was assessed using SDS-PAGE gels, 
consisting of a 15% v/v resolving gel and a 4% v/v stacking gel. Samples of 
protein solution (15 µl) from various steps in the purification were mixed with 
4X SDS-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (60 
mM Tris-HCl pH 7.2, 10% v/v glycerol, 2% w/v SDS, 0.005% w/v 
bromophenol blue, 3% v/v β-mercaptoethanol) to a final sample volume of 
20 µl, vortexed and incubated at room temperature for 15 minutes. Pure 
protein samples were diluted to contain ~10 µg protein. The gels were 
resolved at 140 V for approximately 1 h in SDS-PAGE running buffer (1 g/L 
SDS, 3.03 g/L Tris base, 14.41 g/L glycine). Thereafter, the SDS-PAGE gel 
was placed into destaining solution 1 (methanol, acetic acid and water in a 
50:10:40 v/v ratio) for 5 minutes with gentle stirring, followed by staining 
solution for 15 minutes (methanol, acetic acid and water in a 50:10:40 v/v 
ratio, containing 0.2% w/v Coomassie Brilliant Blue R). The gel was then left 
in destaining solution 2 (methanol, acetic acid and water in a 8:10:82 v/v 
ratio) until the bands were clearly visible for comparison to the molecular 
weights of the SDS-PAGE standard molecular weight marker proteins that 
were run on the same gel.  
A gel for subsequent Western blotting analysis for detection of His6-tagged 
Mhp1 was run simultaneously with the primary SDS-PAGE gel. The samples 
for Western blotting were prepared by making a 1:14 dilution of the initial 
samples for the primary SDS-PAGE gel to a final volume of 15 µl, to which 5 
µl of 4X SDS-PAGE sample buffer was added. The resolved gel for Western 
blotting analysis was transferred onto a Immobilon-P polyvinylidene fluoride 
transfer membrane by electroblotting at 15 V for 20 minutes using a Trans-
Blot SD Semi-dry transfer cell (Bio-Rad Laboratories Inc.). The membrane 
was incubated with 10 ml TBST buffer (25 mM Tris-HCl ph 7.8, 150 mM 
NaCl, 0.05% v/v Tween-20) containing 3% w/v BSA for 1 h with stirring. After 
washing the membrane twice with 15 ml TBST buffer for 10 minutes, it was 
incubated with 10 ml TBST buffer containing 5 µl Hisprobe-HRP solution for 
1 h. This step was followed by four washes with 15 ml TBST buffer for 10 
minutes. Thereafter, the membrane was incubated with 10 ml of SuperSignal 
Working solution for 5 minutes. All the reaction steps were carried out with 
stirring. The sizes of the proteins were compared to High-range Rainbow 
molecular weight markers. Images of SDS-PAGE gels and Western blots 
were taken using a G:Box (Syngene) with the program GeneSnap 
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(Syngene). White light and luminescence images of Western blots were 
merged using the Intelli-Chemi mode in GeneSnap.   
 
2.2.4 Steady-state spectrophotofluorimety  
The binding affinities of various ligands were tested using a Photon 
Technology International fluorescence spectrofluorimeter. Purified protein 
sample was diluted to a final concentration of 140 µg/ml in fluorimetry buffer 
containing 50 mM Tris-HCl pH 7.6, 2% v/v DMSO and storage buffer 
detergent concentration (Table 2.3). The fluorimetry buffer also contained 
0/15/140 mM NaCl, with 140/125/0 mM choline chloride, respectively. The 
choline chloride was added in order to keep the ionic strength constant 
between the solutions. Prior to a titration, the protein solution was incubated 
inside the sample cell of the fluorimeter, at 18 °C for 4.5 minutes in a quartz 
cuvette with a path length of 1 cm with stirring. Thereafter, ligand solution 
(100 mM, dissolved in 100% v/v DMSO) was titrated into the protein solution 
to a final concentration varying from 0-2 mM using a 10 µl Hamilton syringe. 
1.5 minute after each addition of ligand solution, the emitted fluorescence 
was recorded over the wavelength range 310-360 nm with an excitation 
wavelength of 280 nm. Titrations were carried out in duplicates or triplicates 
and the percent fluorescence quenching was calculated with reference to 
that with 0 mM ligand. The results were plotted and fitted using the 
Michaelis-Menten tool in Prism 6 (GraphPad), from which apparent 
dissociation constant (Kd, mM) and the maximal binding (Bmax, %) were 
obtained.  
 
2.2.5 In-house circular dichroism  
Far-UV circular dichroism (CD) data was collected on a Chirascan™ CD 
Spectrometer (Applied Photophysics), funded by the Wellcome Trust grant 
code 094232, using the Pro-Data™ control software. Concentrated protein 
samples were diluted in storage buffer containing the required detergent to 
approximately 0.1-0.2 mg/ml in a quartz cuvette with a 1 mm path length. 
Spectra were recorded at 20 °C over the wavelength range of 180-260 nm 
with a 1 nm step, 0.5 s/step, 4.3 mm bandwidth. Spectra of the buffer were 
also recorded and subtracted from the protein spectra. Thermal melts were 
performed with the same parameters over the range 20-90 °C, with a 1 °C 
step and an additional 30 s for stabilisation of the temperature after each 
increment.  
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2.3 Crystallisation and data collection  
2.3.1 Crystallisation of Mhp1 
The starting crystallisation conditions were based on those previously 
published (Shimamura et al, 2008). In all crystallisation trials, protein where 
the detergent had been exchanged from DDM to NM was used. All solutions 
were passed through a 0.22 µm Millex ® syringe filter unit before being used 
for making crystallisation conditions. With every new batch of native or 
mutant Mhp1, an initial screen was set up with fresh protein to establish the 
optimal crystallisation conditions for that particular purification batch. 
Droplets of protein solution (0.5 or 1.0 µl, ~10-20 mg/ml) were added onto 
non-silliconised glass cover slips, to which well solution was added in a 1:1 
or 1:2 ratio. The cover slips with the mixed droplets were then inverted into a 
hanging-drop setup over the wells of a 24-well Greiner tray and sealed with 
vacuum grease. The wells contained 400 µl of 0.1 M sodium phosphate pH 
7.0, 60-160 mM NaCl and 27-35% v/v PEG 300 and the trays were left to 
equilibrate at 18 °C. Typically, needle-shaped crystals appeared over-night 
and continued to grow over the course of a week. After setting up plates with 
fresh protein, the remaining protein from the purification batch was flash-
frozen in 10-20 µl aliquots and stored at -80 °C for use in subsequent trays 
for further optimisation, mass production and co-crystallisation. The frozen 
aliquots were usually used up within 1 month. In order to improve crystal 
size and quality, a streaking method was developed to mix the well solution 
into the protein droplet (further described in 4.4.3). 
For SeMet-Mhp1, droplets of protein solution (1.5 µl, ~10 mg/ml) were mixed 
with an equal volume of reservoir solution containing 24-28% v/v PEG 300, 
60-120 mM NaCl and 100 mM Bicine (pH 9.0) and left to equilibrate against 
400 µl of the same solution. The trays were left to equilibrate at 4 °C and 
needle-shaped crystals appeared after a couple of days.  
 
2.3.2 Co-crystallisation with ligands 
For co-crystallisation of ligands with mutant Mhp1, the ligands L-BH, L-5-
IMH, L-NMH and BVH were dissolved in 100% PEG 300 to a final 
concentration of 1-5 mM. The ligand-containing PEG 300 solution was 
thereafter used to make up the reservoir solutions for crystallisation set-ups 
as described in 2.3.1. 
 
- 33 - 
2.3.3 Harvesting and cryo-cooling of crystals  
Due to the high content of PEG300 in the crystallisation conditions, the 
crystals were cooled without adding additional cryo-protectant. The crystals 
were typically harvested using nylon loops (0.2-1 mm diameter) or 
MicroLoopsE™ (vertical; 15x150, 30x300, 50x500 or 70x700 µm), and cryo-
cooled by rapid plunging into liquid nitrogen or placement in the path of a 
nitrogen gas stream. For crystal dehydration, a humidity control device 
(HC1) (Sanchez-Weatherby et al, 2009) was used at beamlines I03 and I04 
at Diamond Light Source. After the relative humidity (RH) of the reservoir 
solution from the well with crystal(s) to be studied was established, a crystal 
was mounted on a MicroMesh™ and put on the goniometer in the path of 
the humid air stream. Excess liquid was wicked from underneath the mesh 
by touching with a piece of tissue. Thereafter, the RH was decreased in 
increments of 2% with a 2 minute waiting time in-between. At each humidity 
step, one image of 1° oscillation and 1 s exposure (1% transmission at a flux 
of 2.61 x 1011 photons s-1, 0.9763 Å) was collected to assess the diffraction 
quality and lattice parameters. When a significant contraction of the lattice 
was observed, the crystal was flash-cooled by automatic switch over to a 
nitrogen gas stream and a full diffraction dataset was collected.  
 
2.3.4 Crystallisation for in situ studies and contactless harvesting 
For in situ studies and contactless harvesting, In Situ-1™ and 
CrystalDirect™ crystallisation trays were set up manually, with 0.4-0.5 µl 
droplets mixed in a 1:1 or 1:2 ratio with 45 µl well solution. The solutions 
were prepared with or without ligands as described in 2.3.1 and 2.3.2. 
 
2.3.5 Diffraction data collection and structure solution  
Diffraction data were collected at Diamond Light Source (beamlines I02, I03, 
I04, I04-1 and I24) and the European Synchrotron Radiation Source 
(beamline ID29). The data were processed using xia2 (Winter et al, 2013); 
where indexing, integration and scaling was performed with XDS (Kabsch, 
2010) or DIALS (Waterman et al, 2013) and space group determination and 
merging of the individual data sets was done with POINTLESS and 
AIMLESS from the CCP4 suite (Winn et al, 2011). The Pearson correlation 
coefficient (CC) was used as the main data quality metric and the resolution 
was normally cut at CC1/2 > 0.5 (Karplus & Diederichs, 2012). To avoid 
biasing the Rfree set, the Rfree flags for each data set were copied from the 
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previously published structure with PDB 2JLO (Weyand et al, 2008) in the 
CCP4 programme CTRUNCATE (Winn et al, 2011). The structures were 
solved by molecular replacement (MR) using PHASER (McCoy et al, 2007). 
The principle of MR is to determine the phase of each diffraction reflection, 
which is not recorded during a diffraction experiment, by determining the 
position of a protein search model in the unit cell. Patterson-based methods 
have been widely applied for this purpose and involves matching the peaks 
in the Patterson map calculated for the chosen search model to that of the 
experimental data. The Patterson map, containing peaks for each 
interatomic distance is a result of the Patterson function, is essentially a 
Fourier transform of the intensities of the diffraction pattern (Glusker, 1983). 
The search procedure is normally divided into two steps to make the process 
more efficient; 1) a rotation search, where the correct orientation of the 
search model is determined and 2) a translation search, where the position 
of the correctly oriented model is determined. The procedure has been 
improved and implemented in a wide range of MR programmes (Scapin, 
2013). In PHASER, the improvements have involved the introduction of 
maximum-likelihood statistics and a brute force evaluation of the MR 
solutions (McCoy et al, 2007).  
MR requires a search model of usually more than 30% sequence identity in 
order for the search to be successful. For the Mhp1 structures solved in this 
Thesis, search models of previously published structures of Mhp1 were 
used. In order to validate that the correct solution has been obtained at the 
moderate resolution of the data obtained here, and avoid the propagation of 
model bias throughout the process of refinement, MR searches were 
performed with a selection of search models against each data set. The 
search models included previously published structures of Mhp1 in the 
outward-open conformation (2JLN), the occluded ligand-bound conformation 
(2JLO, 4D1A and 4D1B), the occluded ligand-bound conformation with 
TMH10 in an open conformation (4D1D) as well as in the inward-open 
conformation (2X79). Prior to using these structures as molecular 
replacement search models all bound ligands, ions and metals were 
removed. 
Structures were initially refined using both PHENIX.REFINE (Adams et al, 
2010) and REFMAC5 (Murshudov et al, 2011), and the final structures were 
produced using REFMAC5, where the structures were initially subjected to a 
rigid-body fit, followed by restrained refinement. Parameters included in the 
restrained refinement were jelly-body refinement and the application of 
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external restraints from a reference model using ProSmart built into 
REFMAC5 (Nicholls et al, 2012). B-factor map sharpening was used for map 
visualisation and model building, applying the default B-factor sharpening 
factor (Bsharp) in REFMAC5. 
2.4 Small-angle X-ray scattering studies 
2.4.1 Data collection on dilution series 
Data were collected at beamline BL4-2 at Stanford Synchrotron Radiation 
Lightsource (CA, USA). A 2.5 m sample-to-detector distance was used and 
the wavelength of the radiation was 1.13 Å. Briefly, 8 x 1 s exposures were 
recorded for each sample (either reference buffer or sample dilution) while 
the sample was oscillated back and forth inside a capillary tube. The data 
were automatically scaled, integrated and buffer subtracted using SASTool 
(http://ssrl.slac.stanford.edu/~saxs/analysis/sastool) at the beamline. 
Protein samples (~10 mg/ml) and their respective reference buffers were 
prepared by several rounds of dilution/re-concentration using Vivaspin 20 
MWCO 100,000 spin concentrators, with wash buffer with a reduced 
detergent concentration (10 mM Tris-HCl pH 7.6, 2.5% v/v glycerol, 0.02% 
w/v DDM). The final dialysis buffer or the buffer used for concentration was 
used for making dilution series of the protein. This buffer was also used as 
the reference buffer. All further processing was carried out using the ATSAS 
software package (Petoukhov et al, 2012). Rg, I(0), Dmax and distance 
distribution functions were obtained using the ‘Radius of Gyration’ and 
‘Distance Distribution’ tools in PRIMUS (part of the ATSAS software 
package). Porod volumes were calculated using DATPOROD (part of the 
ATSAS software package).  
2.4.2 SEC-SAXS data collection 
SEC-SAXS data were collected at the SWING beamline at SOLEIL, the 
French national synchrotron facility. Purified protein samples in 10-20 µl 
volumes were shipped to the synchrotron on dry ice and stored at -80 °C. 
Protein samples were diluted in storage buffer containing the corresponding 
detergent to a final concentration of 2-4 mg/ml and a final volume of 50 µl. 
45 µl of the protein samples were injected onto a Superdex™ 200 Increase 
3.2/300 or Bio SEC-3 column, pre-equilibrated with the same buffer at 0.1 
and 0.2 ml/min, respectively, and the elution was monitored using UV 
absorption at 280 nm. 61 frames with 1.5 s exposure time and 1 s dead time 
between frames were collected at the beginning of the elution to provide the 
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buffer signal, and a total of 254 frames were collected across the elution 
peak, with approximately 30 frames covering the main peak. Images were 
radially averaged, normalised and the buffer subtraction was performed 
using the software Foxtrot (http://www.synchrotron-soleil.fr/Recherche/ 
LignesLumiere/SWING). The software package ATSAS (Petoukhov et al, 
2012) was used for downstream analysis and also utilised in conjunction 
with the program Memprot (Perez & Koutsioubas, 2015) to model the 
detergent corona.  
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Chapter 3: Purification and characterisation of variants of the 
Mhp1 protein for structural studies 
3.1 Introduction 
Previously, mutagenesis and subsequent functional studies of Mhp1 mutants 
have helped to identify several variants with altered ligand binding and 
transport behaviour (Jackson, 2012; Simmons et al, 2014). These studies 
have allowed the establishment of sequence-function relationships in Mhp1, 
but have not given any insights into the structural basis behind the altered 
binding and transport of its ligands. The altered ligand binding might be a 
result of the mutations causing structural rearrangements in the protein, or 
the mutants adopting different conformations. One possibility is that the 
mutants preferentially adopt conformational states other than those 
previously observed for the wild-type protein, for example an inward-open 
state. Therefore, the various mutants that exhibit altered ligand binding 
behaviour are very interesting targets for structural studies. 
As outlined in section 1.5, the scope of this thesis is to gain an improved 
understanding of the full transport mechanism of Mhp1. X-ray 
crystallographic studies of Mhp1-ligand complexes have previously given 
insights into the structural basis behind the ligand binding step of the 
transport mechanism in wild-type Mhp1 (Simmons et al, 2014). In this thesis, 
X-ray crystallographic studies are used to explore the effects of mutations 
previously determined to have altered ligand binding activities (Jackson, 
2012; Simmons et al, 2014).  
In this Chapter, the purification and characterisation of a number of Mhp1 
variants are described in preparation for further structural studies. Both 
Mhp1 single-point mutants previously identified to have altered ligand 
behaviour (Simmons et al, 2014; Jackson, 2012) and seleno-L-methionine 
derivatised Mhp1 were prepared (section 3.4). In addition, wild-type Mhp1 
solubilised in maltoside detergents with aliphatic chains of varying length 
were produced (section 3.5) for subsequent small-angle X-ray scattering 
studies (SAXS), exploring the potential of SAXS as a complementary 
technique for Mhp1.  
A combination of a steady-state tryptophan fluorescence quenching assay 
and circular dichroism spectroscopy were used to assess the structural 
integrity, stability of these variants, and subsequently their suitability for 
further structural studies.  
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3.2 The preparation of Mhp1 samples and techniques for 
their characterisation for structural studies 
3.2.1 Introduction 
In this section, the preparation and subsequent characterisation of the Mhp1 
protein for further structural studies will be described, using wild-type Mhp1 
as the example. This section will then serve as a template for the rest of the 
Chapter in the description of the preparation and characterisation of various 
variants of Mhp1; including single-point mutants, seleno-L-methionine 
derivatised Mhp1 and Mhp1 solubilised in various detergents.  
The preparation of wild-type Mhp1 was performed in order to reproduce and 
further optimise the previously published crystallisation conditions 
(Shimamura et al, 2008; 2010). As the crystallisation trials for this project 
would be carried out in a different laboratory than previously, the published 
conditions were reproduced in order to assess whether these conditions 
could be further exploited in this project or whether extensive screening for 
alternative conditions would be required.  
Part of the purification protocol for Mhp1 for crystallisation trials involves the 
exchange of detergent from n-dodecyl-β-D-maltopyranoside (DDM), which is 
initially used to solubilise the protein out of the inner membrane fragments, 
to the three aliphatic chain carbons shorter detergent n-nonyl-β-D-
maltopyranoside (NM) (Figure 3.12). Therefore, the preparation and 
characterisation of wild-type Mhp1 solubilised in NM will be described in this 
section, to which single-point mutants and seleno-L-methionine derivatised 
protein will be subsequently compared. The influence on the outcome of the 
purification and characterisation of Mhp1 in other detergents will be further 
discussed in section 3.5, where the characterisation of Mhp1 solubilised in 
detergents of various length for scattering studies will be described. 
 
3.2.2 Monitoring the purification of Mhp1  
Mhp1 for initial crystallisation trials was purified according to previously 
established protocols, which are described in 2.2.1 (Shimamura et al, 2008). 
The presence of Mhp1 during various steps of the purification was monitored 
by SDS-PAGE and Western blotting. The SDS-PAGE gel showed the total 
amount of proteins in each sample, while Western blotting was used to 
confirm the presence or absence of N-terminally His6-tagged Mhp1. A 
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representative SDS-PAGE gel and corresponding Western blot of a 
purification of Mhp1 is displayed in Figure 3.1.  
 
 
Figure 3.1 SDS-PAGE gel and corresponding Western blot showing the 
progress of the purification of wild-type Mhp1, solubilised in NM. 
SDS-PAGE gel (a) and the corresponding Western blot (b) of samples taken during 
the course of a purification of wild-type Mhp1 for initial crystallisation trials. The 
lanes and samples are the same in both the gel and blot, with the samples on the 
blot being diluted 1:14 times; the gels were run at the same time. The lanes contain: 
1) molecular weight standard ladder with the molecular weights of the standard 
proteins indicated to the left of the gel or blot in kDa; 2) solubilisation mixture before 
ultracentrifugation; 3) supernatant after ultracentrifugation, 4) pellet after 
ultracentrifugation; 5) the unbound material in the flow-through after binding to the 
Ni-NTA resin; 6) wash buffer of the Ni-NTA resin after exchanging the detergent; 
and 7) eluted sample from the Ni-NTA resin using 200 mM imidazole.  
 
The Western blot confirms the presence of Mhp1 in the solubilisation mixture 
prior to ultracentrifugation, which is carried out in order to separate insoluble 
membrane fragments from the soluble fraction containing solubilised protein. 
After the ultracentrifugation step, the Western blot confirms that Mhp1 is 
present in the soluble fraction. The Western blot also shows that small 
amounts of Mhp1 were lost in the insoluble fraction, and while washing the 
Ni-NTA resin.  
The migration of the final, eluted Mhp1 protein corresponds to approximately 
36 kDa on SDS-PAGE (indicated by the arrows in Figure 3.1), while its 
estimated molecular weight from its sequence is 54.6 kDa. Anomalous 
migration of membrane proteins on SDS-PAGE, also termed “gel shifting”, is 
a common occurrence and membrane proteins often migrate at 
approximately 65–75% of their actual molecular weight on SDS-PAGE 
(Ward et al, 2000). This has been proposed to be caused by membrane 
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proteins not becoming completely denatured by SDS due to the presence of 
other detergents and stable hydrophobic contacts within the protein, 
resulting in the proteins migrating further on the gel due to their more 
compact size (Rath et al, 2009). 
 
3.2.3 Assessing secondary structure of Mhp1 using circular 
dichroism 
Circular dichroism was used in order to examine the structural integrity of the 
purified protein samples and their suitability for further X-ray crystallographic 
and scattering studies. Circular dichroism in the UV region can be used to 
study the global structure of proteins, in particular in the far UV CD region 
(180-260 nm) (Kelly et al, 2005). Within this wavelength range, various 
secondary structure motifs in proteins give rise to characteristic spectra. 
Subsequently, CD was used as a quality control to check that the purified 
protein samples were folded and acquired the expected secondary structural 
elements of Mhp1. The overall structure of Mhp1 is comprised of twelve TM 
helices (Weyand et al, 2008; Shimamura et al, 2010), and α-helical folds 
typically give rise to a spectrum with a maximum around 193 nm and minima 
at 208 and 222 nm. 
 
 
 
 
 
 
 
 
 
Figure 3.2 Representative CD spectrum of purified wild-type Mhp1, 
solubilised in NM. 
The CD spectrum for purified Mhp1 (in a buffer containing 10 mM Tris-HCl pH 7.6, 
2.5% v/v glycerol, 0.5% w/v NM) follows the characteristic shape of an α-helical 
protein, with signal maximum at 193 nm and minima at 208 and 222 nm. The CD 
signal is shown as a black line, while the High Tension (HT) voltage is shown as a 
dotted line. The protein concentration was adjusted so as to avoid the HT going 
over 600 V.  
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When recording a CD spectrum of wild-type Mhp1, the presence of these 
characteristic features are seen, which indicates that the purified Mhp1 
protein has predominantly adopted an α-helical fold at 20 °C (Figure 3.2). 
 
3.2.4 Assessing the thermal stability of Mhp1 using circular 
dichroism 
Recording a CD spectrum shows that the protein is folded at the 
temperature at which the spectrum was recorded, but gives no further 
information on the inherent stability of the structure. Therefore, CD was also 
used to monitor the thermal stability of the purified protein samples, in order 
to gain more information on their stability (in particular the mutants) and their 
suitability for further characterisation. The thermal stability was monitored by 
recording CD spectra while increasing the temperature of the sample cell. 
The thermal melts were carried out between 20-90 °C (Figure 3.3). During 
the thermal melt, the characteristic shape of the CD spectrum of an α-helical 
protein, as seen for wild-type Mhp1 in Figure 3.2 disappeared. The peak at 
193 nm decreased, and underwent a shift towards a higher wavelength, and 
the two minima at 208 and 222 nm were also gradually diminished. This 
indicated that the previously adopted α-helical structure of Mhp1 was being 
lost. The decrease in CD signal at 208 nm was then used to assess the 
thermal stability of the protein.  
After the thermal melt, the temperature was lowered back down to 20 °C, for 
which the CD spectrum displayed complete absence of characteristic peaks 
compared to the spectrum recorded at 90 °C. At 90 °C, CD signal was still 
recorded between approximately 190-200 nm, which was most likely the 
peak at 193 nm which had undergone a wavelength shift. Lowering the 
temperature back to 20 °C did not recover the folding of the secondary α-
helical structure, but in fact triggered the complete denaturation of Mhp1, as 
indicated by the absence of CD signal between 190-200 nm. The complete 
denaturation may have been caused by lowering the temperature at a faster 
rate than it was increased during the thermal melt. From the plot of the 
change in CD intensity at 208 nm, the melting temperature (Tm) of wild-type 
Mhp1 was estimated as 50.3 °C using the Global 3™ Analysis Software 
(Applied Photophysics). 
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Figure 3.3 Example of a CD thermal melt assay on wild-type Mhp1, 
solubilised in NM. 
(a) The thermal stability of purified Mhp1 samples (in a buffer containing 10 mM 
Tris-HCl pH 7.6, 2.5% v/v glycerol, 0.5% w/v NM) was assessed by increasing the 
temperature of the CD sample cell from 20-90 °C, and measuring the spectrum in 1 
°C  steps. The CD spectrum of wild-type Mhp1 at 20 °C is shown in black and at 90 
°C in red. A final measurement at 20 °C after the thermal melt up to 90 °C (shown 
in blue) shows that the thermal denaturation of the secondary structure of Mhp1 is 
irreversible. (b) The CD signal at 208 nm was plotted (shown as black dots) against 
temperature and used to assess the thermal stability of the protein.  
 
3.2.5 Assessing ligand binding behaviour using steady-state 
tryptophan fluorescence quenching in wild-type Mhp1 
The functionality of the purified Mhp1 protein samples was studied using a 
steady-state spectrophotofluorimetry assay, monitoring the change in 
tryptophan fluorescence in response to adding ligand. Changes in 
tryptophan fluorescence can be used to monitor structural and kinetic 
changes in proteins (Chen & Barkley, 1998), and has previously been used 
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to study ligand binding in other LeuT family members, for example vSGLT 
(Veenstra et al, 2002) and BetP (Ge et al, 2011). 
 
 
 
 
Figure 3.4 The structural rearrangements in the binding site upon 
binding of L-benzylhydantoin in wild-type Mhp1. 
The residues Trp117, Trp220, Gln42, Gln121, Ala222, Asn318 and Gly219 from the 
crystal structures of the inward-open structure (PDB 2JLN, displayed in light blue) 
and the occluded structure (PDB 4D1B, displayed in coral) are displayed as 
cylinder bonds. The two crystal structures were superposed onto each another in 
the molecular graphics programme CCP4mg (McNicholas et al, 2011). The ligand 
L-BH is shown in a ball-and-stick representation in green, around which the 
residues Trp117 and Trp220 close up around in the occluded structure. The 
residues Gln42, Gln121, Asn318 and Gly219 participate in the putative hydrogen 
bonding network in order to stabilise the hydantoin moiety, and are displayed as 
partially transparent for clarity. Nitrogens are shown in blue and oxygens are shown 
in red. The black dashed arrows indicate the directions of the movement of Trp117 
and Trp220.  
 
In previously published structures of Mhp1, the structural rearrangements in 
the ligand-binding site upon binding of L-BH appear to involve two 
tryptophan residues, Trp117 and Trp220 (Weyand et al, 2008). In the 
transition from the ligand-free outward-open form to the occluded form with 
L-BH bound, the hydantoin moiety of the ligand packs face-to-face against 
Trp117, while Trp220 reorients to form end-on interactions with the benzyl-
moiety of the ligand (Figure 3.4). This involves distinct changes in the 
environment of the tryptophan residues and probably underlies the 
fluorescence change enabling studies of the ligand binding in Mhp1.  
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Monitoring the quenching of tryptophan fluorescence upon binding of L-BH 
in the presence of varying concentrations of sodium chloride has previously 
been used to demonstrate that Mhp1 binds L-BH in a sodium-dependent 
manner (Weyand et al, 2008; Jackson, 2012). In the presence of 15 mM 
sodium chloride, the affinity for L-BH is greatly increased, resulting in a 
lowering of the apparent Kd from 0.737 ± 0.063 mM at 0 mM added sodium 
chloride to 0.036 ± 0.0014 mM at 15 mM added sodium chloride (Jackson, 
2012).  
 
 
Figure 3.5 Representative steady-state tryptophan fluorescence 
quenching assay of the binding of L-BH to wild-type Mhp1, 
solubilised in DDM and NM. 
The figure shows the quench of tryptophan fluorescence in the excitation region 
310-360 nm upon the addition of L-BH (0-2 mM) in the presence of 0 mM (red line) 
or 15 mM (blue line) added sodium chloride. The error bars display the standard 
error of the mean from three replicates of each titration. Mhp1 samples (in 10 mM 
Tris-HCl pH 7.6, 2.5% v/v glycerol, 0.05% w/v or 0.5% w/v NM) were diluted to 140 
µg/ml using buffers containing 50 mM Tris-HCl pH 7.6, 2% v/v DMSO and 0.05% 
w/v or 0.5% w/v NM. The fluorimetry buffer also contained 0/15 mM NaCl and 
140/125 mM choline chloride.  
 
The same well-established assay was used in this Thesis to monitor the 
functionality of the purified Mhp1 protein samples. Figure 3.5 shows 
representative titration curves for preparations of wild-type Mhp1, 
demonstrating the significant increase in L-BH binding in the presence of 
sodium (Table 3.1). Since the reference values quoted above were derived 
from wild-type Mhp1 protein solubilised in DDM, a representative titration 
curve from wild-type Mhp1 solubilised in the same detergent is shown in 
Figure 3.5a. The kinetic parameters obtained in this Thesis fall 
approximately into the same range as previously obtained values (Table 
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3.1). This shows that protein with comparable functionality as previously 
demonstrated is being produced and can thus be compared to previously 
obtained results. The discrepancies are likely to arise from variations in 
protein purification procedure, the batch of inner membranes or, for 
example, the age of the protein when the assays were carried out. As the 
majority of this Thesis concerns the crystallisation of Mhp1, protein 
solubilised in NM was primarily produced. The titration curves for wild-type 
Mhp1 solubilised in NM are shown in Figure 3.5b, and will serve as a 
benchmark for Mhp1 mutants and seleno-L-methionine derivatised Mhp1 
produced for crystallisation trials (3.3-3.4). The influence of detergent length 
on the functionality of Mhp1 will be further discussed in section 3.5.  
 
Table 3.1 Apparent Kd and Bmax values for wild-type Mhp1, solubilised 
in DDM and NM in comparison to previous reference values. 
Mhp1  [Na+] App. Kd (mM)  Bmax (%)  
Wild-type 
Mhp1, DDM * 
0 
15 
0.74 ± 0.063 
0.036 ± 0.0014 
18.90 ± 0.70 
21.80 ± 0.10  
Wild-type 
Mhp1, DDM 
0 
15 
1.27 ± 0.23 
0.040 ± 0.0050 
26.01 ± 2.40 
23.64 ± 0.33  
Wild-type 
Mhp1, NM 
0 
15 
3.66 ± 0.82 
0.27 ± 0.015 
22.93 ± 3.70 
18.95 ± 0.28  
* Reference values from Jackson, 2012. 
 
3.2.6 Discussion 
The various quality controls that were performed on purified wild-type Mhp1 
have been presented in this section. Using CD it was confirmed that 
correctly folded and thermally stable protein was produced. Mhp1 is 
comprised of twelve TM α-helices and the recorded CD spectrum of wild-
type Mhp1 shows the characteristic peaks for an α-helical fold. Using CD, 
the thermal stability of Mhp1 was also assessed. The Tm of wild-type Mhp1 
was estimated to be 50.3 °C. By performing a tryptophan fluorescence 
quenching assay, it was also determined that the wild-type Mhp1 that was 
purified for this project was functional in accordance with previous studies. 
The titrations revealed that the Mhp1 protein bound L-BH in a sodium-
dependent manner, as seen in previous studies, with the affinity of Mhp1 for 
L-BH significantly increasing in the presence of 15 mM sodium (Weyand et 
al, 2008; Jackson, 2012).   
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3.3 Purification and characterisation of mutants of the Mhp1 
protein for crystallographic studies 
3.3.1 Introduction 
Previously, a number of single-point mutants with altered ligand binding 
behaviour have been identified (Jackson, 2012), which are interesting 
targets for structural studies due to their kinetic properties. A number of 
these mutants have been purified and characterised as part of this project 
for X-ray crystallographic studies, in order to establish the structural basis 
behind the altered ligand binding behaviour in these mutants (Table 3.2).  
 
Table 3.2 List of mutants purified and characterised for further 
structural studies. 
The table is a replicated from Table 2.2 in section 2.2.1. 
Mutant Site of the mutation  
Gln42Asn Ligand 
Gln121Asn Ligand 
Asn318Gly Ligand 
Ser312Ala Sodium 
Lys110Leu Bundle/hash 
 
The mutants are categorised by their location in the protein, either in the 
ligand-binding site, the sodium-binding site or on the interface between the 
bundle- and hash-motifs in the Mhp1 protein. The locations of these sites are 
illustrated in Figure 3.6, with respect to the bundle- and hash-motifs. 
Only one mutant studied as part of this Thesis (Lys110Leu) was situated 
neither in the ligand- nor the sodium-binding site. The remaining mutants 
were located in either the ligand- (Gln42Asn, Gln121Asn, Asn318Gly) or 
sodium-binding (Ser312A) site, which are more clearly illustrated in Figure 
3.7. 
The mutants were purified as previously described, initially without any 
modification to the protocols that were used for the wild-type protein. The 
quality of the purified samples of the single-point mutants of the Mhp1 
protein was assessed using CD and fluorescence quenching assays, as 
described for wild-type Mhp1 in section 3.2. 
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Figure 3.6 The bundle- and hash-motifs in the Mhp1 protein, displaying 
the locations of the single-point mutations. 
The Mhp1 protein is illustrated with the bundle- and hash-motifs highlighted, in 
order to display the locations of the single-point mutations in the Mhp1 protein that 
are studied here. The helices comprising the bundle motif (TMHs 3, 4, 8 and 9) are 
displayed as yellow cylinders and the hash motif (TMHs 1, 2, 6 and 7) are displayed 
as red cylinders. The remaining helices and loops are displayed in semi-transparent 
grey for clarity. The residues participating in the ligand and sodium binding sites are 
displayed in coral (location of ligand binding site mutations) and cyan (location of 
sodium binding site mutant). In addition, the location of the residue Lys110Leu is 
displayed in purple (mutant between the bundle- and hash-motifs). The orientation 
of the protein in (a) is roughly the same as in Figure 3.7a, and the protein in (b) is 
rotated by 90°.  
 
3.3.2 Purification of mutants of Mhp1 
The same purification procedures used for wild-type Mhp1, as described in 
section 2.2.1, were applied for the single-point mutants of Mhp1 outlined in 
Table 3.2. As the mutants were produced for crystallisation trials and 
subsequent X-ray crystallographic studies, all the mutants were subjected to 
detergent exchange by NM during the purification procedure. SDS-PAGE 
and Western blotting analysis confirmed the presence of the purified mutant 
Mhp1 (Figure 3.8). For Gln121Asn, a more significant amount of a higher-
molecular weight species was observed, compared to wild-type Mhp1 and 
the other mutants. 
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Figure 3.7 The ligand- and sodium-binding sites in the Mhp1 protein. 
The figure illustrates the ligand-binding site of Mhp1 in complex with L-BH (a) and 
the nearby sodium binding site (b). The orientation of the protein and the colour 
scheme for the individual residues in (a) are roughly the same as in Figure 3.6a. In 
(a), the ligand binding site residues are highlighted in coral, the ligand L-BH in 
green and the nearby sodium as a grey sphere. Hydrogen bonds between the L-BH 
and nearby residues are displayed as black dashed lines and stated in units of Å. 
The sodium binding site residues are displayed in semi-transparent cyan, apart 
from Ile41, which is displayed in cyan as a reference for the orientation of the 
sodium binding site in (b). In (b), the sodium binding site residues are displayed in 
cyan with the coordinating bonds between the residues and the sodium as black 
dashed lines. In both (a) and (b), the non-carbon atoms are coloured red (oxygen), 
blue (nitrogen) and yellow (sulphur). The ribbon diagram of the whole protein is 
displayed in semi-transparent grey.  
 
As the bands are closer to the actual molecular weight of Mhp1 (54.6 kDa), 
this suggests that there is a greater proportion of either fully denatured 
protein present in Gln121Asn samples. Alternatively it could be promoting 
the formation of a protein dimer as the higher molecular weight species is 
also close to approximately twice the molecular weight of the main band. 
The purified samples of the Mhp1 mutants were all subjected to analysis by 
CD, in order to confirm that they were folded and suitable for further 
characterisation and structural studies. All mutants gave rise to a 
characteristic CD spectrum for an α-helical protein (see Appendix B for CD 
graphs). This suggests that the single-point mutations do not affect the 
ability of the protein to fold into its native α-helical fold, with respect to wild-
type Mhp1. In addition, the thermal stability of the mutants was also studied 
using CD, as described in section 3.2.4. It appeared that each mutation 
increased the thermal stability of Mhp1, with respect to the wild-type (Table 
3.3, see Appendix B for CD thermal melt curves). As discussed in section 
(a) 
Thr313 
Ile41 
Ala38 
Ser312 
Ala309 
(b) 
Trp220 
Trp117 
Gln42 
Gln121 
Asn318 Gly219 
2.72 2.98 
2.77 
3.19 
2.47 
Ile41 
Ala38 
Na 
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3.2.6, this indicates that according to the Tm of the Mhp1 mutants, these are 
suitable targets for crystallisation trials. 
 
Figure 3.8 Comparison of the purifications of Mhp1 mutants.  
For each mutant, the left-hand cut-out lane shows the purified Mhp1 protein on a 
SDS-PAGE gel and the right-hand cut-out lane shows the same sample on the 
corresponding Western blot (see Appendix A for full gels). The arrows indicate the 
position of the band that correspond to the Mhp1 protein. For each mutant, the 
SDS-PAGE and Western blot confirm that pure Mhp1 mutant protein was produced 
for further characterisation and structural studies. In some cases, higher molecular 
weight species were observed, and this is potentially protein that has been 
completely denatured by SDS.  
 
The apparent stabilisation may be a result of the mutations restricting 
conformational changes and rigidifying the protein in solution. This finding 
does not correlate with the suggestion that the mutation Gln121Asn may 
destabilise the protein and result in a greater proportion of fully denatured 
protein on an SDS-PAGE gel, but may support the idea that the mutation 
may promote the formation of dimers, due to the potentially increased rigidity 
of the protein as suggested by the CD analysis of the thermal stability. As it 
is difficult to correlate thermal stability and resistance to denaturation by 
Gln42Asn 
 
Wild-type 
 
Lys110Leu 
 
Asn318Gly 
 
Ser312Ala 
 
Gln121Asn 
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SDS, the apparent discrepancy may be attributed to differences in sample 
and SDS-PAGE gel preparation. 
 
3.3.3 Assessing the change in ligand binding in Mhp1 caused by 
single-point mutations 
The steady-state tryptophan fluorescence quenching assay used to study 
the ligand binding was used to investigate how the single-point mutations in 
Table 3.3 affected the ligand binding ability of Mhp1. As described in 3.2.5, 
L-BH was titrated into a solution of the protein in the presence of various 
concentrations of sodium chloride (Figure 3.9, Table 3.4). Since all mutants 
were prepared for crystallisation trials, they were subjected to detergent 
exchange into NM, and will therefore be compared to wild-type Mhp1 
purified in the same detergent (Figure 3.9a). 
 
Table 3.3 Summary of the melting points obtained from thermal melts 
of circular dichroism of mutants of Mhp1, purified in NM. 
Mutant Site of the mutation  Melting temperature (°C) 
Wild-type Ligand 50.3 
Gln42Asn Ligand 65.3 
Gln121Asn Ligand 74.0 
Asn318Gly Ligand 62.4 
Ser312Ala Sodium 62.0 
Lys110Leu Bundle/hash 61.2 
 
Two of the residues in the ligand-binding site, Gln42 and Gln121, were 
probed by changing the glutamine to the close analogue asparagine. Gln121 
has been suggested to form a hydrogen bond with one of the carbonyl 
oxygens on the hydantoin moiety of the ligand, while Gln42 could be forming 
a hydrogen bond with Gln121, thus participating in the hydrogen-bonding 
network that stabilises the hydantoin moiety in the binding site (Weyand et 
al, 2008; Simmons et al, 2014). In addition, Gln42 is situated in close 
proximity to the nearby sodium binding site, with the carbonyl oxygen of the 
adjacent residue Ile41 participating in the coordination of the sodium atom.  
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Figure 3.9 The binding of L-BH to wild-type and mutant Mhp1, 
solubilised in NM.  
The figure shows the fluorescence quench during titrations of L-BH (0-2 mM) with 
the wild-type Mhp1 (a), as well as the Mhp1 mutants Gln42Asn (b), Gln121Asn (c), 
Ser312Ala (d), Asn318Gly (e) and Lys110Leu (f). At the top of each graph, the 
respective position of each mutation is indicated in parentheses. The titrations were 
performed in the presence of 0 mM (red), 15 mM (blue) and 140 mM (black) added 
sodium chloride. Mhp1 samples (in 10 mM Tris-HCl pH 7.6, 2.5% v/v glycerol, 0.5% 
w/v NM) were diluted to 140 µg/ml using buffers containing 50 mM Tris-HCl pH 7.6, 
2% v/v DMSO, 0.5% w/v NM, 0/15/140 mM NaCl and 140/125/0 mM choline 
chloride. The error bars display the standard error of the mean from three replicates 
of each titration.  
 
Plausibly, Gln42 and Gln121 are in close interplay with the ligand and each 
other. In addition, Gln42 and Gln121 are potentially also in interplay with the 
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nearby sodium binding site and mutation of these residues may also be 
affecting the sodium binding.   
The tryptophan fluorescence quenching assay for the ligand binding site 
mutants Gln42Asn and Gln121Asn (Figure 3.9 b, c) shows that the binding 
of L-BH is clearly perturbed by the mutations to the one carbon shorter 
asparagine residues. In the absence of sodium, the low-affinity binding of L-
BH is similar with respect to wild-type. 
 
Table 3.4 Summary of the apparent Kd and Bmax values for the mutants 
of Mhp1, purified in NM. 
Mutant  [Na+] App. Kd (mM)  Bmax (%)  
WT  0 
15 
140 
3.66 ± 0.82 
0.27 ± 0.015 
0.059 ± 0.0071 
22.93 ± 3.70 
18.95 ± 0.28 
16.56 ± 0.28  
Gln42Asn  0 
15 
140 
3.47 ± 1.13 
1.41 ± 0.33 
0.041 ± 0.0040  
38.01 ± 8.78 
29.81 ± 3.81 
21.19 ± 0.23 
Gln121Asn  0 
15 
140 
1.81 ± 0.36 
1.80 ± 0.28 
1.50 ± 0.30 
23.81 ± 2.73 
21.91 ± 1.98 
24.37 ± 2.65 
 Asn318Gly 0 
15 
140 
0.82 ± 0.25 
2.11 ± 0.30 
1.55 ± 0.12 
17.46 ± 2.33 
20.59 ± 1.77 
20.46 ± 0.84 
Ser312Ala 0 
15 
140 
3.76 ± 0.69 
1.90 ± 0.24 
0.94 ± 0.12 
31.79 ± 4.236 
23.43 ± 1.80 
28.94 ± 1.62 
Lys110Leu 0 
15 
140 
1.28 ± 0.52 
4.77 ± 3.23 
n/a 
14.13 ± 3.00 
21.35 ± 11.1 
n/a 
 
In Gln42Asn, the binding at 15 mM sodium is greatly reduced, but the 
presence of almost 10-fold more sodium can restore the sodium-dependent 
binding of L-BH. On the contrary, the binding of L-BH by Gln121Asn does 
not respond to added sodium and remains at approximately the same level 
as binding at 0 mM sodium. This could be due to the putative hydrogen-bond 
to one of the carbonyl oxygen of the hydantoin moiety being broken by 
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shortening of the Gln121 to Asn121 (Figure 3.4), and this bond being 
essential for binding of the ligand. 
The sodium binding site was probed by studying the mutation Ser312Ala 
(Figure 3.9e). Ser312Ala showed a similar behaviour to Gln42Asn, where 
the sodium dependent binding is initially reduced at 15 mM with respect to 
wild-type Mhp1, but is partially restored by the addition of excess sodium. 
Asn318Gly showed a similar behaviour as Gln121Asn, where the affinity for 
L-BH remained approximately as low as in the presence of 0 mM added 
sodium.  
One mutant that was not situated in either the ligand-, or the sodium-binding 
site was also studied, namely Lys110Leu. (Figure 3.9f). The mutation 
Lys110Leu is situated on the interface between the bundle-and hash motifs, 
and showed that the affinity for L-BH was lowered as the sodium 
concentration was increased. The linearity of the plot corresponding to 140 
mM sodium in Figure 3.9f means that the trace could not be fitted to a 
hyperbola. Similar to Gln121Asn and Asn318Gly, the affinity of Lys110Leu to 
L-BH remains low even when sodium is added.  
 
3.3.4 Discussion  
In this section, the purification and characterisation of a number of single-
point mutants of Mhp1 are described, comprising mutations that are found in 
the ligand-binding site (Gln42Asn, Gln121Asn, Asn318Gly), in the sodium-
binding site (Ser312Ala), as well as on the interface between the bundle-
and-hash motifs (Lys110Leu). Overall, the single-point mutants were 
subjected to the same purification and characterisation procedures as 
previously described for wild-type Mhp1, and resulted in the preparation of 
pure and stable samples of the Mhp1 mutant protein. The estimated Tm for 
each of the mutants suggests that stable protein was produced, and that the 
mutations stabilised the Mhp1 protein with respect to the wild-type. The 
tryptophan fluorescence quenching assays show how the ligand binding 
properties of Mhp1 are affected by single-point mutations, outlined in Figure 
3.9 and Table 3.2. In addition, these observations serve as an initial 
indication that different conformations might be adopted by the Mhp1 
mutants and that changes in conformational dynamics might be affected by 
the mutations.  
These changes could be due to the fact that essential stabilising interactions 
are broken, as in the case of Gln121Asn. In the crystal structure of wild-type 
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Mhp1 in its occluded state with L-BH bound (Weyand et al, 2008; Simmons 
et al, 2014), Gln121Asn appears to be in hydrogen bonding distance to one 
of the carbonyl oxygen atoms of the hydantoin moiety of L-BH. By 
shortening the residue to asparagine, the hydrogen bond may be disrupted 
and thus, L-BH cannot be stabilised in its binding site. Alternatively, the 
mutant Gln121Asn could be locked in an different low-affinity conformation 
to which the ligand is less likely to bind.  
In other cases, the changes could be attributed to changes to the dynamics 
and stability of various conformationals. In the presence of 0 mM sodium, 
Gln121Asn, Asn318Gly (ligand-binding site) and Lys110Leu (interface 
between the bundle-and-hash motifs) have higher affinity for L-BH than the 
wild-type protein. This could be due to the mutant protein being stabilised in 
an outward-open form, promoting binding of L-BH. 
In all mutants, the sodium-dependent ligand binding is diminished to a 
certain extent. In the case of Gln42Asn (ligand-binding site) and Ser312Ala 
(sodium-binding site), the partially lost ligand binding affinity could be 
restored upon the addition of excess sodium. This suggests that the 
outward-open conformation might be destabilised, shifting the 
conformational equilibrium towards a lower-affinity, inward-open form. The 
addition of almost 10-fold more sodium is able to shift the equilibrium back to 
a higher-affinity form and restore ligand binding. On the contrary, the 
mutants Gln121Asn and Asn318Gly (ligand-binding site) and Lys110Leu 
(interface between the bundle and hash motifs) appear to remain in a low-
affinity form and do not respond to the same extent as Gln42Asn and 
Ser312Ala to the addition of excess sodium. This suggests that these 
mutants may be locked into an inward-open, low-affinity conformational 
state.  
3.4 Purification and characterisation of seleno-L-methionine 
derivatised Mhp1 for crystallographic studies 
3.4.1 Introduction 
The collection of previously published crystal structures of Mhp1 comprise 
mainly crystal structures of Mhp1 in its occluded form, in complex with 
various ligands, described in section 1.3.2 (Weyand et al, 2008; Simmons et 
al, 2014). These structures have, together with the structure of Mhp1 in the 
outward-open form,  given considerable insight into the structural basis of 
the ligand binding step of the transport mechanism. On the contrary, there is 
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only one crystal structure of Mhp1 in the inward-open state (Shimamura et 
al, 2010), and subsequently much less is known about the transition from the 
ligand-bound occluded state to the inward-open form. Therefore, it is of great 
interest to obtain more structural information on the inward-open form to gain 
more insight about this transition.  
The previously published structure of the inward-open state of Mhp1 was 
obtained from crystals that were produced from seleno-L-methionine 
derivatised protein, under different crystallisation conditions compared to the 
conditions that gave rise to the wild-type structure in the outward-open and 
occluded forms (Shimamura et al, 2010). The resulting crystals also 
crystallised in a different space group, P61  (Table 3.5). As shown in section 
1.3.2, the ligand-binding site in the structure of the inward-open protein 
contained a positive difference density feature, indicating that this site may 
have been occupied by a molecule that could have potentially been 
stabilising that state and thus promoting its crystallisation. This could have 
been a carry-over product from the purification of the methionine auxotrophic 
cells (Peter Henderson, personal communication). In order to gain more 
insight into the structural basis behind the transition from the occluded to the 
inward-open state, it was attempted to reproduce a crystal structure of this 
conformational state at a higher resolution than previously obtained (3.8 Å). 
This could also provide a new opportunity to identify the molecule that 
stabilises the inward-open state. The fact that this ligand putatively locks the 
protein into an inward-open form suggests that this molecule could serve as 
a template for inhibitor design (Shimamura et al, 2010). Regardless of 
whether the stabilising molecule will be present or not, it is also of interest to 
study the inward-open structure in the presence of the hydantoin ligands that 
Mhp1 has previously been co-crystallised with, in order to investigate how 
the ligands interact with Mhp1 on the route to exit the transporter on the 
other side of the membrane.   
 
3.4.2 Purification and characterisation of seleno-L-methionine 
derivatised Mhp1 
Inner membrane preparations of seleno-L-methionine derivatised Mhp1 were 
prepared according to previously established protocols and provided by Mr. 
David Sharples (Shimamura et al, 2010). The inner membrane preparations 
were then subjected to the same purification procedures as used for wild-
type Mhp1. As the seleno-L-methionine derivatised Mhp1 was mainly 
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prepared to perform crystallisation trials, the detergent was exchanged from 
DDM to NM during the washing of the Ni-NTA resin. 
 
Table 3.5 Crystallisation conditions used to obtain the previously 
published crystal structures of the various conformations of 
Mhp1. 
 Orthorhombic Hexagonal 
Conformation of Mhp1 in 
the crystal structure 
Outward-open/ 
occluded 
Inward-open 
PDB ID 
2JLN, 4D1A, 4D1B, 
4D1C, 4D1D 
2X79 
Detergent NM NM 
PEG 300 (% v/v) 27 - 35 24 - 28 
NaCl (mM) 100 100 
Bicine pH 9.0 (mM) - 100 
NaPO4, pH 7.0 (mM) 100 - 
Reservoir volume (µl) 300 400 
Temperature (°C) 20 4 
Crystal morphology Needle-shaped Hexagonal 
Space group P212121 P61 
 
A single band corresponding to His6-tagged, seleno-L-methionine derivatised 
Mhp1 was obtained on a Western blot (Figure 3.10). The main band 
corresponding to Mhp1 migrated approximately as a 45 kDa protein, 
compared to the molecular weight standard proteins, which is consistent with 
the fact that the seleno-L-methionine derivatised Mhp1 has a larger 
molecular weight than wild-type protein (wild-type Mhp1: 54.6 kDa, seleno-L-
methionine derivatised Mhp1 with twenty selenium atoms: 55.5 kDa), and 
that the presence of selenium may cause a difference in resistance to the 
denaturation by SDS. The few faint higher molecular weight bands from the 
eluted, purified protein sample on the SDS-PAGE gel indicates that there 
might be higher-molecular weight impurities or oligomers present, or 
incompletely denatured protein molecules also present (see section 3.2.2).  
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Figure 3.10 The purification of seleno-L-methionine derivatised Mhp1, 
solubilised in NM. 
The lanes in the SDS-PAGE and Western blot contain the same samples, with the 
samples for Western blotting being diluted 1:14 times, and contain: 1) molecular 
weight ladder with the molecular weights marked in kDa left of the gels; 2) 
solubilisation mixture before ultracentrifugation; 3) supernatant and 4) pellet after 
ultracentrifugation; 5) unbound material in the flow-through after binding to the Ni-
NTA resin; 6) wash buffer of the Ni-NTA resin; and 7) eluted sample from the Ni-
NTA resin using 200 mM imidazole.  
 
The fact that higher molecular weight species are not seen on the Western 
blot suggests that these impurities may not be Mhp1, but the 1:14 dilution of 
the samples for Western blotting may have been too low to allow detection 
of any small quantity of oligomeric or partially unfolded Mhp1 molecules. 
Mass spectrometry analysis was carried out by Dr Anton Calabrese and 
showed that one single species of Mhp1 was present in the sample, of the 
expected larger molecular weight with twenty selenium atoms incorporated 
(55.5 kDa). 
The fluorescence quenching assay shows that, in comparison to wild-type 
Mhp1, the affinity of seleno-L-methionine derivatised Mhp1 for L-BH is 
slightly increased in the presence of 0 mM added sodium, but less so in the 
presence of 15 mM added sodium (Figure 3.11, Table 3.6). At 0 mM added 
sodium, this effect could be due to the sodium binding site being stabilised 
by the sodium coordinating residue Met39, thus promoting an outward-open 
conformation with high affinity for L-BH. Alternatively, the twenty methionine 
residues that are evenly distributed throughout the protein may overall 
stabilise and shift the dynamics of the protein in a way that favours binding 
of L-BH.  
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Figure 3.11 The binding of L-BH to seleno-L-methionine derivatised 
Mhp1, solubilised in NM. 
The figure shows the fluorescence quench during titrations of L-BH (0-2 mM) with 
the wild-type Mhp1 (a) and seleno-L-methionine derivatised Mhp1 (b). The titrations 
were performed in the presence of 0 mM (red) and 15 mM (blue) added sodium 
chloride. Mhp1 samples (in 10 mM Tris-HCl pH 7.6, 2.5% v/v glycerol, 10 mM DTT, 
0.5% w/v NM) were diluted to 140 µg/ml using buffers containing 50 mM Tris-HCl 
pH 7.6, 2% v/v DMSO, 10 mM DTT, 0.5% w/v NM, 0/15 mM NaCl and 140/125 mM 
choline chloride. The error bars display the standard error of the mean from three 
replicates of each titration.  
 
Table 3.6 Apparent Kd and Bmax values for seleno-L-methionine 
derivatised Mhp1, solubilised in NM. 
Mhp1  [Na+] App. Kd (mM)  Bmax (%)  
SeMet 0 
15 
1.75 ± 0.53 
0.18 ± 0.023 
19.22 ± 3.35 
16.97 ± 0.50 
WT  0 
15 
3.66 ± 0.82 
0.27 ± 0.015 
22.93 ± 3.70 
18.95 ± 0.28 
 
3.4.3 Discussion  
Seleno-L-methionine derivatised Mhp1 was successfully purified, and the 
subsequent mass spectrometry analysis of the protein confirmed the 
presence of one population of the derivatised protein, with twenty selenium 
atoms incorporated. A small amount of impurities appeared on the SDS-
PAGE gel, and unfortunately CD analysis of the secondary structure and 
thermal stability was not performed that could confirm the structural integrity 
and melting point of the protein. However, the functional analysis of the 
seleno-L-methionine derivatised Mhp1 showed that the protein was 
functional, which suggests that the protein was indeed properly folded. The 
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slight decrease in affinity for L-BH in the presence of 15 mM sodium 
suggests that the sodium binding is affected by the incorporation of seleno-
L-metionine into Mhp1, which is consistent with the fact that the carbonyl 
oxygen of Met39 is involved in the coordination of the sodium. Overall, the 
quality controls indicate that functional and relatively pure protein was 
produced, which will be taken forward to crystallisation trials.  
The tryptophan fluorescence quenching assay shows only a slight decrease 
in binding affinity for L-BH to the seleno-L-methionine derivatised Mhp1 
compared to wild-type protein (Figure 3.11, Table 3.6), and does not give a 
direct indication of whether a different conformational state may be present 
or whether there is another ligand that co-exists in the protein solution and 
binds to the seleno-L-methionine derivatised protein. On the other hand, the 
raw fluorescence intensity values were found to be approximately four times 
lower for seleno-L-methionine derivatised Mhp1 compared to wild-type 
Mhp1, indicating that the initial fluorescence properties of the derivatised 
protein were perturbed, potentially due to the protein adopting a different 
conformation or due to the presence of an additional ligand, as previously 
suggested by structural studies of the seleno-L-methionine derivatised Mhp1 
(Shimamura et al, 2010). 
3.5 Purification and characterisation of Mhp1 in maltoside 
detergents of varying length for scattering studies 
3.5.1 Introduction 
The presence of detergent micelles greatly complicates SAXS studies of 
membrane proteins, as they contribute significantly to the total scattering 
signal and also make it difficult to achieve accurate buffer subtraction. SEC-
SAXS has been suggested as a method to circumvent the problems 
imposed by the presence of detergents in SAXS studies of membrane 
proteins (Weyand et al, 2008; Berthaud et al, 2012b; Simmons et al, 2014). 
In order to investigate the applicability of SEC-SAXS to Mhp1, it was 
prepared in detergents with varying alkyl chain lengths. 
The detergents were chosen on the basis of previous results, where Mhp1 
has been successfully purified in DDM (Weyand et al, 2008; Jackson, 2012; 
Simmons et al, 2014), as well as in NM for crystallisation trials as part of this 
Thesis and for previously published crystal structures. NM differs from DDM 
in that its aliphatic hydrocarbon chain is three carbons shorter. Due to the 
success of the purification of Mhp1 in DDM and NM, the detergents n-
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undecyl-β-D-maltopyranoside (UM) and n-decyl-β-D-maltopyranoside (DM), 
which position themselves in-between DDM and NM in hydrocarbon chain 
length were assayed (Figure 3.12). 
 
 
Figure 3.12 The structure of the maltoside detergents used in this 
project. 
The common maltoside head-group structure is illustrated for the four detergents 
used in this project (blue), with the length of each of the aliphatic hydrocarbon 
chains (red) indicated by the number of carbons in parentheses (nC). 
 
3.5.2 Purification and characterisation of wild-type Mhp1 
solubilised in maltoside-detergents with varying aliphatic 
chain length 
As described in section 2.2.1, detergent exchange was achieved by adding 
an additional washing step of the Ni-NTA resin. The first washing step 
involves washing the resin with buffer containing DDM, in order to initially 
wash off impurities and unbound protein. The second washing step was 
performed using buffer that contained the detergent of interest, which was 
NM in the case when protein was prepared for crystallisation trials. The 
samples of Mhp1 solubilised in various detergents were prepared in two 
batches. Each batch was used to purify two different Mhp1-detergent 
complexes, and was initially solubilised in DDM. After incubation with the Ni-
NTA resin, the resin was divided into two parts and the two parts were 
subjected to separate washes with buffers containing different detergents 
(Figure 3.13).  
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Figure 3.13 The purification of wild-type Mhp1 solubilised in maltoside 
detergents with varying aliphatic chain length. 
The cut-out lanes in the SDS-PAGE gel (a) and corresponding Western blot (b) for 
batch 1, used for the purification of wild-type Mhp1 solubilised in DDM and NM. The 
lanes in the SDS-PAGE gel (c) and corresponding Western blot (d) for batch 2, 
used for the purification of wild-type Mhp1 solubilised in UM and DM. See Appendix 
B for the full gels.  
 
Analysis by Western blotting confirms the presence of Mhp1 in each of the 
eluted samples, which appear to have been prepared with a minimal amount 
of impurities as seen on the SDS-PAGE gels. From the gels, it appears that 
the solubilising detergent does not significantly affect the stability or 
homogeneity of the purified protein.  
The functionality of the wild-type Mhp1 solubilised in the maltoside 
detergents with varying aliphatic chain length was assessed using the 
fluorescence quenching assay. Overall, the same sodium-dependent binding 
is seen as described in 3.2.5, with the affinity for L-BH increasing in the 
presence of 15 mM sodium (Figure 3.14). The general trend is that the 
apparent Kd and Bmax increase the shorter the reconstituting maltoside 
detergent is (Table 3.7).  
 
DDM  NM  (a) (b) (c) (d) DDM  NM  UM  DM  UM  DM  
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Figure 3.14 The binding of L-BH to wild-type Mhp1, solubilised in 
maltoside detergents of varying length.  
The figure shows the fluorescence quench during titrations of L-BH (0-2 mM) with 
the wild-type Mhp1, solubilised in the maltoside detergents DDM (a), UM (b), DM 
(c) and NM (d). The number of carbons (nC) in the hydrocarbon chain is indicated 
next to the abbreviations of each detergent. The titrations were performed in the 
presence of 0 mM (red) and 15 mM (blue) added sodium chloride. Mhp1 samples 
(in 10 mM Tris-HCl pH 7.6, 2.5% v/v glycerol, 10 mM DTT, 0.5% w/v NM) were 
diluted to 140 µg/ml using buffers containing 50 mM Tris-HCl pH 7.6, 2% v/v 
DMSO,% w/v detergent as indicated for the storage buffer in Table 2.3, 0/15 mM 
NaCl and 140/125 mM choline chloride. The error bars display the standard error of 
the mean from three replicates of each titration.  
 
The shorter the detergent the protein is reconstituted into, the smaller would 
be the putative detergent corona surrounding the hydrophobic belt around 
the protein. The effect of this is that more of the protein may become 
exposed to the solvent than with a longer detergent, potentially causing the 
formation of transient protein-protein interactions that might disrupt the 
binding of ligands. Another possibility is that a smaller detergent corona 
might create more strain around the protein, making it more rigid and less 
mobile. This is a more likely cause for the observed decrease in binding 
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affinity, as the tighter detergent corona might be restricting the 
conformational changes that are required to occur for ligand binding.  
 
Table 3.7 Summary of the apparent Kd and Bmax values for Mhp1 
solubilised in maltoside detergents of varying length. 
Detergent  [Na+] App. Kd (mM)  Bmax (%)  
DDM 0 
15 
2.32 ± 0.20 
0.13 ± 0.016 
26.92 ± 1.49 
22.2 ± 0.55 
UM  0 
15 
1.76 ± 0.12 
0.19 ± 0.010 
32.14 ± 1.30 
24.33 ± 0.30 
DM 0 
15 
8.26 ± 6.68 
0.26 ± 0.031 
54.06 ± 36.96 
23.3 ± 0.73 
NM 0 
15 
12.82 ± 29.02 
0.44 ± 0.041 
43.59 ± 88.15 
20.24 ± 0.63 
 
3.5.3 Discussion  
Wild-type Mhp1 was successfully produced in four maltoside detergents with 
varying aliphatic chain length, for subsequent studies by SEC-SAXS. The 
SDS-PAGE and Western blotting analysis indicated that the final detergent 
which was used to solubilise the Mhp1 protein did not significantly affect the 
protein’s integrity or stability in terms of their resistance to denaturation by 
SDS.  
The binding affinity decreases with shorter aliphatic chain, indicating that the 
most crystallisable type of Mhp1 (solubilised in NM) is the one that binds L-
BH the weakest. This could be due to the fact that shorter detergents may 
make the protein more rigid and restrict the conformational changes required 
to bind ligands efficiently. However, it is difficult to assess the degree of the 
detergent exchange that is achieved by changing the wash buffer of the Ni-
NTA resin; SEC-SAXS will potentially be a useful tool to assess this.  
An approximate thickness of DDM detergent corona, derived from previously 
reported values determined using SAXS, is 39.6-41.2 Å (Lipfert et al, 2007) 
while the thickness of a DM micelle is likely to be 36.0-37.6 Å. The average 
thickness of the E. coli inner cytoplasmic membrane has previously been 
reported to be 37.5 ± 0.5 Å (Shimamura et al, 2010; Mitra et al, 2004). This 
suggests that an NM detergent corona might be too small to support 
efficiently the conformational changes required for optimal ligand binding.  
- 64 - 
 
3.6 General discussion and conclusions 
In this Chapter, the purification and characterisation of a number of variants 
of Mhp1 are described, including single-point mutants, seleno-L-methionine 
derivatised protein, as well as protein solubilised in detergents with varying 
aliphatic chain length. These variants were prepared and characterised for 
further X-ray crystallographic and scattering studies.  
A number of mutants; including  Gln42Asn, Gln121Asn, Ser312Ala, 
Asn318Gly, Thr313Ile as well as Lys110Leu were successfully produced. All 
the mutants were investigated using CD, confirming that they adopted an α-
helical fold and are thermally stable in the temperature range at which the 
subsequent characterisation and structural studies are carried out. The Tm 
has been suggested to be an important factor for the success of protein 
crystallisation trials. A study has shown that protein with a Tm of 44.85 °C or 
higher crystallised in 49% of cases (Shimamura et al, 2010; Dupeux et al, 
2011). This suggests that the wild-type Mhp1 protein produced here, of 
which the melting point was estimated to be 50.3 °C, is a good candidate for 
initial crystallisation trials. All single-point mutants appeared to have higher 
Tm values than wild-type, suggesting that all these mutants should be equally 
good crystallisation targets as wild-type Mhp1, provided that they adopt a 
crystallisable conformation. The tryptophan fluorescence quenching assays 
on the mutants give insights into the change in conformational dynamics that 
the mutants undergo, which affects the ligand binding. Obtaining an 
alternative conformational state along the path of the alternating access 
mechanism is of great interest, and will be further investigated in Chapter 5. 
In particular, an inward-open like conformational state is desirable, as there 
is only one crystal structure available for Mhp1 in this conformation 
(Shimamura et al, 2010). For this purpose, seleno-L-methionine derivatised 
Mhp1 was also produced, in order to attempt the reproduction of the inward-
open form of Mhp1 to further establish the structural basis behind ligand 
transport through the protein and the coupling of the transport of sodium and 
ligand. In addition, the studies of the Mhp1 mutants highlighted the mutants 
Gln42Asn and Ser312Ala as potential targets to study the molecular basis 
behind how sodium and ligands are co-transported. In these mutants, the 
sodium-dependent ligand binding is diminished with respect to the wild-type 
protein, but can be restored to some degree upon the addition of excess 
sodium.   
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Having established the purification procedures to produce stable and 
functional protein, and identified the altered functionality of various mutants, 
the next step is the structural characterisation of these variants in order to 
establish the structural basis behind their altered functional behaviour. This 
primarily involves subjecting these mutants to crystallisation trials and 
structure solution where well-diffracting crystals will be obtained.  
Despite the fact that there are crystallisation conditions already published for 
Mhp1, crystallisation still remains a trial-and-error process, with no 
guarantee that the protein produced for this project will produce well-
diffracting crystals. Therefore, Mhp1 reconstituted into various detergents 
was also produced in order to investigate the potential of using SEC-SAXS 
as an alternative structural technique for the characterisation of membrane 
transport proteins that are reluctant to crystallise. Interestingly, the 
characterisation of these Mhp1-variants showed that the protein loses its 
efficiency to bind ligand with shorter detergent, and this will be further 
investigated in Chapter 6.  
The mutants and variants studied in this Thesis make up only a minor 
fraction of the possible combinations of mutations and detergent 
combinations possible. Therefore, future directions involve extending the 
repertoire of mutants, as well as studying the effect of combinations of 
mutations in the Mhp1 protein, in order to further unravel the structural basis 
behind the transport mechanism of Mhp1.  
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Chapter 4: Optimisation of the crystallisation of Mhp1 mutants 
for X-ray crystallographic studies  
4.1 Introduction  
Obtaining a crystal structure may be viewed as the ultimate experiment to 
obtain structural information about a protein of interest. X-ray crystallography 
has the potential to provide structural information at near-atomic resolution, 
from which the structural basis of the interactions between single residues 
and ligands and associated conformational changes can be clearly 
elucidated.  
However, obtaining a crystal structure requires the production of well-
diffracting protein crystals, a process which is, even today, a trial-and-error 
process that usually requires extensive screening and optimisation of 
crystallisation conditions. In addition, it is especially challenging for 
membrane proteins due to their hydrophobic nature, as discussed in section 
1.4.4.  
As outlined in section 1.5, one of the central aims of this Thesis is to study 
Mhp1 mutants with altered ligand binding behaviour in order to gain more 
knowledge about the transport mechanism of the protein. In Chapter 3, the 
production and characterisation of a number of Mhp1 variants was 
described, for which previously published crystallisation conditions of Mhp1 
provide an excellent starting point for crystallisation trials. However, the 
majority of the protein purifications and crystallisation trials that led to the 
previously published structures were carried out at the Membrane Protein 
Laboratory (MPL) at Diamond Lightsource, from membrane preparations 
that were produced at the University of Leeds and shipped to the MPL. 
Although the bacterial fermentations and membrane preparations for this 
project were carried out in the same environment and according to the same 
procedures, the protein purification and crystallisation trials were to be 
carried out at the University of Leeds under different environmental 
conditions. Even though the previously published conditions were successful 
in yielding crystals, further optimisation was still required to obtain well 
diffracting crystals. In this Chapter, the optimisation and experiments carried 
out in order to obtain well-diffracting crystals of the variants of Mhp1 for 
crystallographic studies are described.  
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4.2 Reproduction and optimisation of previously published 
crystallisation conditions 
4.2.1 Introduction 
Previously established crystallisation conditions have made it possible to 
determine structures of the Mhp1 protein in various conformational states, as 
well as in complex with a series of different hydantoin compounds (Weyand 
et al, 2008; Shimamura et al, 2010; Simmons et al, 2014). Two different 
crystallisation conditions have been identified, giving rise to two different 
crystal forms, in which the protein adopts different conformations (Table 4.1). 
The majority of the previously published crystal structures, adopting either 
the outward-open or occluded states, crystallised in an orthorhombic lattice 
in space group P212121 (Weyand et al, 2008; Simmons et al, 2014). The only 
structure of Mhp1 in the inward-open state crystallised in a hexagonal crystal 
lattice in space group P61, under more basic conditions and in a different 
buffer (Shimamura et al, 2010).  
Table 4.1 Crystallisation conditions used to obtain the previously 
published crystal structures of the various conformations of 
Mhp1. 
The table is replicated from Table 3.5 in section 3.4.1. 
 Orthorhombic Hexagonal 
Conformation of Mhp1 in 
the crystal structure 
Outward-open/ 
occluded 
Inward-open 
PDB ID 
2JLN, 4D1A, 4D1B, 
4D1C, 4D1D 
2X79 
Detergent NM NM 
PEG 300 (% v/v) 27 - 35 24 - 28 
NaCl (mM) 100 100 
Bicine pH 9.0 (mM) - 100 
NaPO4, pH 7.0 (mM) 100 - 
Reservoir volume (µl) 300 400 
Temperature (°C) 20 4 
Crystal morphology Needle-shaped Hexagonal 
Space group P212121 P61 
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These two different crystallisation conditions will be referred to as the 
conditions for the orthorhombic or hexagonal crystal form in this Thesis. 
These crystallisation conditions also gave rise to different crystal 
morphologies, with the conditions for the orthorhombic form giving rise to 
long needle-shaped crystals (Shimamura et al, 2008), while the conditions 
for the hexagonal form producing hexagonal crystals (Peter Henderson, 
personal communication). In order to assess whether these conditions could 
be further exploited for the Mhp1 variants produced for this project, or 
whether re-screening for alternative crystallisation conditions would be 
required, reproduction of the crystallisation conditions outlined in Table 4.1 
was initially attempted. 
 
4.2.2 Reproduction of the crystallisation conditions for the 
outward-open and occluded forms with wild-type Mhp1 
Wild-type Mhp1 was produced according to previously published 
procedures, which have been described in Chapter 2 and 3. This protein 
was used for initial trials for the reproduction of the crystallisation conditions 
for the orthorhombic crystal form. In the initial trials, the conditions from the 
original publication (Table 4.1) were replicated in 24-well plates in a hanging-
drop configuration, and left to incubate in a crystal tray incubator at 18 °C. 
The concentration of polyethylene glycol (PEG) 300 was varied between 27-
37% (v/v) with 2% increments and the sodium chloride concentration was 
varied between 60-120 mM with 20 mM increments. Since an essential step 
in the purification of Mhp1 for crystallisation trials was the detergent 
exchange from n-dodecyl-β-D-maltopyranoside (DDM) to n-nonyl-β-D-
maltopyranoside (NM) (Shimamura et al, 2008), both DDM-solubilised and 
NM-solubilised wild-type Mhp1 were prepared and subjected to initial 
crystallisation trials. Both proteins were suspended over the same 
crystallisation wells in the initial screen and it was found that detergent 
exchange in NM is indeed required to promote crystal formation, also for the 
protein produced for this Thesis. In the droplets containing DDM-solubilised 
Mhp1, no crystals formed while showers of crystals readily appeared in the 
droplets containing NM-solubilised Mhp1 (Figure 4.1). 
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Figure 4.1 Crystallisation of wild-type Mhp1 solubilised in DDM and NM. 
The photo depicts a crystallisation well with 0.25 µl droplets of DDM-solubilised (a, 
c) and NM-solubilised (b, d) Mhp1 mixed in a 1:1 (a, b) and 1:2 (c, d) ratio with a 
reservoir solution containing 29% (v/v) PEG 300, 80 mM NaCl and 100 mM NaPO4 
(pH 7.0) in a hanging-drop configuration over 300 µl of the reservoir solution. No 
crystals formed in the droplets with DDM-solubilised Mhp1, while NM-solubilised 
Mhp1 readily formed into needle-shaped crystals. The photo was taken three days 
after setting up the tray.  
 
After the initial crystallisation screen, narrower grid screens were set up 
around the conditions that gave rise to the largest crystals, using left over 
protein from the purification, that had been flash frozen in liquid nitrogen and 
stored at -80 °C. The final optimal conditions varied between purification 
batches, but typically the largest crystals were obtained at 30-33% (v/v) PEG 
300,100 mM sodium chloride and 100 mM NaPO4 (pH 7.0).  
 
4.2.3 Reproduction of the crystallisation conditions for the 
inward-open form with wild-type and seleno-L-methionine 
derivatised Mhp1 
The production of seleno-L-methionine derivatised Mhp1 was described in 
section 3.4.2. The protein was subjected to the previously published 
crystallisation conditions for the hexagonal crystal form (Table 4.1). The 
screens were set-up in 24-well plates in a hanging-drop configuration and 
left to incubate at 4 °C. At the time of the set-up of these screens, a crystal 
tray incubator with accurate temperature control at 4 °C was not available, 
so the trays were incubated in a cold-room (4 °C). These trials resulted in 
the formation of long needle-shaped crystals, but no hexagonal crystals. The 
(a) (b) 
(c) (d) 
1 mm 
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needle-shaped crystals were considerably thinner than obtained with wild-
type protein in trials to reproduce the conditions for the orthorhombic crystal 
form, and hence could not be harvested for diffraction studies. One reason 
for this outcome could that the temperature control was not sufficiently 
accurate in the common cold-room. With temperature fluctuations due to the 
daily use of the room, the equilibration of the crystallisation droplet against 
the reservoir solution could have been disturbed. These trials were also 
repeated with (un-derivatised) wild-type Mhp1, which gave rise to needle-
shaped crystals similar to those obtained from the crystallisation conditions 
for the orthorhombic crystal form. 
To repeat the experiment with more accurate temperature control, crystal 
trays were set up and left to incubate in a Rock Imager 1000 (Formulatrix) 
crystal tray hotel at 4 °C. The Rock Imager 1000 is designed to store only 
96-well plates. Hence, the crystallisation conditions for the hexagonal crystal 
form were scaled down from 24- to 96-well plates by a scale factor of 0.15. 
This resulted in 0.22 µl droplets of protein solution being mixed in a 1:1 ratio 
(resulting in 0.44 µl  droplets) with 60 µl of reservoir solution, where the PEG 
300 concentration was varied between 24-29% and the concentration of 
sodium chloride was varied between 50-200 mM. The crystallisation droplets 
were set up in a sitting-drop configuration, and set up using a robot rather 
than by hand. In this scaled down screen, no crystals were obtained at all. 
This could be because the smaller volume and altered geometry of the 
crystal tray perturbed the crystal growth kinetics preventing nucleation.  
 
4.2.4 Discussion 
Crystals of NM-solubilised wild-type Mhp1 in the orthorhombic crystal form 
were successfully reproduced using the published crystallisation conditions, 
yielding typically 0.1-1 mm long needle-shaped crystals. The harvesting and 
diffraction quality of these crystals will be described in the following section 
(4.3). 
In contrast, the crystallisation conditions for the hexagonal crystal form, 
which were used to obtain the structure of the inward-open form of seleno-L-
methionine derivatised protein, did not yield hexagonal crystals. Only long 
needle-shaped crystals were obtained, which were considerably thinner than 
the crystals obtained for wild-type Mhp1. These crystals could not be 
successfully harvested for diffraction data collection to evaluate the crystal 
form.  
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There are several possible reasons for the lack of hexagonal crystals from 
either the seleno-L-methionine derivatised Mhp1 or with non-derivatised 
wild-type protein. For trials in 24-well plates, inaccurate temperature control 
during the equilibration of the crystallisation tray is likely to have disrupted 
the crystal growth process. When reproducing the conditions in a more 
controlled environment using a Rock Imager 1000 with accurate temperature 
control at 4 °C, the conditions had to be modified to adapt them to the 96 
well plate format. Scaling down the conditions, and changing the 
configuration of the crystallisation trials into a sitting-drop configuration 
appeared to alter the growth kinetics so much that no crystals of either form 
were obtained with seleno-L-methionine derivatised Mhp1. 
Only one previously published structure of Mhp1 crystallised in the inward-
open state in a hexagonal lattice and space group P61 (PDB 2X79), has 
been reported. In contrast, the five other published structures of Mhp1 are all 
crystallised in the outward-open or occluded states with an orthorhombic 
lattice and space group P212121 (PDB 2JLN, 4D1B, 4D1A, 4D1C and 4D1D). 
This distribution of space groups obtained from Mhp1 crystals suggests that 
the orthorhombic crystal form might be more favoured, potentially due to the 
fact that the outward-open or occluded states might be more stable, and 
hence crystallisable, forms of the protein.  
The presence of unidentified electron density in the ligand binding site of the 
previous structure of Mhp1 in the inward-open form suggests that this 
conformation may be stabilised by ligand binding. The main difference 
between the structure determined of the protein in the inward-open 
conformation is that the crystals were produced from seleno-L-methionine-
derivatised protein. As well as resolving the Mhp1 protein in an inward-open 
conformation, the electron density map also revealed a significant positive 
electron density feature in the ligand binding site. This positive electron 
density feature could not be assigned to any of the components in the 
crystallisation conditions, and has been proposed to be a carry-over product 
from the purification of the seleno-L-methionine derivatised protein from 
methionine auxotrophic E. coli cells (Peter Henderson, personal 
communication). It is possible that this carry-over is expression and/or 
purification batch specific and that in the derivatised protein prepared during 
for this Thesis, the ligand was absent.  
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4.3 Protein crystal harvesting and cryo-protection methods 
4.3.1 Introduction 
Prior to a crystallographic experiment at a synchrotron or in-house X-ray 
source, the protein crystals need to be harvested from the crystallisation 
drop, mounted in appropriate crystal sample holders and in cases where the 
data collection will be carried out at cryogenic temperatures (near 100K), 
cryo-protection is also required (Pflugrath, 2004).  
Data collection at cryogenic temperatures greatly reduces radiation damage 
induced by the X-ray radiation in protein crystals, and makes it possible to 
collect complete data sets from single crystals (Garman & Schneider, 1997; 
Hope, 1988). The standard method for cryo-cooling crystals is flash-cooling 
by plunging mounted crystals into liquid nitrogen. However, this process 
often introduces artefacts into the crystal lattice due to mismatches in the 
thermal expansion coefficients between the solvent in the crystal interstitial 
volumes and the protein (Alcorn & Juers, 2010). Inhomogeneous and/or 
crystallisation of the solvent phase can cause high crystal mosaicity, 
reduced resolution and ice rings in the diffraction pattern. Cryo-protection of 
protein crystals attempts to minimise the detrimental effects of the cooling on 
the crystal lattice. Strategies for cryo-protection involve, for example, 
subjecting crystals to higher concentrations of cryo-protecting agents such 
as PEG or glycerol, the roles of which are to exclude and minimise excess 
solvent in the crystal lattice (Berejnov et al, 2006; Garman & Mitchell, 1996; 
McFerrin & Snell, 2002).  
 
4.3.2 In-house harvesting and cryo-protection of Mhp1 crystals 
The crystals obtained from the initial crystallisation trials were harvested in-
house for screening at the in-house X-ray source or at a synchrotron. 
Various sample mounts were used, such as nylon loops, MiTeGen 
MicroMeshes™ (Figure 4.3b) and elongated MiTeGen MicroLoopsE™, 
which are designed to support long rod-shaped crystals. The sample mounts 
were selected according to the crystal size and position in the droplet prior to 
opening the crystallisation well. For the previously published crystal 
structures of Mhp1, no additional cryo-protection was performed and the 
crystals were flash-cooled by being directly plunged into liquid nitrogen 
(Weyand et al, 2008; Shimamura et al, 2010; Simmons et al, 2014). 
Therefore, in the initial harvesting attempts crystals were cooled by direct 
plunging into liquid nitrogen. 
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The harvesting procedure of the Mhp1 crystals obtained here presented a 
number of challenges. In most cases, the crystals would break upon 
attempting to extract them from the droplet with the sample mounts. In other 
cases, the crystals would start bending, or even dissolving, as soon as the 
crystallisation droplet was interfered with. In cases where there was 
precipitation in the droplets, crystals would often stick to the precipitate, 
making it difficult to harvest even a fragment of these crystals. From the 
crystal fragments that were harvested and cooled, the resulting diffraction 
ranged between 15-6 Å and was often irregular, with split spots and/or 
multiple overlapping lattices (Figure 4.2). No reproducible difference was 
observed in the quality of the diffraction with different choices of crystal 
mount. 
 
 
 
 
 
 
 
 
 
Figure 4.2 A low-resolution diffraction pattern from an Mhp1 crystal. 
The image shows an example of a typical diffraction pattern obtained from the initial 
crystals of the Mhp1 protein. The dashed grey circle shows the diffraction limit at 6 
Å, and the inset displays a zoomed-in section of the diffraction pattern, highlighting 
the presence of multiple lattices. 
 
According to previous studies, the minimal concentration of PEG 200 and 
PEG 400 required for successful cryo-protection of protein crystals is 35.7-
37.5% and >35% (v/v), respectively (McFerrin & Snell, 2002; Berejnov et al, 
2006). This suggests that the minimal concentration of PEG 300 required for 
successful cryo-protection is likely to be in the range between 35-37.5% 
(v/v). After optimisation of the crystallisation conditions for the orthorhombic 
crystal form (Table 4.1), the reservoir solution typically contained 30-33% 
PEG 300. During the crystallisation experiment, the PEG 300 concentration 
6 Å 
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increases due to dehydration of the crystallisation droplet as it equilibrates 
against the reservoir solution. However, it is difficult to determine whether 
the dehydration of the droplet is sufficient for the concentration of PEG 300 
to reach an appropriate concentration range for cryo-protection of the Mhp1 
crystals.  
To determine whether the low, disordered diffraction obtained from the initial 
crystals of wild-type Mhp1 was a result of cryo-cooling artifacts, further cryo-
protection was attempted. This was done by increasing the concentration of 
PEG 300 in the crystallisation droplet by step-wise replacement of the liquid 
in the crystallisation droplet. This was done by adding 1 µl of mother liquor 
solution to the crystallisation droplet, containing a higher concentration of 
PEG 300 than in the reservoir solution over which the crystals that were 
being harvested had grown. After letting the added solution merge with the 
crystallisation droplet, 1 µl was removed from the merged droplet. This 
procedure was then repeated several times with progressively higher PEG 
300 concentrations. The PEG 300 concentration was typically increased in 
1-2% steps. However, this strategy was unsuccessful as the crystals 
dissolved upon the addition of any additional solutions to the crystallisation 
droplet. No crystals could be successfully harvested in these experiments. 
Therefore, direct plunging into liquid nitrogen without any further cryo-
protection was subsequently used during this project.  
 
4.3.3 An alternative harvesting strategy to minimise Mhp1 crystal 
handling 
Overall, the crystals from wild-type Mhp1 obtained using the crystallisation 
conditions for the orthorhombic crystal form appeared to be highly fragile 
and sensitive to any outside interference. This made the harvesting of the 
Mhp1 crystals very challenging, and the resulting low and disordered 
resolution reflects the the fragility of these crystals. An alternative 
crystallisation strategy was devised to minimise the handling of the crystals, 
in order to investigate whether it is the actual harvesting procedure, which 
involved (often) repeated mechanical manipulation of the crystals while 
trying to mount them into the sample mounts. The crystallisation experiment 
was modified in order to grow crystals directly on mounts for diffraction data 
collection (Figure 4.3). This modification circumvents the harvesting step, 
completely avoiding making any direct contact with the crystals. If the 
harvesting step of the fragile crystals is the primary cause for the low and 
disordered diffraction, this should be an efficient strategy to improve the 
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diffraction quality. The crystallisation conditions for the orthorhombic crystal 
form were used, with wild-type Mhp1. As in the previous crystallisation trials 
performed here, the conditions were set up in 24-well plates, sealed with 
vacuum grease and MiTeGen MicroMeshes™ (Figure 4.3b) were used as 
the sample mounts as they provided a solid support for the crystallisation 
droplet. Crystals readily formed on the MicroMeshes™ (Figure 4.3b), with 
dimensions ranging between 100-500 µm and the meshes could be rapidly 
cooled by plunging into liquid nitrogen. The success of crystallisation in 
these trials is likely because the geometry of the set up depicted in Figure 
4.3a closely resembles the hanging-drop configuration normally employed in 
the initial crystallisation trials. 
 
 
Figure 4.3 The set-up for growth of crystals directly on micro-meshes 
for data collection. 
(a) The illustration depicts a crystallisation well in a 24-well plate. The micromeshes 
used in this experiment were positioned on the rim of the crystallisation well, which 
was pre-greased with vacuum grease, using a pair of tweezers. After placing the 
protein solution and the well solutions onto the mesh, forming the crystallisation 
droplet, the cover slip was placed on top of the pin. The mesh was glued to one 
side of the pin, with enough room for a crystallisation droplet despite the opposite 
side of the pin lying against the cover slide. The vacuum grease around the rim of 
the crystallisation well kept the well sealed from the outside. After leaving the tray to 
equilibrate, the pin was removed using a pair of tweezers, quickly placed into a re-
usable goniometer base and cooled by rapid plunging into liquid nitrogen. (b) The 
size of the crystals that grew on the meshes ranged between 100-500 µm. In the 
photo, the mesh is 400 µm in diameter, and the mesh apertures are 10 µm. 
 
However, no usable diffraction data were collected from these crystals. In 
many cases, crystals were found to be overlapping, which resulted in highly 
disordered and overlapping diffraction patterns with resolution limits not 
exceeding 6 Å.  
 
Pin with  
mesh 
Coverslip 
Vacuum  
grease 
Goniometer base 
Crystallisation drop 
(a) (b) 
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4.3.4 In situ data collection 
A more straight forward and established method for minimising crystal 
handling is in situ diffraction, where the entire crystallisation tray is mounted 
in the X-ray beam at a synchrotron beamline and the crystals are tested for 
diffraction directly in their respective wells (Axford et al, 2012). In situ 
diffraction studies were carried out with wild-type Mhp1 using a MiTeGen In 
Situ-1™ crystallisation plate, designed specifically for this type of 
experiment. The crystallisation trays were set up manually, with 0.5 μl 
protein solution being mixed in a 1:1 ratio with reservoir solution, and 
resulted in needle-shaped crystals 100-500 μm in length. Only very weak 
diffraction spots were observed and a unit cell could be obtained for only one 
of the crystals out of the 27 screened for diffraction. The diffraction was 
highly anisotropic, diffracting at the most to 6 Å, but the lattice could be 
indexed in space group P121 with lattice parameters of a = 92.9 Å, b = 109.4 
Å, c = 114.5 Å, α = β = γ = 90°. 
Despite the fact that the In Situ-1™ crystallisation plate has been designed 
to give rise to minimal background scattering, the low level of background 
scattering could still be high enough to obscure the weak diffraction from the 
Mhp1 crystals. Crystals of detergent-solubilised membrane proteins typically 
contain a significantly higher solvent content compared to soluble proteins 
(Carpenter et al, 2008), resulting in weaker diffraction in comparison to 
soluble protein crystals with similar unit cell sizes. In addition, the presence 
of the crystallisation droplet surrounding the crystals is likely to be a major 
source of background scattering that could be obscuring the low diffraction 
intensities from the crystals grown in the in situ tray. Another possibility for 
the lack of diffraction is simply that disordered crystals formed in the wells, 
perhaps as a result of the alternative vapour-diffusion configuration (sitting-
drop, smaller reservoir volume) compared to the initial classic hanging-drop 
vapour diffusion experiments made with wild-type Mhp1. Finally, the 
crystallisation tray was also transported in a polystyrene box to Diamond 
Lightsource, and the crystals may have suffered internal damage during 
travel.  
 
4.3.5 Discussion 
In this section, the harvesting and cryo-cooling procedures tested for crystals 
of wild-type Mhp1 have been described. The crystals were harvested using 
conventional methods, with cryo-cooling by directly plunging the crystals into 
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liquid nitrogen without any additional cryoprotection. Additional cryo-
protection was attempted but was not successful as the crystals were found 
to dissolve upon the addition of any solution to the crystal containing 
droplets. Indeed, the crystals occasionally dissolved and readily broke during 
any harvesting procedure. The pronounced fragility of these crystals is a 
likely reason for the poor quality of the diffraction that could be obtained from 
these crystals.  
Due to the apparent fragility of the Mhp1 crystals obtained here and the 
difficulties arising during the harvesting procedure, alternative strategies for 
crystal growth and harvesting were investigated to minimise crystal handling.  
The crystallisation set-up described in 4.3.3 is an easy way to minimise 
crystal handling, using conventional and standard consumables and 
materials usually used for crystallisation experiments. If crystallisation 
conditions that do not require additional cryo-protection are available, this 
alternative crystallisation set-up should be an efficient strategy to make the 
harvesting step less time-consuming. However, this strategy did not improve 
the diffraction quality of Mhp1 crystals and no usable diffraction data were 
collected from the crystals grown directly on MicroMeshes™.  
The more straight forward strategy to minimise crystal handling is in situ 
diffraction studies. Crystals were successfully grown in in situ plates, but 
gave rise to only extremely weak diffraction sports and no usable diffraction 
data could be collected.  
4.4 Using diffusion to aid and optimise the crystallisation of 
mutant Mhp1 
4.4.1 Introduction 
Convection-free crystallisation, which can be achieved either under 
microgravity conditions or within thin capillaries, has been shown to promote 
the growth of highly well-ordered crystals (Vergara et al, 2005). In order to 
utilise this phenomenon, microfluidic devices have been developed that have 
been shown to improve the crystallisation process (Dhouib et al, 2009; 
Emamzadah et al, 2009). In section 1.4.4, the basic principle behind protein 
crystallisation is described. Various methods, such as vapour-diffusion, 
dialysis or the batch methods are used to bring the protein solution to a 
supersaturated state, from which crystals may form and grow if the 
supersaturation is achieved in the nucleation zone.  
- 78 - 
In a counter-diffusion experiment, the protein and precipitant solution are in 
a configuration that allows the two solutions to diffuse into one another, for 
example, from opposite ends of a thin capillary. This creates a 
supersaturation gradient across the capillary, allowing for a wider sampling 
of the phase diagram, increasing the probability of achieving successful 
crystal formation and growth (Figure 4.4). 
 
 
 
 
 
 
 
 
Figure 4.4 The phase diagram in a counter-diffusion crystallisation 
experiment. 
The phase diagram corresponds to the diagram depicted in Figure 1.10. The purple 
arrows depict how the concentrations of the protein and precipitant solutions vary 
during a counter-diffusion experiment. The creation of a supersaturation gradient 
allows for the sampling of the nucleation zone, allowing crystal nucleation and 
formation from various positions in the phase diagram.  
 
The crystals of wild-type Mhp1 that were produced using standard 
crystallisation and harvesting approaches gave rise to low resolution and 
disordered diffraction patterns, likely as a result of the fragility of these 
crystals. In order to further explore whether the crystal growth could be 
improved, crystallisation trials were performed using various approaches 
available to harness diffusion for crystal growth optimisation.  
 
4.4.2 Commercially available trays for counter-diffusion 
crystallisation trials 
A number of commercially available crystallisation trays in which counter-
diffusion is utilised to optimise crystallisation were tested with wild-type 
Mhp1 in order to investigate whether this is a viable strategy for optimisation 
of crystal growth.  
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Figure 4.5 The original CrystalFormer™ crystallisation tray for crystal 
growth by counter-diffusion.  
a) Schematic of the CrystalFormer™ tray produced by Microlytic (2.5 x 7.5 cm), 
with the red circles representing the inlets for the protein solution, while the multi-
coloured circles represent the inlet wells for precipitants or screening solutions. The 
side view in the red box shows the configuration of the crystallisation channel. 
Figure from Stojanoff et al., 2011. b) The photographs show some of the wild-type 
Mhp1 crystals formed in the channels of the CrystalFormer™, The left panel depicts 
part of the well where protein was added, and the middle panel is a close up of the 
same channel, showing the size gradient of crystals formed with a precipitant 
solution of 32% PEG 300 and 100 mM NaPO4 pH 7.0. The right panel shows a 
bigger crystal grown along the direction of the micro-channel, in the presence of 
29% PEG 300, 100 mM NaCl and 100 mM NaPO4 pH 7.0. 
 
One of the trays tested with wild-type Mhp1 was the original 
CrystalFormer™ from Microlytic (Stojanoff et al, 2011). This tray has micro-
channels connecting the inlet wells for protein and precipitant solution with 
diameters of 0.1 x 0.15 x 10 mm and a total channel volume of 150 nm3 on a 
small footprint tray (Figure 4.5a). 0.3 µl of protein or reservoir solution were 
aliquoted into each well, sealed with clear tape and left to equilibrate at 20 
°C.  
Wild-type Mhp1 crystals grew readily in the micro-channels of the 
CrystalFormer™ tray. Pronounced crystal size gradients were observed and 
the longest crystals grew to approximately 1 mm (Figure 4.5b). This 
demonstrates that Mhp1 are able to successfully grow within a concentration 
gradient.  
 
(a) (b) 
100 µm  100 µm  
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Figure 4.6 The CrystalHarp™ tray for crystal growth by counter-
diffusion. 
(a) The figure is adapted from the CrystalHarp™ manual supplied by Molecular 
Dimensions. Each crystallisation experiment was contained in a 30 mm long quartz 
capillary with an internal diameter of 0.1 mm. The protein and precipitant solutions 
were loaded into the inlet wells, through which the capillaries were also running. In 
order to allow the solutions to start diffusing through the capillaries, the capillary 
sections running through the inlet wells were broken using a tool supplied with the 
CrystalHarp™ kit. (b) The dimensions of the plastic frame complies with the SBS 
format for screening plates, which made it possible to perform in situ diffraction 
studies. The photos are snapshots from the online camera at the I03 beamline at 
Diamond LightSource, with the red encircled cross representing the position of the 
beam.  
 
A second crystallisation tray that utilises counter-diffusion, the CrystalHarp™ 
from Molecular Dimensions was also tested. In the CrystalHarp™, 30 mm 
long quartz capillaries with an internal diameter of 0.1 mm are mounted in a 
tray that complies with the dimensions formulated by the Society for 
Biomolecular Screening (SBS), giving rise to a channel volume of 236 nm3 
per crystallisation trial. The capillaries are connected to inlets for protein and 
screening solutions (Figure 4.6a). The crystallisation conditions for the 
orthorhombic crystal form (Table 4.1) were pre-mixed in eppendorf tubes 
and added to the inlet wells. Since the dimensions of the plastic frame of the 
CrystalHarp™ is an SBS format tray, in situ diffraction experiments could be 
performed by mounting the entire tray in a dedicated tray mount at a 
synchrotron beamline. 
Crystals also grew readily in the quartz capillaries, both along and 
perpendicular to the direction of the capillaries. The length of the crystals 
typically varied between 100-300 µm. In situ data collection was performed 
at the I03 beamline at Diamond Lightsource but no diffraction data were 
obtained from the crystals in the quartz capillaries (Figure 4.6b). As for 
(a) 
Inlet wells 
Quartz capillaries 
30 mm 
50 µm  
(b) 
50 µm  
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crystals screened for diffractionin the MiTeGen In situ-1 tray (section 4.3.4), 
the crystals grown in the CrystalHarp™ were immersed in crystallisation 
mother liquor, which could be giving rise to background scattering that 
masks the diffraction from the crystals.  
 
4.4.3 Drop morphology modification to optimise crystal growth 
It was discovered that changing the morphology of the crystallisation droplet 
gave rise to a similar crystal growth outcome as when using commercially 
available microfluidic devices for crystallisation trials by counter-diffusion.  
By pipetting the droplet of precipitant solution next to the protein droplet 
while applying a streaking motion with the pipette tip while dispensing the 
precipitant solution through the protein droplet, creating an elongated 
droplet, promoted the formation of a size gradient of crystals in the droplet 
(Figure 4.7). The streaking motion may be causing the formation of a 
temporary gradient of the protein vs. the precipitant solution, mimicking the 
gradients formed in the CrystalHarp™ and CrystalFormer™ and allowing the 
protein and reservoir solution to slowly diffuse into each other.  
The resulting gradient typically resulted in the formation of showers of 
smaller crystals at one end of the droplet that gradually got bigger with a 
few, typically mm-long crystals, protruding from the shower of the smaller 
crystals (Figure 4.8). These crystals were larger and thicker than those 
previously obtained in the initial crystallisation trials, and were considerably 
better separated from the other crystals in the droplet. These crystals were 
also much easier to harvest due to their size and separation from the other 
crystals in the droplet.  
 
4.4.4 Crystallisation of Mhp1 mutants 
The drop morphology modification trick was applied during crystallisation 
trials of the Mhp1 mutants that were described in 3.3. The Mhp1 mutant 
Gln42Asn, in complex with L-BH and L-IMH, were the first mutant ligand 
combinations to be successfully crystallised in this manner. The obtained 
crystals were harvested as described in 4.3.2 and cooled by direct plunging 
into liquid nitrogen without any further cryo-protection. These crystals 
reproducibly gave rise to clean diffraction beyond 4 Å, which is a significant 
improvement on the diffraction quality being obtained previously from wild-
type Mhp1 crystals. This crystallisation strategy, involving the drop 
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morphology modification, was therefore applied to all the other mutants 
studied as part of this Thesis. 
 
 
Figure 4.7 The drop streaking procedure used to introduce a temporary 
gradient of protein vs. precipitant concentration to optimise 
crystal growth. 
The temporary gradient of protein and the precipitating agents in the mother liquor 
was introduced by applying a streaking motion when setting up the crystallisation 
droplet in the following steps: (a) The protein droplet, shown in orange and marked 
with P, was first applied to the cover slide. The grey cone represents a pipette tip. 
(b) The mother liquor droplet, shown in blue and marked with ML, was applied next 
to the protein droplet without making contact with it. As the ML was extruded from 
the pipette tip, the tip was streaked through the protein droplet, indicated by the 
dashed arrow. (c) The cover slide was then inverted in a hanging-drop configuration 
over the crystallisation well. (d) The photos show the formation of crystals over 
three days, with the initial formation of showers of smaller crystals from which a few 
large crystals grew.  
 
Figure 4.8 shows crystals of the Mhp1 mutant Gln42Asn in complex with L-
BH under low-sodium/high-potassium conditions, clearly depicting the crystal 
size gradient formed in the crystallisation droplet.  
Crystals were obtained for all mutants studied as part of this Thesis, either in 
their apo form or in complex with various ligands. All types of crystals were 
screened for diffraction at synchrotron beamlines, and data sets were 
collected from a series of mutant-ligand complexes (summarised in Table 
4.2) in space group P212121, typically with unit cell parameters of a ≈ 90.0, b 
≈ 107.0, c ≈ 107.0 Å, α = β = γ = 90°. The resulting structures that were 
P 
(a) 
ML 
(b) 
(c) 
Day 1 Day 2 
Day 3 1 mm 
ML 
P 
(d) 
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solved from the data sets collected from these crystals will be described in 
Chapter 5.  
Table 4.2 The outcome of the crystallisation trials of Mhp1 mutants. 
Mutant Site of the 
mutation  
Crystals obtained 
(apo or ligand-
complex) 
Data sets collected 
Gln42Asn Ligand Apo, in complex with 
L-BH,  L-IMH or BVH 
In complex with L-BH 
(under high-sodium and 
under low-sodium 
conditions) and L-IMH. 
Gln121Asn Ligand Apo, in complex with 
L-BH or L-IMH  
No data collected due to 
low or poor diffraction. 
Asn318Gly Sodium Apo No data collected due to 
low or poor diffraction. 
Ser312Ala Sodium In complex with BVH 
or L-NMH 
In complex with L-NMH. 
Lys110Leu Bundle/hash In complex with L-BH 
and L-IMH 
In complex with L-BH and 
L-IMH. 
 
4.4.5 Discussion  
Crystallisation by counter-diffusion was initially shown to be successful 
strategy for Mhp1 using commercially available microfluidic trays, including 
the CrystalHarp™ and the CrystalFormer™. Crystals grown in the 
CrystalHarp™ tray were screened for diffraction in situ, but did not give rise 
to any diffraction. This could have been due to the fact that the crystals were 
immersed in solvent, reducing the diffraction signal in a similar way as during 
conventional in situ studies (section 4.3.4).  
Based on the success of these initial experiments, a new crystallisation 
protocol for Mhp1 was developed that used a drop streaking approach to 
generate a gradient of protein vs. precipitant concentration, enabling the two 
solutions to diffuse slowly into each other. By applying a streaking motion 
upon setting up the crystallisation droplet, resulting in an elongated droplet, 
a crystal size gradient was obtained, in which a few larger and thicker, well-
separated crystals typically appeared. These crystals were considerably 
easier to harvest and when tested for diffraction at a synchrotron beamline, 
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routinely gave rise to diffraction beyond 4 Å. These crystals crystallised in 
space group P212121, indicating that the favoured orthorhombic lattice of 
Mhp1 was reproduced. 
 
 
Figure 4.8 The size distribution of crystals of Gln42Asn in complex with 
L-BH, achieved by drop morphology modification. 
Adding a streaking motion upon setting up the crystallisation droplet greatly 
enhanced the crystallisation outcome of Mhp1 mutants. The photo depicts crystals 
of the Mhp1 mutant Gln42Asn in complex with L-BH (a), in the presence of 29% 
PEG 300, 100mM KCl and 100mM KPO4. The modification gave rise to larger 
crystals with improved diffraction quality, routinely diffracting < 4 Å (b). 
 
Applying this crystallisation protocol for the Mhp1 mutants studied as part of 
this Thesis, crystals of a number of mutant-ligand complexes were obtained. 
From these crystals, diffraction data for the mutants Gln42Asn, Ser312Ala 
and Lys110Leu, in complex with various ligands and under varying 
crystallisation conditions were collected. The structures of these mutant-
ligand complexes will be further discussed in Chapter 5.  
Crystals were obtained for all mutants, either in their apo form or in complex 
with a ligand, apart from the Mhp1 mutants Ser312Ala and Lys110Leu, 
which only crystallised in the presence of ligands. Diffraction data sets were, 
however, only obtained from mutant-ligand crystals, and hence not from any 
of the apo crystals. This suggests that Mhp1 mutants form more ordered 
crystals in the presence of ligand. During crystallisation trials, it did appear 
that the Mhp1 mutants crystallised more readily in the presence of ligands. 
This could be due to the ligands promoting crystallisation by acting as 
nucleation agents in the crystallisation mixture. Alternatively, the ligands may 
stabilise and rigidify the conformation of the mutants and hence give rise to a 
better ordered and better diffracting lattice. This idea is supported by the fact 
1 mm 4 Å 
(a) (b) 
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that no usable diffraction data were obtained from the crystals of the mutants 
in their apo form.  
4.5 Post-crystallisation treatments to improve diffraction  
4.5.1 Introduction 
Dehydration has been shown to be a successful method to improve 
diffraction from protein crystals (Esnouf et al, 1998; Heras et al, 2003; 
Abergel, 2004). Dehydration of protein crystals acts as an alternative 
strategy for cryo-protection, as crystals at an optimal relative humidity (RH) 
and with no surrounding mother liquor can often be directly cryo-cooled 
(Pellegrini et al, 2011). In some of these cases, dehydration of protein 
crystals has occurred coincidentally, for example with capillaries cracking or 
crystallisation wells not being sealed properly (Abergel, 2004). Other more 
systematic approaches to dehydrate protein crystals involve, for example, 
transfer to crystallisation wells with an increasing salt concentration, or 
soaking crystals in dehydrating agents (Heras & Martin, 2005). A 
disadvantage of these methods is that the outcome of the dehydration is 
only apparent after the diffraction experiment, making these methods time- 
and material-consuming. In order to overcome these drawbacks, humidity-
controlling systems have been developed for adjusting the RH prior to 
crystal cryo-cooling (Sjögren et al, 2002; Kiefersauer et al, 2000), or for 
dehydration of crystals mounted in the X-ray beam at crystallography 
beamlines (Sanchez-Weatherby et al, 2009). Performing the dehydration on-
line gives the user full control to monitor and adapt the dehydration protocol 
to the changes in diffraction.  
Controlled dehydration using the Humidity Control device HC1 (Sanchez-
Weatherby et al, 2009) has already been used for some of the Mhp1 ligand-
complex structures previously published, namely the structures of Mhp1 in 
complex with L-IMH and the L-NMH structures (Simmons et al, 2014). Due 
to the unsuccessful attempts to cryo-protect Mhp1 crystals described here, 
controlled dehydration was chosen as an alternative cryo-protection method 
to be tested.  
 
4.5.2 On-line humidified gas stream for the dehydration of Mhp1 
crystals at room-temperature 
Diffraction data were collected from a crystal of wild-type Mhp1 to a 
resolution of 3.8 Å (see Table 4.3 for statistics), which had been subjected to 
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controlled dehydration using the HC1 device and then flash cooled in a 
cryogenic gas stream at the diffraction end-station at the I03 beamline at 
Diamond Lightsource. At this beamline both the HC1 and cryogenic stream 
device are mounted on a bracket which allows them to be automatically 
swapped to flash cool samples when an optimal diffraction quality has been 
obtained. In this experiment, the RH was decreased from 98% to 80%, with 
step of 2% and a dehydration rate of 2% per minute. Between each step, the 
crystal was left to equilibrate for approximately 2 minutes, and the diffraction 
quality and change in the lattice parameters was monitored by collecting a 
diffraction image (1 s, 1° oscillation, 1% transmission to give a flux of 2.61 x 
1011 photons s-1) after each step. When a significant decrease of the 
diffraction limit was observed, the crystal was rapidly cryo-cooled by 
automatically switching the HC1 device for the cryogenic gas stream at 100 
K and a full data set was collected.  
The starting RH value of 98% was predetermined using the HC1 software at 
the beamline, by monitoring the size of an approximately 1 µl droplet of the 
mother liquor (from the well containing the crystal that was to be studied; in 
this case containing 27% PEG 300, 100 mM NaCl and 100mM NaPO4, pH 
7.0) in a Hampton nylon loop (~ 0.7 mm diameter). The nylon loop was 
oriented with its plane perpendicular to the on-axis camera and the thickness 
of the droplet was monitored using the image recognition package normally 
used for crystal centering and plotted against the RH value. The RH value 
was adjusted until no change in droplet size was observed and this RH value 
was then used as the starting value for the dehydration experiment.   
A change in the lattice was clearly visualised during the course of the 
dehydration (Figure 4.9), as well as a decreasing diffraction limit. This loss of 
high-resolution diffraction was most likely due to local radiation damage, as 
the diffraction limit was restored if a diffraction image was collected at a 
different position on the crystal. Irreversible effects on the diffraction quality 
were also observed. During the dehydration process, a powder diffraction 
ring appeared at ~ 37 Å, which remained even when diffraction images were 
collection at other positions on the crystals after the appearance of this ring 
(Figure 4.9). The ring may correspond to a peak in the scattering pattern of 
NM micelles, as scattering patterns of DDM and DM micelles include peaks 
at approximately 39 and 34 Å, respectively (Lipfert et al, 2007).  
This could involve a phase change of the detergent phase in the crystal 
lattice, or a local rearrangement resulting in a more structured detergent 
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phase. The contraction of the crystal lattice is likely to also compact the 
detergent corona surrounding the protein molecules.  
 
 
Figure 4.9 Dehydration of a wild-type Mhp1 crystal. 
Diffraction images of 1° oscillation collected while the crystal was subjected to 
dehydration. The red squares encircle three arbitrarily chosen diffraction spots, 
illustrating a change in the lattice as the diffraction spots move out of the plane of 
the detector. The blue arrow in the diffraction image at 91% RH points to a ring that 
appeared during dehydration, which may be a result of reorganisation and/or 
compaction of the detergent phase in the crystal lattice. 
 
The observed change in the diffraction pattern upon the dehydration of the 
wild-type Mhp1 crystal was due to a contraction of the crystal lattice. The 
structure of dehydrated wild-type Mhp1 was indexed in space group P212121, 
exhibiting contracted unit cell edges (a = 86.3, b = 101.7, c = 107.2 Å, α = β 
= γ = 90°) compared to the initial lattice at 98% RH (a = 92.0, b = 109.0, c = 
114.0 Å, α = β = γ = 90°). The data could be used to obtain a molecular 
replacement solution and initial refinement was performed to values of Rwork/ 
Rfree of 27.92/31.18% (Table 4.3).  
The lattice was also contracted with respect to the lattice of the crystals from 
Mhp1 variants produced as part of this Thesis that were not subjected to 
controlled dehydration. These were in space group P212121 with typical unit 
cell parameters of a ≈ 90.0, b ≈ 107.0, c ≈ 107.0 Å, α = β = γ = 90° (section 
4.4.4). 
 
 
 
 
RH: 93 %  
 
91 %  
 
89 % 
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Table 4.3 Data collection statistics for the structure of wild-type Mhp1 
subjected to controlled dehydration using the HC1 device. 
 Wild-type Mhp1 
Wavelength (Å) 0.9763 
Temperature (K) 100 
Space group P212121 
Molecules per assym. unit 1 
Unit cell parameters (Å, °) a = 86.3, b = 101.7, c = 107.2, α = β = γ = 90 
Resolution (Å) 67.24 - 3.8 (4.25-3.80) 
No. of measured reflections 69252 (9719) 
No. of unique reflections 19576 (2683) 
Multiplicity 7.1 (7.3) 
Completeness (%) 99.4 (99.0) 
<I/σ(I)> 8.7 (1.6) 
CC1/2 0.99 (0.89) 
Wilson B factor (Å2) 231.8 
Anisotropy ΔB (Å2) 119.5 
Rmerge (%) 0.125 (1.475) 
Rmeas (%) 0.146 (1.713) 
Rp.i.m. (%) 0.074 (0.861) 
Matthews coefficient (Å3 Da-1) 4.31 
Solvent content (%) 71.48 
Rwork (%)  27.92 (35.57) 
Rfree (%) 31.18 (38.80) 
R.m.s.d.   
       Bonds (Å) 0.0100 
       Angles (°) 1.3918 
Ramachandran outliers (%) 1.53 
Average B factor (Å2) 187.4 
                  Values in parentheses are for the highest resolution shell. 
 
 
4.5.3 Discussion 
Controlled dehydration using the HC1 device at a synchrotron beamline was 
successfully performed on wild-type Mhp1 crystals, demonstrating that it is a 
suitable method to obtain good quality data from Mhp1 crystals. Compared 
to the data statistics of a crystal from the Mhp1 mutant Gln42Asn in complex 
with L-BH, which was cooled by plunging into liquid nitrogen (discussed 
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further in section 5.2.2), the data obtained from a dehydrated crystal with a 
contracted lattice shows improvements in the anisotropy of the data, as well 
as the temperature B factors of the data and the model (Table 4.4). 
 
Table 4.4 Comparison of data statistics obtained from a crystal 
subjected to controlled dehydration prior to cryo-cooling and a 
crystal cooled by plunging into liquid nitrogen. 
 
Wild-type Mhp1  
(cooled after controlled 
dehydration) 
Gln42Asn-(L-BH)  
(cooled directly by plunging into 
liquid nitrogen) 
Unit cell parameters (Å) a = 86.3, b = 101.7, c = 107.2 a = 91.9, b = 107.1, c = 107.2 
High resolution limit (Å) 3.80 3.74 
Wilson B factor (Å2) 231.8 309.5 
Anisotropy ΔB (Å2) 119.5 146.5 
Rmerge (%) 0.125 (1.475) 0.040 (1.192) 
Rmeas (%) 0.146 (1.713) 0.056 (1.641) 
Rp.i.m. (%) 0.074 (0.861) 0.038 (1.124) 
Solvent content (%) 71.48 74.56 
Average B factor (Å2) 187.4 253.0 
 
The dehydration of the crystal from a RH of 98% to 80% induced a reduction 
of the unit cell volume by approximately 18%, resulting in closer packing of 
the Mhp1 molecules in the crystal lattice. This could have reduced the 
mobility of the protein molecules in the detergent rich lattice, giving rise to a 
better packed lattice. With time constraints due to the availability of 
beamtime and the HC1 device, a reproducible protocol for the dehydration of 
Mhp1 crystals was not devised. Further exploration of parameters of the 
dehydration procedure, for example the steps of decrease in RH, the rate of 
dehydration in each step and the equilibration time between each step would 
allow optimisation of the protocol to the crystals to obtain the best possible 
data (Awad et al, 2013). It is likely that the crystals could be pushed to a 
lower humidity level, resulting in an even greater reduction in unit cell 
volume and solvent content, and thus in an even better ordered packing of 
the molecules in the lattice. This could result in a further improvement of the 
anisotropy and B factors of the model, as seen in Table 4.4. An optimised 
protocol would minimise radiation damage by simply not collecting as many 
diffraction images in order to monitor the process, hence preserving the full 
diffraction power of the crystals.  
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The packing of Mhp1 molecules in the lattice obtained from the crystals 
prepared here can be described as ‘zig-zag chains’ of Mhp1 molecules 
(running in the direction of the c-axis), packing against each other in a 
staggered fashion in the directions which are equivalent to the putative 
membrane plane in which the protein is embedded (in the directions of the a- 
and b-axes), illustrated in 
Figure 4.10a and b. The dehydration of a wild-type Mhp1 crystal produced 
here resulted in a contraction of the unit cell parameters by a = 92.0 " 86.3, 
b = 109.0 " 101.7, c = 114.0 " 107.2 Å, resulting in a contraction in the 
direction of the ‘zig-zag chains’, as well as in the directions of the putative 
membrane plane, packing the chains closer against each other. Comparing 
the lattice resulting from a crystal that had been subjected to the controlled 
dehydration with one obtained previously (with typical lattice parameters a ≈ 
90.0, b ≈ 107.0, c ≈ 107.0 Å, see section 4.4.4), the contraction occurred 
mainly in the directions of the a- and b-axes. The contraction of the a- and b-
axes results in closer packing of the protein chains against each other, 
probably packing the detergent phase. This is consistent with the 
appearance of a detergent powder diffraction ring in the diffraction pattern 
upon dehydration, possibly occurring due to reorganisation of the detergent 
molecules in the lattice upon the lattice contraction.  
All other previously published crystal structures of Mhp1 (Weyand et al, 
2008; Shimamura et al, 2010; Simmons et al, 2014) have a similar packing 
apart from the structure of the Mhp1 protein in an outward-open 
conformation (PDB 2JLN, Weyand et al, 2008), illustrated in Figure 4.10c. 
This structure is resolved to the highest resolution obtained so far for Mhp1 
crystals, 2.85 Å. The crystal from which these data were collected came 
from a relatively old tray, and the high resolution could have potentially been 
caused by slow dehydration due to the long-term storage (Peter Henderson 
and Alexander Cameron, personal communication). The 2JLN lattice is also 
in space group P212121, with unit cell parameters a = 79.7, b = 109.1, c = 
113.8 Å. The 2JLN lattice is different from the lattice obtained for the Mhp1 
mutants here by that the protein chains run along the b-axis, and that there 
are additional crystal contacts made between the chains in the a- and c-
plane. This further stabilisation is a likely reason for the high quality and 
resolution of the 2JLN data. Potentially, the Mhp1 protein crystals obtained 
as part of this Thesis could also be further contracted by controlled 
dehydration to obtain a change in the lattice similar to that seen in the 2JLN 
lattice, with additional crystal contacts stabilising the lattice. Perhaps the 
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observed putative detergent organisation during dehydration, as well as the 
decrease in resolution is due to the starting stages of a major lattice 
rearrangement where the protein molecules re-pack into a tighter and better 
stabilised lattice.  
 
 
Figure 4.10 The crystal packing of Mhp1 molecules in the P212121 
lattice. 
The packing of Mhp1 molecules are displayed in an un-contracted lattice (a), a 
lattice contracted by controlled dehydration (b) and the packing in the structure 
2JLN of Mhp1 in an outward-open form (c). The protein molecules are displayed in 
a cartoon representation and the arrows represent the directions of the unit cell 
axes a, b and c. 
4.6 Contact-less harvesting by photo ablation 
4.6.1 Introduction 
Automation of the various steps of X-ray crystallographic experiments has 
greatly spurred the acquisition of crystal structures in the past decade 
(Wasserman et al, 2012). Preparing crystallisation solutions, dispensing the 
solutions into crystallisation trays and setting up crystallisation screens, as 
well as  visualisation and inspection can be automated and performed in a 
high-throughput manner using crystallisation robots and dedicated crystal 
storage hotels. At crystallography beamlines, extensive efforts have also led 
to the development of automatic mounting and centering of crystals into the 
c 
a 
b 
c 
b 
a 
c 
a 
b 
a 
c 
a 
(a) (b) (c) 
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X-ray beam, as well as automatic data collection protocols (Svensson et al, 
2015). In addition, pipelines for automatic data processing are also being 
developed and made available to users of crystallography beamlines 
(Brockhauser et al, 2012; Monaco et al, 2013). These efforts have greatly 
increased the throughput of X-ray crystallographic experiments. 
One step in the process from crystal to structure that still requires ample 
human intervention is the crystal harvesting and cryo-cooling step. The 
harvesting and cryo-cooling steps often require extensive optimisation, in the 
process of which precious crystals are lost and/or damaged, which ultimately 
results in poor diffraction data. 
At the European Molecular Biology Laboratory (EMBL) in Grenoble, an 
automatic system for harvesting and cryo-cooling has been developed  
(Cipriani et al, 2012) in order to bridge the automation gap between the 
crystallisation screening and data collection processes. The CrystalDirect 
system involves growing crystals in custom-made crystallisation trays, where 
crystallisation droplets are set up in a sitting-drop configuration, with the 
droplets resting on a thin polyimide film (12.5 μm thick), which is compatible 
with X-ray data collection and laser-induced photo ablation (Figure 4.11a) 
(Cipriani et al, 2012). The custom-made tray containing crystals is then 
placed in a robotic set-up which uses a laser cutting tool to excise a segment 
of the film of a desired shape, containing the crystal(s) whose position has 
been marked in the CrystalDirect software interface. Initially, a small hole is 
cut by the laser outside of the area where the crystal is positioned, in order 
to make aspiration of the solvent of the crystallisation droplet possible. 
Through a second hole cut next to the crystal, a hollow pin is positioned 
through which liquid from the droplet is aspirated to minimise the solvent 
around the crystal.  
The pin is then covered with glue while the laser makes the first incision in 
the film underneath where the pin will be repositioned. After re-positioning 
the glued pin next to the crystal, the laser makes the final cuts of the chosen 
shape (Figure 4.11b, c). Thereafter, the cut out film is automatically 
transferred into a cryogenic stream, from which the pin can be manually 
placed into a cryo-vial for storage before screening experiments at a 
synchrotron beamline. 
Due to the challenges during manual crystal harvesting of Mhp1 crystals as 
a result of the fragile nature of the crystals, the CrystalDirect system was 
recognised as an optimal approach to minimise crystal handling and 
potentially improve the diffraction data obtained from the Mhp1 crystals.  
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Figure 4.11 The CrystalDirect system for contact-less crystal 
harvesting by photoablation. 
Crystals for contact-less harvesting are grown in a sitting-drop configuration on a 
thin polyimide film in custom-made SBS format trays (a). The trays are placed into 
the robotic setup using holes for holding the tray in place (green arrows in a) The 
automated crystal harvesting procedure involves marking the crystal to be 
harvested in the CrystalDirect computer software interface, after which a fragment 
of film around the crystal is cut out by the laser (b). Panel b is adapted from the 
publication describing the initial version of the CrystalDirect system (Cipriani et al, 
2012). In the version of the system used in this work, the laser had been configured 
to cut out a great variety of shapes (c), increasing the harvesting possibilities from 
crystallisation droplets containing multiple crystals. For the needle-shaped Mhp1 
crystals obtained in this project, elongated shapes (marked with red asterisks) were 
typically used. The photos in panels a and b are adapted from Cipriani et al. 2012, 
while panel c is adapted from the website of CRIMS©, the Crystallization 
Information Managements System at EMBL, Grenoble (https://embl.fr/htxlab/ 
index.php?option=com_content&view=article&id=30&Itemid=327). 
 
4.6.2 Method and mutants tested 
Mhp1 crystals were crystallised manually in custom-made crystallisation 
trays supplied by the CrystalDirect team and transported to Grenoble in a 
sealed polystyrene box at room temperature. Crystals of wild-type and 
mutant Mhp1, in complex with various ligands (summarised in Table 4.5) 
were harvested using the CrystalDirect system. In order to maximise the 
chances of obtaining good crystals in a sitting-drop configuration in a 
different tray, crystallisation droplets (0.3-0.5 μl) were set up in various ratios 
(1:1, 1:2, 2:1) with and without the streaking motion described in 4.4.3. In 
(a) (b) 
(c) 
* 
* * 
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addition, samples of the Mhp1 mutant Gln42Asn were also shipped on dry 
ice to the EMBL for automatic crystallisation on site.  
Table 4.5 Summary of the crystals of Mhp1 variants, manually 
crystallised in custom-made trays, harvested using the 
CrystalDirect system. 
Variant Number of samples 
harvested 
Wild-type (apo) 6 
Gln42Asn (apo) 0 
Gln42Asn-(L-BH) 4 
Gln42Asn-(L-IMH) 0 
Lys110Leu-(L-BH) 11* 
Lys110Leu-(L-IMH) 5 
Ser312Ala-(L-BH) 0 
Ser312Ala-(L-IMH) 0 
Asn318Gly (apo) 14* 
  * Diffraction obtained. 
However, no crystals were obtained from the automatic crystallisation, 
indicating that the shipping conditions on dry ice may have affected the 
crystallisability of the protein. During this project, this was the only occasion 
where protein was shipped on dry ice for crystallisation trials. It has been 
shown that the pH of protein solutions stored in eppendorf tubes on dry ice is 
lowered (Murphy et al, 2013), which may be detrimental for the quality of the 
Mhp1 mutant samples for crystallisation trials.  
In total, 40 samples were harvested and screened for diffraction, yielding 
one data set of the Mhp1 mutant Lys110Leu in complex with L-BH (see 
Table 4.6 for data statistics) from a crystal which was cut-out from the film 
using an elongated shape (Figure 4.12c). The structure could be solved in 
space group P212121 with the unit cell parameters a = 87.5, b = 101.8 , c = 
105.6, α = β = γ = 90°. The lattice of the crystal of Lys110Leu in complex 
with L-BH was contracted to a similar degree as that obtained by subjecting 
wild-type Mhp1 crystals to controlled dehydration (4.5.2). During contact-less 
harvesting, most of the crystallisation droplet is aspirated away prior to the 
excision of the film fragment, followed by rapid transition into a cryo-stream. 
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As during controlled dehydration, the aspiration step during contact-less 
harvesting may be eliminating a significant amount of excess solvent, giving 
rise to a tighter packed lattice. 
 
 
Figure 4.12 Contact-less harvesting of Lys110Leu crystals. 
The photos depict the same crystallisation droplet containing crystals of the Mhp1 
mutant Lys110Leu in complex with L-BH before (a) and after (b) harvesting. The 
blue dashed rectangle in a and b indicates the position of the crystal that was 
marked for harvesting, and the portion of the excised film fragment (encircled by 
orange dashed lines) where it was contained. The red dashed lines show the 
approximate position of the incisions made for aspiration, which was made possible 
by cutting a small hole in the film next to the crystals (small cross in b). 
 
4.6.3 Investigation of cooling conditions during in-house 
harvesting 
Similar to the structure of wild-type Mhp1 obtained by controlled dehydration 
(section 4.5.2), the crystals harvested and tested using the CrystalDirect 
system also had a contracted lattice with respect to the original data sets 
obtained from crystals that were subjected to conventional cooling by 
plunging into liquid nitrogen, as discussed in 4.3.2.  
What was common between the controlled dehydration method and the 
contact-less harvesting, was that crystals in both methods were cooled by 
transfer into a cryogenic stream, rather than being plunged directly into liquid 
nitrogen.  
In principle, cooling by plunging into liquid nitrogen or by transfer into a 
gaseous nitrogen stream has little effect on the outcome of the diffraction 
(Warkentin & Thorne, 2007). This is due to the fact that liquid nitrogen 
evaporates to form a nitrogen gas layer. Cooling rates are significantly 
slower in gas compared to in liquid, and with protein crystals with a size 
average in the µm range, they traverse through the gaseous layer for a 
considerable amount of time. Hence, the actual cooling of such crystals 
(a) (b) 
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occurs in the gaseous layer (Warkentin & Thorne, 2009), mimicking the 
relatively slow cooling conditions during cryo-cooling by transfer into a 
cryogenic nitrogen gas stream.  
During in-house crystal harvesting and cooling, it was attempted to maintain 
an even amount of liquid nitrogen in the dewar by continuously topping up 
the vessel containing the nitrogen. Despite this, the thickness of the gas 
layer was likely to vary, for example with the daily temperature and humidity 
of the room.  
Table 4.6 Data collection and refinement statistics for the structure of 
the Lys110Leu mutant in complex with L-BH, obtained by contact-
less harvesting. 
 Lys110Leu-(L-BH) 
Wavelength (Å) 0.9763 
Temperature (K) 100 
Space group P212121 
Molecules per assym. unit 1 
Unit cell parameters (Å, °) a = 87.6, b = 101.8, c = 105.6, α = β = γ = 90 
Resolution (Å) 45.86 - 4.32 (4.48-4.32) 
No. of measured reflections 45464 (6603) 
No. of unique reflections 3742 (574) 
Multiplicity 6.9 (6.5) 
Completeness (%) 98.4 (90.3) 
<I/σ(I)> 5.7 (1.4) 
CC1/2 0.998 (0.861) 
Wilson B factor (Å2) 163.2 
Anisotropy ΔB (Å2) 106.21 
Rmerge (%) 0.175 (1.282) 
Rmeas (%) 0.203 (1.499) 
Rp.i.m. (%) 0.103 (0.769) 
Matthews coefficient (Å3 Da-1) 4.31 
Solvent content (%) 71.50 
Rwork (%)  29.41 (35.72) 
Rfree (%) 33.15 (32.40) 
R.m.s.d.   
       Bonds (Å) 0.0060 
       Angles (°) 1.0319 
Ramachandran outliers (%) 0.66 
Average B factor (Å2) 203.0 
                     Values in parentheses are for the highest resolution shell. 
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In addition, many additional factors come into play due to human 
intervention, such as the time spent trying to catch the crystal in the loop, 
associated mechanical stress on the crystal and the time spent in the 
atmosphere during transfer of the crystal from the crystallisation droplet to 
the dewar containing liquid nitrogen. For fast plunging, the level of nitrogen 
in the dewar will affect the air-path and, despite keeping the level of nitrogen 
topped up, it is difficult to ensure full consistency between each harvesting 
attempt. 
Therefore, the two cooling methods were investigated to determine whether 
cooling in a nitrogen stream could be a more reproducible method for crystal 
cooling, potentially giving rise to a tighter lattice (as seen for crystals 
subjected to controlled dehydration or contact-less harvesting).  
Two Mhp1 mutants, Lys110Leu and Gln42Asn, were tested on the same 
occasion, in order to make sure they were subjected to the same 
temperature and humidity. All the crystals of the Mhp1 mutant Lys110Leu 
came from one tray (approximately five months old) and all the crystals of 
the Mhp1 mutant Gln42Asn (approximately six month old) samples came 
from another tray. No direct correlation was observed between fast plunging 
into liquid nitrogen vs. transfer into a cryo-stream, confirming that the cooling 
of crystals most likely occurs in the gas layer above the liquid nitrogen. The 
reason for obtaining a contracted lattice from both controlled dehydration 
using the HC1 device and the contact-less harvesting using the CrystalDirect 
system may thus be attributed to the extensive elimination of excess solvent 
around the crystals. 
Table 4.7 Comparison of cooling method and lattice parameters. 
Sample Cooling method Unit cell parameters  
a, b, c (Å) 
Resolution (Å) 
Lys110Leu-IMH Cryo-stream 90, 106, 107 4.0 
Lys110Leu-IMH Cryo-stream 89, 105, 107 4.1 
Lys110Leu-IMH Rapid plunging 90, 107, 107 3.9 
Gln42Asn-BVH Cryo-stream 90, 106, 108 3.8 
Gln42Asn-BVH Cryo-stream 88, 103, 106 3.7 
Gln42Asn-BVH Cryo-stream 92, 107, 109 3.7 
Gln42Asn-BVH Rapid plunging 89, 105, 106 3.8 
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4.6.4 Discussion 
The CrystalDirect experiments have several things in common with the in 
situ studies described in section 4.3.4. The crystallisation droplets in the 
trays had similar volumes, were both set up in a sitting-drop configuration 
and were both transported for a significant amount of time in a polystyrene 
box to the synchrotrons where the experiments were conducted. Reasons 
for the fact that diffraction data could be collected from crystals harvested 
using the CrystalDirect system of sufficient quality to solve the crystal 
structure of the Mhp1 mutant Lys110Leu in complex with L-BH, in 
comparison to the in situ crystals is that the liquid from the crystallisation 
droplet was aspirated from the film around the crystal(s). This suggests that 
the hydration level of the crystals, as well as the amount of surrounding 
liquid, is a very important factor for obtaining high quality diffraction data 
from crystals of detergent-solubilised Mhp1.  
The diffraction screening performed on crystals harvested using the 
CrystalDirect systems did not have a high success rate, where only 1 out of 
47 crystals screened for diffraction gave rise to a data set of sufficient quality 
to solve the structure of the protein (Table 4.5). A reason for the low success 
rate of data sets collected vs. number of crystal samples harvested could be 
that the aspiration step was not successful in every harvesting attempt. As 
indicated by in situ studies of Mhp1 crystals, minimising the amount of liquid 
surrounding the crystals is potentially very important, either by increasing the 
signal-to-noise ratio or by minimising the hydration level of the crystals and 
their lattice. 
As in all the other steps of the automatic crystal harvesting, the aspiration 
step was monitored via a live feed from a camera filming the crystal being 
harvested. In many cases for the crystallisation droplets containing Mhp1 
crystals, the droplets appeared to be covered with a skin, which did not allow 
for full aspiration of the droplet. This was clearly seen with liquid still being 
visible in the droplet and in some cases the crystals would even float around 
in the remaining liquid. In these cases, the automatic harvesting process 
was paused and the aspiration step was repeated, sometimes with a longer 
time length of the aspiration, in order to remove as much liquid as possible. 
This repeated process of aspiration was likely to affect the crystal quality by 
applying mechanical stress. In addition, the laser will also excise the skin 
covering the droplets. If there was residual skin covering the crystallisation 
droplet upon the final laser excision step, the skin would also be covering the 
harvested crystal on the excised film fragment, which could have also 
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affected the quality of the resulting diffraction. Despite this, the harvesting 
experiments performed using the CrystalDirect system suggests that this is a 
viable harvesting method, even for membrane proteins.  
Two different cooling methods were tested to see whether they have an 
effect on the lattice tightness. These were either fast plunging into liquid 
nitrogen or direct transfer into a cryogenic nitrogen gas stream at 100 K. It 
was found that transfer into a cryogenic stream appeared to result slightly 
more often in a tighter lattice (as seen for dehydrated crystals), compared to 
direct plunging into liquid nitrogen. However, as no strong correlation was 
seen between the method of crystal cooling and the lattice dimensions, it is 
more likely that it is the extensive removal of excess solvent around the 
crystals during controlled dehydration and contact-less harvesting 
(aspiration) that results in a tighter and more well-ordered lattice. 
Comparing the data statistics from the crystal of the Mhp1 mutant 
Lys110Leu in complex with L-BH, which was harvested by contact-less 
harvesting, to a crystal which was cooled by plunging into liquid nitrogen 
(Table 4.8), a similar improvement is seen as for a crystal that was subjected 
to controlled dehydration (see Table 4.4 in section 4.5.3). The higher 
merging R-factors observed for the data obtained by contact-less harvesting 
could be caused by, for example, the shape of the film fragment used for the 
crystal, as it was observed that the longer cut-out shapes often flickered in 
the X-ray beam from the flow of the cryogenic stream. 
 
Table 4.8 Comparison of data statistics obtained from a crystal 
harvested by contact-less photo-ablation and a manually 
harvested crystal. 
 Lys110Leu-(L-BH)  (contact-less harvesting) 
Gln42Asn-(L-BH) 
(manual harvesting) 
Unit cell parameters (Å) a = 87.6, b = 101.8, c = 105.6 a = 91.9, b = 107.1, c = 107.2 
High resolution limit (Å) 4.32 3.74 
Wilson B factor (Å2) 163.2 309.5 
Anisotropy ΔB (Å2) 106.21 146.5 
Rmerge (%) 0.175 (1.282) 0.040 (1.192) 
Rmeas (%) 0.203 (1.499) 0.056 (1.641) 
Rp.i.m. (%) 0.103 (0.769) 0.038 (1.124) 
Solvent content (%) 71.50 74.56 
Average B factor (Å2) 203.0 253.0 
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4.7 General discussion and conclusions 
In this Chapter, the optimisation of the crystallisation conditions for Mhp1 
crystals have been described. Initially, the previously published conditions 
for the orthorhombic crystal form were successfully reproduced, yielding 
needle-shaped crystals. These crystals were harvested in-house and did not 
give rise to high quality diffraction, diffracting at best to 6 Å at a synchrotron 
source. Moreover, the diffraction was highly anisotropic and disordered. 
The crystallisation conditions for the hexagonal crystal form, in which the 
(seleno-L-methionine derivatised) Mhp1 protein had previously crystallised in 
an inward-open conformation were not reproduced. This could have been 
due to differences in protein expression and/or purification batch specific 
carry over of a ligand from the media used during the growth of methionine 
auxotrophic E. coli cells for the production of the protein in comparison to the 
original experiment. The crystal structure of seleno-L-methionine derivatised 
Mhp1 suggests that the obtained inward-open conformation may be 
stabilised by this unidentified ligand. 
The low quality diffraction obtained from Mhp1 crystallised under the 
conditions for the orthorhombic crystal form is likely due to the fragility of the 
Mhp1 crystals. This probably stemmed from the high solvent content due to 
the protein being solubilised in detergent. Crystal breaking and dissolving 
during harvesting attempts led to the exploration of alternative crystallisation 
and data collection strategies, that would minimise crystal handling. Mhp1 
crystals grown either on MicroMeshes™ or in in situ plates were screened 
for diffraction, however, this gave rise to either no or very weak and low-
resolution diffraction.  
The anisotropic diffraction limit of 6 Å of the initial Mhp1 crystals was 
overcome by introducing drop morphology modification into the 
crystallisation experiment. By applying a ‘streaking’ motion when setting up 
the crystallisation droplets, a size gradient of crystals was formed in the 
droplet. The size gradient resembled the gradients obtained in counter-
diffusion aided crystallisation experiments performed using the commercially 
available CrystalHarp™ and CrystalFormer trays. The size gradient typically 
resulted in a few large mm-long crystals growing out of a shower of smaller 
crystals. These crystals diffracted reproducibly to beyond 4 Å and were used 
to solve the structures of for example the Mhp1 mutants Gln42Asn in 
complex with L-BH and L-IMH (further discussed in Chapter 5). 
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These crystals did, however, still diffract anisotropically, due to the 
morphology of the crystals. Higher resolution is always desired in order to 
gain more detailed insight in to the structure of the protein. Therefore, further 
strategies were explored for the improvement of the Mhp1 crystals and their 
resulting data, including controlled dehydration and contact-less harvesting. 
Both controlled dehydration and contact-less harvesting were successful 
strategies to obtain a tighter lattice and improved-quality electron density 
maps. This was probably due to the removal of the solvent surrounding the 
crystal, causing a contraction of the detergent phase and thus more well-
ordered packing in the crystals. Additionally, during contact-less harvesting 
the mechanical stress normally put on crystals during manual harvesting is 
minimised. However, these methods have certain logistic drawbacks. 
Controlled dehydration studies are tedious and time-consuming with the 
required steps of manual harvesting, closing the experimental hutch, 
stepwise dehydration (minutes per step) while collecting diffraction images to 
evaluate the dehydration process, before final data collection. If the mounted 
crystal does not diffract, or the dehydration procedure causes severe 
damage to the crystal, the experimental hutch needs to be re-opened and a 
new crystal needs to be mounted. This makes it difficult to achieve the same 
throughput as would normally be the case with automatically mounted cryo-
cooled samples during synchrotron beamtime. It is thus challenging to 
establish a robust dehydration protocol. The drawback of contact-less 
harvesting is the limited availability of the CrystalDirect system, currently 
only being available at the EMBL in Grenoble. The use of this facility 
requires transportation and/or shipping of protein samples or crystal to the 
site, which can also cause damage to the protein or crystal samples.  
Nevertheless, these studies have demonstrated the importance of controlling 
the hydration level of detergent-solubilised Mhp1 crystals in order to obtain 
higher quality well-ordered crystals. In order to overcome the logistical 
drawbacks discussed above, and increase the throughput of crystallographic 
studies of Mhp1 crystals, strategies and methods for solvent removal should 
be explored for use in the home laboratory. For example, there are several 
commercially available sample mounts with special channels for liquid 
removal by wicking available. In order to control the humidity during 
harvesting to avoid unnecessary swelling or contraction of the crystal during 
harvesting, an in-house humidified gas stream could be used. 
In conclusion, this Chapter has outlined the steps taken in order to improve 
the diffraction obtained from Mhp1 wild-type and mutant crystals for further 
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structural studies. The various experiments have given an insight into the 
challenges usually encountered during membrane protein crystallisation, and 
have demonstrated that the hydration level is important for the crystals 
obtained here. Future studies should involve further exploration of solvent 
removal strategies in order to obtain well-ordered crystals and higher quality 
diffraction data.  
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Chapter 5: X-ray crystal structures of Mhp1 mutant-ligand 
complexes  
5.1 Introduction 
The previously published crystal structures of Mhp1 are believed to 
represent three key conformational states of the alternating access transport 
mechanism; the outward-open, occluded and inward-open conformations 
(Shimamura et al, 2010; Weyand et al, 2008). Although these structures 
provide insight into the progression of the transport mechanism, they provide 
only static snapshots of a highly dynamic process. Despite efforts to link 
these still snapshot images and shed light on the events occurring between 
them, using for example computer simulations (Shimamura et al, 2010; 
Adelman et al, 2011) or spectroscopic studies (Kazmier et al, 2014), many 
questions about the exact mechanism of transport still remain unanswered. 
One of the most intriguing features of the substrate transport in this type of 
secondary active transporters is the mechanism by which the transport of 
ligands and ions are coupled.  
Previous mutagenesis and subsequent functional studies have identified 
several mutants of Mhp1 that display altered ligand binding and transport 
behaviour, where hydantoin ligands either bind with very low affinity to Mhp1 
or where the sodium-dependent binding is abolished (Jackson, 2012). These 
findings suggest that the mutations could be altering the conformation that 
the Mhp1 protein adopts in solution, such that it prevents ligand binding or 
affects sodium-dependent binding. This makes the identified mutants ideal 
candidates for structural analysis in order to explore more conformations of 
the protein and further probe the transport mechanism. 
The purification and characterisation of several of these mutants was 
described In Chapter 3. In order to investigate how the structure of Mhp1 
was affected by the mutations and to understand the structural basis for the 
altered ligand binding, all the variants described in Chapter 3 were subjected 
to crystallisation trials. After a series of optimisation steps in order to improve 
the diffraction quality of the Mhp1 mutant crystals, which were obtained by 
modifying previously published crystallisation conditions (described in 
Chapter 4), several data sets with diffraction limits beyond 4 Å were 
collected from crystals of Mhp1 mutants in complex with various ligands. The 
mutants for which data were collected and crystal structures were solved are 
Gln42Asn, Ser312Ala and Lys110Leu. These mutants allowed probing of the 
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structure in different locations in the protein, such as the ligand-binding site 
(Gln42Asn), the sodium-binding site (Ser312Ala) and the area between the 
bundle-and-hash motif (Lys110Leu).  
5.2 X-ray crystal structures of mutant-ligand complexes of 
the Mhp1 mutant Gln42Asn 
5.2.1 Introduction  
One mutant that successfully yielded crystals suitable for X-ray 
crystallographic studies was the mutant Gln42Asn. Gln42 is situated in the 
ligand-binding site in the wild-type Mhp1. The hydantoin moiety is stabilised 
in the binding site by π-stacking interactions with Trp117, as well as a 
hydrogen-bond network formed by the residues Gln121, Asn318 and 
Gln219. The aryl moieties of hydantoin ligands interact with Trp220, forming 
π-interaction (Weyand et al, 2008; Simmons et al, 2014) (Figure 5.1).  
 
 
Figure 5.1 Illustration of the ligand-binding site in wild-type Mhp1.  
The figure illustrates the ligand-binding sites of wild-type Mhp1 in complex with L-
BH (a) and in complex with L-IMH (b), where figure in (a) is replicated from Figure 
3.7a. The ligand binding site residues are highlighted in coral, the ligand L-BH as a 
ball-and-stick model in green and the nearby sodium as a grey sphere. Hydrogen 
bonds between the L-BH and nearby residues are displayed as black dashed lines 
and distances stated in units of Å. The sodium binding site residues are displayed 
in semi-transparent cyan, apart from Ile41, which is displayed in cyan as a 
reference for the orientation of the sodium binding site in Figure 5.9. The non-
carbon atoms are coloured red (oxygen) and blue (nitrogen). The ribbon diagram of 
the whole protein is displayed in semi-transparent grey. The PDB codes for the 
respective structures depicted in this figure are 4D1B (a) and 4D1A (b) (Simmons et 
al, 2014).  
(a) (b) 
Ala38 
Trp220 
Trp117 
Gln42 
Gln121 
Asn318 Gly219 
2.72 2.98 
2.77 
3.19 
2.47 
Ile41 
Ala38 
Na 
Trp220 
Trp117 
Gln42 
Gln121 
Asn318 Gly219 
2.35 3.20 
3.07 
3.27 
2.81 
Ile41 Na 
- 105 - 
Gln42 could also be participating in the hydrogen-bonding network that 
stabilises the hydantoin moiety of the ligands when bound, since it is in 
hydrogen-bonding distance to Gln121, which in turn makes a  hydrogen 
bond to a carbonyl oxygen on the hydantoin moiety together with Asn318 
(Figure 5.1). 
Gln42 is also connected to the nearby sodium-binding site, with the carbonyl 
oxygen of the adjacent residue Ile41 participating in the coordination of the 
sodium ion. Due to its position, connecting the sodium- and ligand binding 
sites, Gln42 may play a potential role in the coupling mechanism. This 
hypothesis is supported by functional studies of the Gln42Asn mutant. The 
tryptophan fluorescence quenching assays of the Gln42Asn mutant show 
that the sodium-dependent binding of L-BH is perturbed as a result of the 
mutation (Figure 5.2). 15 mM sodium, which in the wild-type protein is 
sufficient to saturate all binding sites with L-BH, is not sufficient to saturate 
the binding sites in the Gln42Asn mutant, resulting in an increase in the 
apparent Kd (Table 5.2).  
 
 
Figure 5.2 The binding of L-BH to wild-type Mhp1 and the Mhp1 mutant 
Gln42Asn, solubilised in NM. 
The figure shows the quench of the tryptophan fluorescence during titrations of L-
BH (0-2 mM) with wild-type Mhp1 (a) and the Mhp1 mutant Gln42Asn (b). The 
titrations were performed in the presence of 0 mM (red), 15 mM (blue) and 140 mM 
(black) added sodium. Mhp1 samples (in 10 mM Tris-HCl pH 7.6, 2.5% v/v glycerol, 
0.5% w/v NM) were diluted to 140 µg/ml using buffers containing 50 mM Tris-HCl 
pH 7.6, 2% v/v DMSO, 0.5% w/v NM, 0/15/140 mM NaCl and 140/125/0 mM 
choline chloride. The error bars display the standard error of the mean from three 
replicates of each titration. The titrations show that in the presence of 15 mM 
sodium, binding of L-BH is not enhanced in Gln42Asn to the same level as in the 
wild-type protein. At least 140 mM sodium is instead required to achieve a similar 
effect in the mutant as in the wild-type protein.  
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However, the lost binding capacity is restored in the presence of 140 mM 
sodium. A similar behaviour is observed for the more potent ligand L-IMH, 
where 14C L-IMH cell uptake assays show that when 150 mM sodium is 
present, as much as 82.5 ± 2.5% of the wild-type uptake of the ligand occurs 
in the Gln42Asn mutant (Jackson, 2012). This indicates either that the 
sodium is not able to bind to its site between residues Ala38, Ile41, Ala309 
and Ser312 as easily due to binding site remodelling as a result of the 
mutation, or that the protein has adopted a low-affinity conformation that 
diminishes the ability of the ligand to bind. 
In this section, crystal structures of the Gln42Asn mutant in complex with the 
ligands L-BH and L-IMH are presented and compared to previous structures 
of the wild-type protein in complex with the same ligands. Two crystal 
structures of Gln42Asn in complex with L-BH were obtained from different 
buffer conditions; high- and low-sodium conditions in order to investigate 
effect of sodium on the conformation of the protein in the presence of ligand. 
 
5.2.2 The structure of the Mhp1 mutant Gln42Asn in complex with 
L-BH  
The structure of the mutant Gln42Asn in complex with L-BH was determined 
at a resolution of 3.75 Å (Table 5.1). and solved in space group P212121 with 
unit cell parameters a = 91.8, b = 107.1, c = 107.2 Å, α = β = γ = 90°. These 
data came from the first crystals that had been obtained by optimising the 
crystallisation experiment by drop morphology modification (described in 
section 4.4.3-4). The crystal from which the data were collected was cooled 
by direct plunging into liquid nitrogen. Despite the fact that the unit cell 
parameters were similar to previously published crystal structures of the 
wild-type Mhp1 protein and the protein molecules were found with similar 
orientations and positions in the unit cell, direct Fourier transformation and 
rigid-body fitting of these structures as initial models did not work. This  was 
indicated by high R-factors (Rwork and Rfree > 39%) after rigid body 
refinement. Therefore, the structure was solved by molecular replacement. 
The three different published conformations of the Mhp1 protein; outward-
open (2JLN), occluded with various ligands (2JLO, 4D1A and 4D1B) and 
inward-open (2X79) were tested as molecular replacement search models 
and the resulting solutions were subjected to rigid-body refinement, followed 
by restrained refinement of the resulting rigid-body fitted model. Prior to 
using these structures as molecular replacement search models all bound 
ligands, ions and metals were removed. The outward-open and the occluded 
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structures were placed in similar orientations compared to previous 
structures, but the best initial R-factors were obtained from the occluded 
structures (Rwork/Rfree ≈	27/32%). This indicated that the Gln42Asn protein 
predominantly adopted an occluded conformation in the crystal. The 
structure of Mhp1 in complex with L-IMH (4D1A) was used as the final 
search model in molecular replacement as this structure came from the 
highest quality data (A. Cameron, personal communication). The inward-
open structure (2X79) was also tested as a search model but gave high R-
factors after initial refinement (Rwork and Rfree > 39%). No significant 
difference electron density was observed in the FO — FC map around the 
site of the mutation. However, at the low working resolution of this structure 
(3.75 Å), the mutation, which essentially corresponds to a change of length 
of the side chain of 1.2-1.5 Å will be undetectable unless it causes a major 
conformational change in the protein. There was no major indication in the 
FO — FC map of major alterations to the conformational state of the protein, 
and the occluded conformation seems to be minimally perturbed when L-BH 
is bound.  
 
Figure 5.3 The structure of the Gln42Asn mutant in complex with L-BH. 
The figure in (a) displays the final refined model of the Mhp1 mutant Gln42Asn in 
complex with L-BH, as a cartoon representation in coral and the 3.75 Å 2FO — FC 
map (blue mesh). The helix marked with a black arrow is zoomed in on in (b), 
depicting residues Trp145-Ile158 in coral to better show the fit of the model to the 
2FO — FC map. (c) The 2FO — FC (blue mesh, contoured at 1.5 σ) and FO — FC 
(green mesh, contoured at 2.0 σ) maps after initial refinement, showing the positive 
difference density in the FO — FC map occurring only for the hydantoin part of L-BH 
(shown in green as a ball and stick model). 
 
When replacing Gln42 with Asn42 in the model, the residue was initially 
oriented in the same orientation as Gln42, based on the suggested rotamers 
in Coot (Emsley et al, 2010), pointing towards the aromatic part of the ligand. 
Phe158 
Trp145 
(b) (a) (c) 
Trp220 
Trp117 
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In this position, the interaction with Gln121 would be weakened, as the 
putative hydrogen-bonding distance increased from 2.81 Å to 3.59 Å. After 
further refinement, the position of Asn42 could be adjusted to better fit the 
electron density, pointing towards Gln121, bringing the two residues together 
and potentially strengthening the interaction, restoring the original putative 
hydrogen bond (to 2.63 Å). However, this did not give rise to a significant 
change in R-factors, and at this resolution it is difficult to determine the exact 
orientation of a single residue. 
In the hydantoin ligand-binding site, positive difference electron density in 
the FO — FC map was clearly seen between Trp117 and Trp220 early in the 
refinement. L-BH, in the same extended binding mode as seen in 4D1B 
(Simmons et al, 2014), was placed into the binding site. However, the 
electron density covered only the hydantoin moiety of the ligand (Figure 5.3). 
The missing density for the benzyl moiety of L-BH suggests that the ligand 
could be exhibiting flexibility around the carbon-carbon bonds that connect 
the hydantoin and the benzyl moiety. Due to the extra space generated by 
the shortening of Gln42 to Asn42 and the resulting reduction in electrostatic 
repulsion, the L-BH could be adopting several conformations, resulting in the 
electron density of the benzyl group of the ligand cancelling out between the 
molecules throughout the crystal. 
 
5.2.3 The structure of the Mhp1 mutant Gln42Asn in complex with 
L-IMH 
For the Mhp1 mutant Gln42Asn in complex with L-IMH, diffraction data were 
collected with a resolution of 4.0 Å (Table 5.1). The data were of comparable 
quality to the data of the mutant Gln42Asn in complex with L-BH (section 
5.2.2), and were collected on the same occasion, and also came from a 
crystal that had been optimised by drop morphology modification and cooled 
by direct plunging into liquid nitrogen. The structure was solved in the same 
space group as the complex with L-BH, with similar cell parameters 
(P212121, a = 90.9, b = 106.9, c = 108.1 Å, α = β = γ = 90°). As for the Mhp1 
mutant Gln42Asn in complex with L-BH, 4D1A was used as the search 
model in molecular replacement and no major differences in overall 
conformation of the protein were seen during the course of refinement. 
Positive difference electron density in the FO — FC map was seen between 
Trp117 and Trp220, and L-IMH, in the same binding mode as in 4D1A, was 
placed into the structure. As seen for the structure of Gln42Asn in complex 
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with L-BH, there was no electron density for the indolylmethyl group of the 
ligand in the final refined model (Figure 5.4). 
 
 
Figure 5.4 The ligand binding site in the structure of the Gln42Asn 
mutant in complex with L-IMH. 
The 4.0 Å 2FO — FC (blue mesh, contoured at 1.5 σ) for the overall final refined 
model of the Mhp1 mutant Gln42Asn in complex with L-IMH (a), and showing the 
ligand binding region where only the hydantoin part of L-IMH (shown in green as a 
ball and stick model) is observed. 
 
This indicated, yet again that the ligand was flexible in its binding site, 
potentially as a result of the additional space created in the binding site by 
the shortening of Gln42 to Asn42. 
 
5.2.4 The structure of the Mhp1 mutant Gln42Asn in complex with 
L-BH under low-sodium conditions  
The Gln42Asn-ligand complex structures have shown that the mutation does 
not significantly alter the overall conformation of the protein compared to 
ligand-complex structures of the wild-type protein (Simmons et al, 2014). As 
for the wild-type structures with ligands, the Gln42Asn-ligand complex 
structures adopt an occluded conformation, with each respective ligand 
bound in the ligand-binding site. No significant changes to the structure at 
the site of the mutation were observed at the working resolution. One 
possible reason for this could be that all the crystal structures presented 
here so far were produced under high-sodium conditions, i.e. in the 
Trp220 
Trp117 
(b) (a) 
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presence of 100 mM sodium chloride and 100 mM sodium phosphate in the 
crystallisation mother liquor. 
Table 5.1 Crystallographic data processing and refinement statistics 
for the structures of the Mhp1 mutant Gln42Asn in complex with L-
BH and L-IMH. 
Values in parentheses are for the highest resolution shell. 
 
 Gln42Asn-(L-BH) Gln42Asn-(L-IMH) 
Wavelength (Å) 0.9686 0.9686 
Temperature (K) 100 100 
Space group P212121 P212121 
Molecules per assym. 
unit 1 1 
Unit cell parameters 
(Å, °) 
a = 91.9, b = 107.1, c = 107.2, 
α = β = γ = 90 
a = 90.9, b = 106.9, c = 108.1, 
α = β = γ = 90 
Resolution (Å) 42.47-3.74 (4.18-3.74) 42.62-4.0 (4.47-4.00) 
No. of measured 
reflections 34878 (9511) 37848 (10517) 
No. of unique 
reflections 10926 (2986) 9175 (2517) 
Multiplicity 3.2 (3.2) 4.1 (4.2) 
Completeness (%) 96.1 (93.9) 98.1 (97.3) 
<I/σ(I)> 13 (1.3) 7.9 (2.0) 
CC1/2 1.00 (0.76) 0.998 (0.897) 
Wilson B factor (Å2) 309.5 321.9 
Anisotropy ΔB (Å2) 146.5 140.1 
Rmerge (%) 0.040 (1.192) 0.076 (0.665) 
Rmeas (%) 0.056 (1.641) 0.098 (0.861) 
Rp.i.m. (%) 0.038 (1.124) 0.061 (0.541) 
Matthews coefficient 
(Å3 Da-1) 4.83 4.81 
Solvent content (%) 74.56 74.45 
Rwork (%) 27.08 (35.28) 26.96 (36.18) 
Rfree (%) 31.30 (33.86) 32.62 (36.01) 
R.m.s.d.   
   Bonds (Å) 0.0100 0.0090 
   Angles (°) 1.4114 1.3147 
Ramachandran 
outliers (%) 0.66 1.76 
Average B factor (Å2) 253.0 241.1 
- 111 - 
At this sodium concentration, the protein is essentially under conditions 
under which the binding sites become saturated (Figure 5.5). In the 
previously reported crystal structure of Mhp1 in the outward-open state, 
there is an intact sodium-binding site (Weyand et al, 2008), while in the 
inward-open structure the sodium-binding site is disrupted (Shimamura et al, 
2010). In addition, computer simulations show that a sodium ion escapes 
from the inward-open form of the protein on a time-scale of < 2 ns 
(Shimamura et al, 2010; Adelman et al, 2011). These findings suggest that 
the sodium could be stabilising the outward-open form, turning the protein 
over into a conformation with high affinity for the ligands, and which then 
turns over into an occluded conformation when the ligand has bound. 
At lower sodium concentrations (15 mM), the Gln42Asn mutant has lowered 
affinity for L-BH compared to the wild-type Mhp1 (Figure 5.2), and could be 
adopting a conformational state where L-BH binding is prevented, potentially 
an inward-open or empty occluded form (Table 5.2).  
 
 
Figure 5.5 The binding of L-BH to the Mhp1 mutant Gln42Asn, 
solubilised in NM, under high- and low sodium conditions. 
The figure shows the fluorescence quench during titrations of L-BH (0-2 mM) with 
the Mhp1 mutant Gln42Asn in the presence of an increasing sodium concentration 
and no added potassium (a), as well as in the presence of an increasing potassium 
concentration and no added sodium (b). The titrations were performed in the 
presence of 0 mM (red), 15 mM (blue) and 140 mM (black) added sodium chloride. 
The buffer components are the same as indicated in Figure 5.2, apart from the 
titrations with KCl where NaCl was replaced by the same concentrations of KCl. 
The error bars display the standard error of the mean from three replicates of each 
titration. The titration curves show that L-BH binding is greatly enhanced with a 
higher sodium concentration, while this effect is abolished when the NaCl is 
substituted with KCl. 
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Therefore, in order to study the conformation of the Gln42Asn mutant 
without having sodium as the driving force of conformational changes, the 
tryptophan fluorescence quenching assay was repeated for the Gln42Asn 
mutant but with potassium chloride instead of sodium chloride. The 
substitution of the monovalent cation was done in order to later use these 
conditions in crystallisation trials. This demonstrated that L-BH bound to a 
slightly lower extent at 0 mM salt, but the synergistic enhancement of the 
ligand binding seen with increasing sodium concentration was abolished 
(Figure 5.5). 
 
Table 5.2 Binding parameters for the Mhp1 mutant Gln42Asn and L-BH 
in the presence of sodium or potassium. 
Mhp1  [Na+] App. Kd (mM)  Bmax (%)  
Wild-type 
 
 
Gln42Asn 
0 
15 
140 
0 
15 
140 
3.66 ± 0.82 
0.27 ± 0.015 
0.059 ± 0.0071 
3.47 ± 1.13 
1.41 ± 0.34 
0.041 ± 0.0040 
22.93 ± 3.70 
18.95 ± 0.28 
16.56 ± 0.28  
38.01 ± 8.78 
29.81 ± 3.81 
21.19 ± 0.23  
 [K+]    
Gln42Asn 0 
15 
140 
2.82 ± 0.33 
3.02 ± 0.44 
2.55 ± 0.20 
31.71 ± 2.47 
33.67 ± 3.34 
30.43 ± 1.53 
 
A potential scenario is that Gln42Asn favours the inward-open conformation, 
which is a low-affinity form for L-BH, and requires a higher amount of sodium 
to drive the conformational equilibrium towards a ligand-bound state due to 
the fact that the sodium binding site has been perturbed by the mutation. 
The tryptophan fluorescence quenching assay indicates that in the absence 
of increasing sodium concentration, Gln42Asn remains in the low-affinity 
state as there is no response to the addition of potassium. 
Therefore, in order to investigate whether an alternative conformation is 
adopted under low-sodium conditions, crystals were produced under similar 
conditions as in the tryptophan fluorescence quenching assay described 
above. This was achieved by substituting sodium chloride and sodium 
phosphate with the equivalent potassium salt and buffer, preserving the ionic 
strength of the crystallisation mother liquor. This alteration to the 
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crystallisation conditions did not affect the crystallisability of the protein, and 
gave rise to crystals of the usual needle-shaped morphology. Wild-type 
protein, as well as the Gln42Asn mutant in the presence and absence of 
ligands were subjected to these crystallisation trials and yielded crystals, but 
diffraction data were successfully collected only from Gln42Asn crystals in 
the presence of L-BH. 
The structure of the Gln42Asn mutant in complex with L-BH under low-
sodium conditions was determined to a resolution of 3.80 Å (Table 5.3). and 
was obtained from a crystal that was cryo-cooled by fast plunging into liquid 
nitrogen. Even though the crystal was not subjected to controlled 
dehydration, its unit cell is contracted to a similar degree as previously 
obtained by controlled dehydration using the HC1, when compared to the 
original Gln42Asn models in complex with L-BH and L-IMH. One possible 
reason for this is that the crystal that was used to collect these data came 
from a crystallisation tray that was approximately five months old2. During 
this time, being stored in a ventilated crystal tray incubator, it is very likely 
that the droplet was slowly becoming dehydrated, therefore giving rise to a 
similar effect as during controlled dehydration on the beamline (Kazmier et 
al, 2014; Abergel et al, 2003; Abergel, 2004). 
Despite the indication from the tryptophan fluorescence quenching assay 
that Gln42Asn could be adopting an alternative conformation under these 
crystallisation conditions, the structural data indicated that the protein 
adopted an occluded conformation in the crystal, with a potassium ion bound 
in the sodium binding site. 
Using an occluded structure (4D1A) as the search model in molecular 
replacement resulted in the lowest R-factors after initial refinement of each 
molecular replacement solution, and no apparent conformational deviation 
from the occluded conformation was seen in the resulting electron density 
map for Gln42Asn in complex with L-BH under low sodium conditions. 
In the initial stages of refinement, positive difference electron density was 
clearly seen in both the ligand and ion-binding sites, and the L-BH together 
with a potassium ion could be modelled. In the structure of the Gln42Asn 
mutant in complex with L-BH under high-sodium conditions (5.2.2), there 
was no electron density for the aromatic portion of the ligand, indicating that 
the ligand had gained flexibility and adopted several conformations in its 
                                            
2 Set-up date of tray: 8th July 2014, harvesting date: 9th December 2014  
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binding site. The electron density resolved the L-BH better than under high-
sodium conditions, with electron density covering the benzyl group as well 
as the hydantoin moiety of L-BH (Figure 5.6). 
 
Table 5.3 Crystallographic data processing and refinement statistics 
for the structures of the Mhp1 mutant Gln42Asn in complex with L-
BH under low-sodium conditions. 
 
Gln42Asn-(L-BH),  
low-sodium/high-potassium 
conditions 
Wavelength (Å) 0.9795 
Temperature (K) 100 
Space group P212121 
Molecules per assym. unit 1 
Unit cell parameters (Å, °) a = 89.0, b = 105.3, c = 105.6, α = β = γ = 90 
Resolution (Å) 57.14 - 3.80 (4.25-3.80) 
No. of measured reflections 58877 (12165) 
No. of unique reflections 9299 (1986) 
Multiplicity 6.3 (6.1) 
Completeness (%) 90.1 (68.9) 
<I/σ(I)> 11.5 (1.1) 
CC1/2 0.999 (0.702) 
Wilson B factor (Å2) 275.4 
Anisotropy ΔB (Å2) 151.1 
Rmerge (%) 0.072 (2.139) 
Rmeas (%) 0.085 (2.562) 
Rp.i.m. (%) 0.045 (1.392) 
Matthews coefficient (Å3 Da-1) 4.53 
Solvent content (%) 72.86 
Rwork (%)  26.36 (44.49) 
Rfree (%) 31.48 (37.22) 
R.m.s.d.   
       Bonds (Å) 0.010 
       Angles (°) 1.447 
Ramachandran outliers (%) 0.66 
Average B factor (Å2) 235.9 
                   Values in parentheses are for the highest resolution shell. 
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Figure 5.6 Ligand binding site in the structure of the mutant Gln42Asn 
in complex with L-BH under low-sodium conditions. 
The 3.8 Å 2FO — FC (blue mesh, contoured at 1.5 σ) map after refinement, showing 
the entire protein as a cartoon representation in coral (a), as well as the ligand 
binding site where the entire L-BH (shown in green as a ball and stick model) is 
resolved in the electron density map. TMH10 is encircled in (a) and coloured in 
brown in as depicted in Figure 5.7. 
 
Another feature that distinguished this structure of the Gln42Asn mutant in 
complex with L-BH under low-sodium and high-potassium conditions, 
compared to the same complex structure under high-sodium conditions, was 
that part of the trans-membrane helix 10 (TMH10) was not resolved in the 
2FO — FC map (Figure 5.7). This indicates that the segment (residues 
Phe355-Leu365) adopts multiple conformations in the crystal. Omitting the 
loop and refining the structure did not recover any positive difference density 
features in the FO — FC map for either the outward-open or occluded 
conformations. Superposing an occluded structure with an outward-open 
TMH10 resulted in negative difference density for the open conformation of 
TMH10, while the closed conformation remained unresolved. 
 
5.2.5 Diffraction data collection on crystals of the Mhp1 mutant 
Gln42Asn in complex with BVH 
Due to the uncertainties in how the ligands bind in the Gln42Asn mutant, 
particularly for the aryl groups of L-BH and L-IMH under high sodium 
Trp117 
Trp220 
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TMH10 
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conditions, diffraction data collection was attempted on crystals that had 
been produced in the presence of a brominated form of L-BH; BVH. Bromine 
gives rise to anomalous scattering at its absorption K-edge (13.4737 keV), 
which is within the accessible wavelength range at synchrotron beamlines 
for macromolecular crystallography. 
 
 
Figure 5.7 Cross-refinement to confirm the conformation of a segment 
of TMH10 in the structure of Gln42Asn-(L-BH) under low-sodium 
conditions. 
(a) In the final refined structure, residues Phe355-Leu366 in the occluded 
conformation (brown) were poorly resolved in the 2FO — FC map (blue mesh, 
contoured at 1.5 σ). (b) Running a cross-refinement with an open TMH10 (teal) 
resulted in significant negative difference density in the FO — FC map (red mesh, 
contoured at -3.0 σ), and some positive density is seen for a closed TMH10 (green 
mesh, contoured at 3.0 σ). 
  
Using the bromine anomalous signal, the position of the bromine within the 
protein structure should be unambiguously determined, and the BVH ligand 
has previously been used for this purpose with Mhp1 (Simmons et al, 2014). 
Several diffraction data sets were collected of the mutant Gln42Asn in 
complex with BVH, but no anomalous signal was ever  detected during the 
data processing, and as a result, the generated anomalous difference maps 
Phe355 
Leu365 
(a) (b) 
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did not contain any significant peaks in the ligand binding site. Performing 
fluorescence scans on the crystals revealed that there was bromine present 
in the crystals to varying degrees, but in some of the structures of the mutant 
in complex with BVH there was no indication of the ligand being bound, due 
to the absence of electron density both in the 2FO — FC and FO — FC maps. 
A possible reason for not seeing the ligand in the binding site is that the 
ligand was not sufficiently soluble during co-crystallisation. If it had bound, 
the failure to detect anomalous signal could also have either been due to X-
ray induced cleavage of the bromine, or the fact that the aryl group of the 
ligands is simply too mobile within the hydrophobic pocket, as indicated by 
the absent electron density for the aryl groups of L-BH and L-IMH in the 
respective crystal structures of the Mhp1 mutant Gln42Asn under high-
sodium conditions.  
 
5.2.6 Discussion 
Crystal structures of the Mhp1 mutant Gln42Asn in complex with the 
hydantoin ligands L-BH and L-IMH have been determined in order to 
investigate the apparent loss of sodium-dependent ligand binding observed 
in the tryptophan fluorescence quenching assays. Two different structures of 
the mutant in complex with L-BH were determined, coming from different 
crystallisation conditions; high- and low-sodium conditions.  
The crystal structures show that the mutant Gln42Asn adopts an occluded 
conformation in the crystal, similar to the previously published structures of 
the wild-type protein in complex with ligands (Jackson, 2012; Weyand et al, 
2008; Simmons et al, 2014). There were no clear indications of significant 
conformational changes in the crystal structures of this mutant with the 
ligands compared to the wild-type protein, apart from TMH10 potentially 
adopting multiple conformations under low-sodium conditions. Nor were any 
significant local changes observed at the site of the mutation. However, all 
these crystal structures were only resolved to a resolution of 3.74 - 4.00 Å. 
At this low resolution, it is likely that any subtle conformational changes due 
to a single point mutation will not be detectable.  
Tryptophan fluorescence quenching assays of the mutant Gln42Asn and L-
BH suggested that the sodium-dependent ligand binding has been 
abolished, but could be restored upon the addition of excess sodium. In the 
structures of the Gln42Asn mutant in complex with L-BH and L-IMH, there 
was positive difference electron density in the FO — FC map at the ligand 
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binding sites, indicating that the ligands were bound. These crystal 
structures came from crystals that had been produced under high-sodium 
conditions (in the presence of 100 mM sodium chloride and 100 mM sodium 
phosphate buffer), consistent with the presence of bound ligands. 
The shortening of Gln42 to Asn42 may have resulted in the aryl groups of 
the ligands gaining flexibility, as a result of opening up of the binding pocket 
and weakened interactions between the residue and the ligand. Electron 
density was absent for the aryl substituents of L-BH and L-IMH under high-
sodium conditions, which may have resulted from the fact that the charged 
Gln42 normally orients the aryl group by electrostatic interactions, while in 
the presence of the shorter Asn42 this interaction is less pronounced. This 
fits with the previous hypothesis that Gln42 could be playing a role in 
shaping the binding pocket for the ligands (Simmons et al, 2014). In an 
attempt to localise the orientation of the aryl groups in the Mhp1 mutant 
Gln42Asn, diffraction data collection was attempted on crystals of the mutant 
in complex with BVH. However, no anomalous signal was detected, which 
also supports the idea that the aryl groups might be flexible in the Mhp1 
mutant Gln42Asn. Looking at surface representations of the binding sites in 
the Gln42Asn mutant structure before and after mutating the residue, it is 
apparent that the hydrophobic pocket for the aromatic moiety becomes 
slightly expanded (Figure 5.8), provided that the Asn42 does adopt the 
modelled conformation which preserves the hydrogen-bond to Gln121 
(5.2.2). However, from the surface representations it is not apparent that the 
ligands could adopt sufficiently different conformations in different protein 
molecules, to result in a range of displacement that would be great enough 
to cancel the electron density for the entire aryl groups.  
On the contrary, in the structure of the Gln42Asn mutant in complex with L-
BH under low-sodium conditions, the entire L-BH is resolved in the electron 
density. This could be due to the larger potassium ion in the sodium binding 
site compensating for the extra space in the binding site as a result of the 
mutation by shifting Asn42 closer to the ligand, hence helping to stabilising 
and resolving the entire ligand clearly. Alternatively, since the structure 
under-low sodium conditions was produced from crystals with a contracted 
lattice, the quality of the ligand density could also be attributed to the better 
quality of the data.  
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Figure 5.8 Surface representations of the binding sites in the structures 
of Gln42Asn in complex with L-BH. 
The figure shows the accessible surface generated by the residues in the ligand 
binding site. The protein and corresponding surface for the structure of Gln42Asn in 
complex with L-BH before replacing Gln42 with Asn in the model is depicted in 
coral, while the refined structure with the mutation Asn42 in place is depicted in 
yellow. The black arrow shows the direction of the expansion of the ligand-binding 
site.  
 
The tryptophan fluorescence quenching assay suggests, however, that L-BH 
does not bind to the Gln42Asn mutant in the presence of potassium (Figure 
5.5). The crystal structure of the mutant in complex with L-BH under low 
sodium and high potassium conditions adopts an occluded state and shows 
that both L-BH and a potassium ion are bound. A possible explanation for 
this discrepancy between the functional assay and the crystal structure is 
that the conformational equilibrium is affected by whether the protein is in 
solution or in the crystalline form. Previous double electron-electron 
resonance (DEER) spectroscopy studies studies have shown that Mhp1 
samples the inward- and outward-open conformations in solution (Kazmier 
et al, 2014). If the life-time of the inward-open conformation is on a faster 
time-scale than the crystal nucleation and/or growth rate, this conformation 
is less likely to take part in forming the protein crystal. In addition, the 
growing crystal lattice could act as a conformational selection filter, 
stabilising the outward-open or occluded conformations to which the ligand 
can bind. 
Another possibility, is that there could be a residual amount of sodium 
present in the crystallisation experiment due to contamination from, for 
Ile41 
Gln/Asn42 
Gln121 
Trp220 
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example, plastic vials and the equipment used. This residual level has been 
determined to be 0.33 mM (Ivanova et al. publication in preparation), and it 
is possible that even the residual amount of 0.33 mM sodium is enough to 
drive the protein conformational equilibrium slightly towards the crystallisable 
occluded conformation, in combination with the growing crystal lattice acting 
as conformational selection filter. 
 
5.3 X-ray crystal structure of a mutant-ligand complex of the 
Mhp1 mutant Ser312Ala 
5.3.1 Introduction 
In the original structure of Mhp1 in the outward-open form (Weyand et al, 
2008), a putative sodium-binding site was identified, situated between TM1 
and TM8. Sodium-binding sites have been identified in equivalent positions 
in LeuT and vSGLT, indicating that this site is conserved. Tryptophan 
fluorescence quenching assays conformed that the ligand-binding is sodium 
dependent in Mhp1, and hence a sodium ion was modelled into this site. In 
the crystal structure, the sodium is coordinated by the carbonyl oxygen 
atoms of Ala38, Ile41 (TM1) and Ala309 (TM8), as well as the hydroxyl 
oxygens of the side chains of Ser312 and Thr313 (TM8) (Jackson, 2012; 
Weyand et al, 2008; Shimamura et al, 2010) (Figure 5.9). The sodium-
binding site in Mhp1 is situated approximately 7-9 Å from the hydantoin 
binding site, towards which the adjacent residue Gln42 points. Since Ser312 
participates directly in coordinating the sodium, it is a suitable residue to 
mutate to probe the effect on the conformation of Mhp1 of a potentially 
disrupted sodium-binding site. As discussed in 5.2.4, the sodium-binding site 
in the inward-open form of Mhp1 is disrupted, which was also confirmed by 
computer simulations (Shimamura et al, 2010). Therefore, disruption of the 
sodium binding site by the Ser312Ala mutation could potentially stabilise an 
inward-open state. As for the Gln42Asn mutation, the Ser312Ala mutation 
essentially abolished the sodium-dependent binding of L-BH in Mhp1 at 15 
mM added sodium (Jackson, 2012). 
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Figure 5.9 Illustration of the sodium-binding site in wild-type Mhp1. 
The figure is replicated from Figure 3.7b, and shows the square-pyramidal 
coordination of sodium (grey sphere) in the Mhp1 protein. The view of the sodium 
binding site with respect to the ligand binding site can be seen in Figure 5.1. The 
residues coordinating sodium (Ala38, Ile41, Ala309, Ser312 and Thr313) are 
displayed in cyan with the coordinating bonds between as black dashed lines. The 
non-carbon atoms are coloured red (oxygen), blue (nitrogen) of yellow (sulphur). 
The ribbon diagram of the whole protein is displayed in semi-transparent grey.  
This could be attributed to the fact that the loss of the coordinating bond 
from the side chain hydroxyl oxygen of Ser312 disrupts the sodium binding 
site. Here, it is shown that at a higher concentration of added sodium (140 
mM), some of the ligand-binding capacity is restored (Figure 5.10). 
 
 
Figure 5.10 The binding of L-BH to wild-type Mhp1 and the Mhp1 
mutant Ser312Ala, solubilised in NM. 
The figure shows the fluorescence quench during titrations of L-BH (0-2 mM) with 
wild-type Mhp1 (a) and the Mhp1 mutant Ser312Asn (b). The titrations were 
performed in the presence of 0 mM (red), 15 mM (blue) and 140 mM (black) added 
sodium chloride. The buffer components are the same as indicated in Figure 5.2. 
The error bars display the standard error of the mean from three replicates of each 
titration.  
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5.3.2 Structure of the Mhp1 mutant Ser312Ala in complex with L-
NMH 
The Ser312Ala mutant was subjected to crystallisation trials in the absence 
and presence of all ligands previously used (Table 2.1) under high-sodium 
conditions, but crystals were obtained only of the apo-form and in complex 
with the ligands BVH and L-NMH. Diffraction data were, however, collected 
from only one crystal of the mutant in complex with L-NMH. The resolution of 
the diffraction data obtained from the crystal was 3.58 Å (Table 5.4), and the 
structure was solved in space group P212121 with a unit cell of a = 88.7, b = 
103.3, c = 108.1 Å (Figure 5.11a). The slight contraction of the a- and b-axes 
of the unit cell may be a result of that at the time of harvesting, the tray was 
approximately three months old3. Using the structure 4D1D as the molecular 
replacement search model resulted in the lowest initial R-factors.  
 
Figure 5.11 The ligand binding site in the structure of the Ser312Ala 
mutant in complex with L-NMH.  
The 2FO — FC (blue mesh, contoured at 1.5 σ) map after refinement (a), where the 
L-NMH ligand was nicely resolved (shown in green as a ball and stick model, 
placed in the same orientation as in 4D1D) at the initial stages of refinement, with 
the positive difference density peaks in the FO — FC (green mesh, contoured at 3.0 
σ) confirming the position of the ligand (b). 
Early in the refinement process, there was clear density in both of the 2FO — 
FC and the FO — FC maps in the ligand binding site, into which the L-NMH 
ligand fitted well (Figure 5.11b). As for 4D1D, TMH10 was resolved in the 
                                            
3 Tray set-up date: 19th November 2014, crystal harvesting: 17th February 2015, 
data collection: 22nd February 2015  
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electron density map in an outward-open conformation, indicating that the L-
NMH bound to the Ser312Ala mutant in the same way as it inhibits wild-type 
Mhp1. Due to the bulky nature of the naphthyl substituent of the ligand, it 
prevents occlusion of TMH10 (Simmons et al, 2014). 
 
Table 5.4 Data collection and refinement statistics for the structure of 
the Mhp1 mutant Ser312Ala in complex with L-NMH. 
 Ser312Ala-(L-NMH) 
Wavelength (Å) 0.9174 
Temperature (K) 100 
Space group P212121 
Molecules per assym. unit 1 
Unit cell parameters (Å, °) a = 88.7, b = 103.3, c = 108.1, α = β = γ = 90 
Resolution (Å) 103.33 - 3.58 (3.83 -3.58) 
No. of measured 
reflections 73441 (12761) 
No. of unique reflections 12189 (2159) 
Multiplicity 6.0 (5.9) 
Completeness (%) 99.8 (99.9) 
<I/σ(I)> 11.5 (1.1) 
CC1/2 0.997 (0.699) 
Wilson B factor (Å2) 178.3 
Anisotropy ΔB (Å2) 100.6 
Rmerge (%) 0.100 (1.689) 
Rmeas (%) 0.116 (2.030) 
Rp.i.m. (%) 0.119 (2.045) 
Matthews coefficient (Å3 
Da-1) 4.51 
Solvent content (%) 72.77 
Rwork (%)  25.29 (40.87) 
Rfree (%) 31.09 (44.52) 
R.m.s.d.   
       Bonds (Å) 0.0097 
       Angles (°) 1.3556 
Ramachandran outliers 
(%) 0.88 
Average B factor (Å2) 163.1 
                       Values in parentheses are for the highest resolution shell. 
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5.3.3 Discussion 
A structure of the Ser312Ala mutant was solved in complex with the Mhp1 
inhibitor L-NMH. The crystal structure revealed that the ligand was bound in 
the binding site, and that the mutant adopted a similar conformation as the 
wild-type protein in complex with the inhibitor, with the occluding helix 10 in 
an outward-conformation (Simmons et al, 2014). The crystal structure 
indicates that the L-NMH inhibits the Ser312Ala mutant, as it inhibits the 
wild-type protein, by preventing the occlusion of TMH10.  
For the Ser312Ala mutant, as well as for the Gln42Asn mutant, it has been 
shown that the sodium-dependent ligand binding is abolished at lower 
sodium concentrations. For both mutants, the ligand binding capacity was 
restored, to varying degrees, by adding almost 10-fold more sodium. The 
position of the residues put them in contact with the sodium-binding site, with 
the mutations possibly perturbing and causing remodelling of the sodium 
binding site.  
As for some of the structures of the Mhp1 mutant Gln42Asn, the structure of 
the Ser312Ala mutant was produced under high-sodium conditions, which 
was probably enough to turn the protein over into the occluded state and 
cause the ligand to bind.  
 
5.4 X-ray crystal structures of mutant-ligand complexes of 
the Mhp1 mutant Lys110Leu 
5.4.1 Introduction 
Lys110 is situated on the interface between the so-called bundle- and hash-
motifs (Shimamura et al, 2010), as illustrated in Figure 5.13. From 
comparing the crystal structures of the outward- and inward-open states of 
wild-type Mhp1, the hash-motif seems to undergo an approximately 30° 
rotation with respect to the bundle-motif, opening the substrate binding 
cavity to the intracellular side of the protein during the conformational 
transition to the inward-open state. Lys110 is situated on TMH3, pointing 
towards TMH6 of the bundle-motif and the mutation to Leu could potentially 
be destabilising the interactions between the bundle- and hash-motifs, 
promoting a conformational change towards the inward-open state. This 
hypothesis is supported by the tryptophan fluorescence quenching assay on 
the Lys110Leu mutant with L-BH, which shows that L-BH binds with very low 
affinity to the Lys110Leu mutant (Figure 5.13).  
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Figure 5.12 The bundle- and hash-motifs in the Mhp1 protein, 
displaying the locations of Lys110. 
The figure is replicated from Figure 3.6. The Mhp1 protein is illustrated with the 
bundle- (red) and hash-motifs (yellow) highlighted as cylinders. The helices 
comprising the bundle motif (TMs 3, 4, 8 and 9) are displayed in red and the hash 
motif (TMs 1, 2, 6 and 7) is displayed in yellow. The remaining helices and loops 
are displayed in semi-transparent grey for clarity. The location of Lys110 is 
displayed in purple.  
 
 
Figure 5.13 The binding of L-BH to wild-type Mhp1 and the Mhp1 
mutant Lys110Leu, solubilised in NM. 
The figure shows the fluorescence quench during titrations of L-BH (0-2 mM) with 
wild-type Mhp1 (a) and the Mhp1 mutant Lys110Leu (b). The titrations were 
performed in the presence of 0 mM (red), 15 mM (blue) and 140 mM (black). The 
buffer components are the same as indicated in Figure 5.2. The titration curve at 
140 mM could not be fitted. The error bars display the standard error of the mean 
from three replicates of each titration.  
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The affinity of the mutant for L-BH appears to follow the reverse trend as 
seen for the wild-type protein, with the affinity being further lowered in the 
presence of 15mM sodium chloride. However, within the experimental 
errors, the affinity is not significantly affected by the concentration of sodium 
chloride. 
 
5.4.2 Structure of Mhp1 mutant Lys110Leu in complex with L-BH 
The structure of the mutant Lys110Leu in complex with L-BH was initially 
described in section 4.6.2 and was obtained from a crystal that was 
harvested by contact-less photoablation. Data were also collected of the 
mutant Lys110Leu in complex with L-BH from a crystal that had been 
subjected to controlled dehydration, and the resulting structure from these 
data will be presented here. The structure was solved in space group 
P212121 to a resolution of 3.85 Å (Table 5.5).  
 
 
Figure 5.14 The ligand binding site in the structure of the Lys110Leu 
mutant in complex with L-BH.  
The 2FO — FC (blue mesh, contoured at 1.5 σ) map after initial refinement, 
resolving the L-BH ligand (shown in green as a ball and stick model, placed in the 
same orientation as in 4D1B) and the positive difference density peaks in the FO — 
FC (green mesh, contoured at 3.0 σ) confirming the position of the ligand. 
 
Controlled dehydration was carried out and resulted in a contracted lattice 
with unit cell parameters of a = 88.1 Å, b = 103.1 Å, c = 105.7 Å. Despite the 
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tryptophan fluorescence quenching data indicating that the affinity of the 
mutant Lys110Leu for L-BH is very low, electron density was clearly 
resolved for L-BH in the ligand-binding site in the structure of Lys110Leu 
(Figure 5.14). 4D1A was used as the molecular replacement search model, 
and there were no indications of any shift in the bundle- and hash-motifs.  
 
5.4.3 Structure of Mhp1 mutant Lys110Leu in complex with L-IMH 
Three data sets were collected from crystals of Lys110Leu in complex with 
L-IMH on the same occasion, coming from crystals that had been cryo-
cooled both by fast plunging into liquid nitrogen, as well as transfer into a 
cryo-stream. Data processing of the three data sets revealed that all crystals 
exhibited a relaxed lattice (a = 89-90 Å, b = 105-107 Å, c = 107 Å) in space 
group P212121. The best data statistics as well as lowest R-values after initial 
refinement of the molecular replacement solution using 4D1A as the 
molecular replacement search model came from the crystal that was cooled 
by fast plunging into liquid nitrogen (Table 5.5) which diffracted to 4 Å 
resolution. Early in refinement, positive electron density features in the FO — 
FC map were seen in the binding site, covering both the hydantoin and 
indolyl moities of L-IMH when placed into the ligand binding site (Figure 
5.15).  
 
Figure 5.15 The ligand binding site in the structure of the Mhp1 mutant 
mutant in complex with L-IMH.  
The final 2FO — FC (blue mesh, contoured at 1.5 σ) map, with electron density 
covering the L-IMH ligand (shown in green as a ball and stick model, placed in the 
same orientation as in 4D1A).  
Trp117 
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At this resolution, there were no distinct features in the FO — FC map 
indicating major structural changes around the site of the mutation.  
 
Table 5.5 Data collection and refinement statistics for the structure of 
the Mhp1 mutant Lys110Leu in complex with L-BH and L-IMH. 
 Lys110Leu-(L-BH) Lys110Leu-(L-IMH) 
Wavelength (Å) 0.9795 0.9174 
Temperature (K) 100 100 
Space group P212121 P212121 
Molecules per 
assym. unit 1 1 
Unit cell 
parameters (Å, °) 
a = 88.1, b = 103.0, c = 105.74, 
α = β = γ = 90 
a = 89.4, b = 105.14, c = 106.8, 
α = β = γ = 90 
Resolution (Å) 41.00 - 3.88 (4.30-3.85) 74.91 - 4.00 (4.47-4.00) 
No. of measured 
reflections 31021 (5618) 56220 (15868) 
No. of unique 
reflections 8270 (1526) 8435 (2300) 
Multiplicity 3.8 (3.7) 6.7 (6.9) 
Completeness (%) 90.1 (68.9) 94.5 (92.3) 
<I/σ(I)> 9.8 (1.1) 7.4 (1.1) 
CC1/2 0.999 (0.805) 0.998 (0.595) 
Wilson B factor (Å2) 260.5 239.4 
Anisotropy ΔB (Å2) 140.79 86.34 
Rmerge (%) 0.058 (1.369) 0.057 (1.251) 
Rmeas (%) 0.075 (1.766) 0.072 (1.586) 
Rp.i.m. (%) 0.047 (1.302) 0.044 (0.959) 
Matthews 
coefficient (Å3 Da-1) 4.40 4.73 
Solvent content (%) 72.04 74.02 
Rwork (%) 28.49 (39.40) 27.43 (38.55) 
Rfree (%) 32.27 (33.86) 30.18 (40.59) 
R.m.s.d.   
Bonds (Å) 0.0100 0.0105 
Angles (°) 1.4471 1.3854 
Ramachandran 
outliers (%) 1.10 0.66 
Average B factor 
(Å2) 235.8 129.4 
Values in parentheses are for the highest resolution shell. 
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However, there was no electron density visible for TMH10, indicating that 
this segment of the protein adopts several conformations in the structure, or 
remains flexible in the crystal lattice. This could be a result of the slight 
destabilisation between the bundle- and hash-motifs, preventing TMH10 
closing around the ligand binding site. 
 
5.4.4 Discussion  
Crystal structures of the Lys110Leu mutant in complex with the ligands L-BH 
and L-IMH have been solved. The tryptophan fluorescence quenching assay 
shows that L-BH binds with very low affinity to the Lys110Leu mutant, and 
the affinity is further lowered with increasing sodium concentration. This is 
potentially due to the fact that the mutation destabilises the interactions 
between the bundle- and hash-motifs, causing a conformational turnover into 
the inward-open form. The crystal structures, however, indicate that the 
Lys110Leu mutant adopts an occluded conformation, with the ligands L-BH 
and L-IMH bound.  
Despite the fact that the tryptophan fluorescence quenching assay indicated 
that the Lys110Leu mutant could be adopting a low-affinity conformation, 
such as for example an inward-open form, the crystal structures presented 
here indicate that this form may be a highly transient and/or unstable form to 
crystallise under the conditions used here. The conformations of the Mhp1 
mutants studied here appear to be highly dependent on the crystal lattice 
environment. One reason for this could be that the time-scales of 
conformational dynamics vs. crystal formation and growth promote the 
crystallisation of the outward-open form, allowing ligands to bind and Mhp1 
to adopt the occluded form. Another reason is the absence of stabilising 
ligands (as seen for the previously published inward-open structure of 
seleno-L-methionine derivatised Mhp1). 
 
5.5 General discussion and conclusions 
In this chapter, several new structures of Mhp1 mutant-ligand complexes are 
presented; including structures of the three Mhp1 mutants Gln42Asn, 
Ser312Ala and Lys110Leu in complex with L-BH, L-IMH or L-NMH under 
various crystallisation conditions, where primarily the sodium concentration 
was varied. The various mutant and ligand combinations for which structures 
were solved are summarised in Table 5.6.  
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Table 5.6 Summary of the mutant-ligand structures described in 
Chapter 5.  
Mutant Ligand  Crystallisation 
condition 
Res. Cooling method 
Gln42Asn L-BH High-sodium 3.74 Å Cooled by plunging into 
liquid nitrogen 
Gln42Asn L-IMH High-sodium 4.00 Å Cooled by plunging into 
liquid nitrogen 
Gln42Asn L-BH Low-sodium,  
high-potassium 
3.80 Å Cooled by plunging into 
liquid nitrogen, crystal from 
old tray 
Ser312Ala L-NMH High-sodium 3.58 Å Cooled by plunging into 
liquid nitrogen, crystal from 
old tray 
Lys110Leu L-BH High-sodium 3.88 Å Subjected to controlled 
dehydration 
Lys110Leu L-IMH High-sodium 3.91 Å Cooled by plunging into 
liquid nitrogen 
 
Overlaying all the obtained structures shows that there are no significant 
conformational changes present between the various mutant-ligand 
complexes (Figure 5.16a), apart from the region of TMH10 that closes up 
upon the ligand binding site (Figure 5.16b). In each of the ligand binding 
sites of the mutants, the ligand is found to be bound in its binding site 
(Figure 5.16c). 
The three mutations probe various sites in the protein. While the Gln42Asn 
and Ser312Ala mutations probe the ligand- and sodium-binding sites, 
respectively, the Lys110Leu mutation probes the interface between the 
bundle- and hash-motifs. The tryptophan fluorescence quenching assay 
reveals that the binding of L-BH is reduced in all three mutants to various 
degrees. The degree of the reduction of L-BH binding also depends on the 
amount of sodium present. The reduction in L-BH binding could be due to 
the protein adopting an alternative conformational state that has very low 
affinity for the ligand, and this was explored using X-ray crystallography by 
subjecting the mutants to crystallisation trials in the absence and presence 
of ligands.  
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Figure 5.16 Comparison of the Mhp1 mutant-ligand complex structures. 
All the structures of the Mhp1 mutant-ligand complexes superimposed (a), 
displaying no significant conformational changes apart from in the section of 
TMH10 that closes upon the ligand binding site (highlighted in b). In panel (c) the 
ligand binding site of each respective structure is shown, where the ligands were 
found to bind in the binding site. The ligand binding sites in (c) are in the same 
orientation as in (a) and (b).  
 
The resolution and quality of the data was comparable to previously 
published structures of wild-type Mhp1 in complex with hydantoin ligands 
(Weyand et al, 2008; Simmons et al, 2014). The resolution of the data was 
high enough to resolve the overall global conformation of the protein, and in 
all cases the mutants Gln42Asn, Ser312Ala and Lys110Leu crystallised in 
the occluded state, with ligands bound in their respective ligand binding 
Gln42Asn-(L-BH) Gln42Asn-(L-IMH) 
 
Gln42Asn-(L-BH) – low sodium 
Lys110Leu-(L-BH) Lys110Leu-(L-BH) Ser312Ala-(L-NMH) 
(a) (b) 
(c) 
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sites. Any subtle local changes at the sites of the mutations were not 
detected at this resolution.  
In all the mutant-ligand complex structures presented here, there was 
evidence that the ligands had bound in their respective binding sites. In the 
cases of the Gln42Asn mutant in complex with L-BH and L-IMH (high-
sodium conditions), as well as the Ser312Ala mutant in complex with L-
NMH, it was most likely the high concentration of sodium present in the 
crystallisation conditions that stabilised the outward-open form of the 
mutants, allowing the ligands to bind. For the Gln42Asn mutant in complex 
with L-BH under low-sodium conditions, as well as the Lys110Leu in 
complex with L-BH, the tryptophan fluorescence quenching assays indicated 
that L-BH would not be expected to bind but yet ligands were clearly 
observed in their respective binding sites. In this case, it could be that 
conformational selection during crystal formation and growth stabilised the 
outward-open and the occluded states of the protein, promoting ligand 
binding. 
No crystal structures were obtained in their apo-form, despite all being 
subjected to crystallisation trials in the absence of ligands. Some mutants 
did yield crystals (for example Gln42Asn, Ser312Ala, Asn318Gly and 
Gln121Asn) but they diffracted to a very low resolution or not at all. The 
presence of the ligands may have improved the crystallisability of the 
mutants by promoting the conformational change into the occluded form, 
which could be a more robust and crystallisable form of the protein. 
Alternatively, the ligand could have acted as a nucleating agent, aiding 
crystallisation.  
In order to further explore alternative conformational states of the Mhp1 
protein, the crystallisation conditions for the mutants that did not yield 
crystals, and hence were not taken forward for structural studies, could be 
optimised. The mutants (as well as the wild-type protein) could also be 
subjected to low-sodium conditions, which was shown to yield diffracting 
crystals for the structure of Gln42Asn in complex with L-BH (5.2.4) in order 
to potentially identify a mutant that does adopt an alternative conformation in 
the crystal. In order to address the problem of the potential low sodium 
contamination, 15-crown-5 ether could be added to the crystallisation mother 
liquor to ensure that no sodium is present for interaction with the protein 
(Lamb et al, 1980). This would also be an interesting modification to the 
crystallisation experiment to explore, as it has been demonstrated that 
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crown-ethers can also promote crystallisation by stabilising inter-molecular 
interactions (Lee et al, 2014).   
The fluorescence quenching assays suggest that the mutants presented 
here could be adopting alternative low-affinity conformations, such as for 
example an inward-open form, however a ligand-bound outward-open or 
occluded form was obtained for each of the structures of the mutant-ligand 
complexes. This suggests that the crystal formation and growing crystal 
lattice may be affecting the conformational equilibrium. In the absence of 
potentially stabilising molecules as seen the previously published inward-
open structure of seleno-Lmethionine derivatised Mhp1, alternative 
strategies and crystallisation conditions need to be sought to obtain a native 
form of the inward-open conformation or indeed any other alternative 
conformation.  
Here, only conventional vapour diffusion crystallisation trials of detergent-
solubilised protein were performed. One example of an alternative 
crystallisation technique for membrane proteins is the lipidic-cubic phase 
(LCP) crystallisation technique (Caffrey & Cherezov, 2009), that puts the 
protein in a lipid-rich environment and may thus affect the conformational 
equilibrium in such a way that it will allow the crystallisation of alternative 
crystal forms.  
Another route would be to improve the overall resolution of the diffraction 
data, which would allow identification of finer local structural 
rearrangements. This could be achieved by identifying an alternative crystal 
form by extensive screening of conventional crystallisation screens, or for 
LCP conditions. If no alternative form is found, there are further 
modifications that could enhance the quality of the crystals obtained. For 
example, shortening the detergent from DDM to NM strongly promotes 
crystal formation. Further decreasing the length of the aliphatic chain of 
detergent by exchanging it to octyl-maltoside would expose more of the 
protein that could strengthen crystal lattice contacts and the smaller micelle 
would give rise to a tighter lattice. If exchanging the detergent to n-octyl-β-D-
maltopyranoside (OM) causes the protein to aggregate due to an increased 
exposure of hydrophobic patches, OM:NM mixtures could potentially provide 
a milder way of decreasing the amount of detergent in the crystal. In 
addition, the protocols for controlled dehydration could be further optimised 
in order to improve the data quality.   
Apart from improving the quality of the crystals and resulting data, other 
strategies could also be employed to stabilise alternative conformational 
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states. For example, LeuT has been stabilised in the inward-open form using 
a combination of mutations and conformation-specific antibodies 
(Krishnamurthy & Gouaux, 2012) and such a strategy could be employed for 
Mhp1. In order to address discrepancies between tryptophan fluorescence 
quenching assays of the protein solution and what we see in the crystal 
structures, single crystal X-ray fluorescence spectroscopy could be used to 
further investigate the effect of the crystal lattice on ligand binding.  
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Chapter 6: SAXS data collection on  
Mhp1-detergent complexes  
6.1 Introduction  
In Chapter 5, a number of novel Mhp1 mutant-ligand structures were 
presented. The functional characterisation of the mutants suggested that the 
mutants may be adopting alternative conformational states. In order to 
investigate this, the mutants were subjected to X-ray crystallographic 
studies. Any alternative conformation, in addition to the already published 
crystal structures of Mhp1 in the outward-open, occluded and inward-open 
states (Weyand et al, 2008; Shimamura et al, 2010), would give further 
insight into the transport mechanism beyond the knowledge we already have 
from the previous structures.  
However, under the crystallisation conditions used and due to potential 
conformational selection imposed by the growing protein crystal, no new 
crystal form was obtained with a conformation not previously seen. Nor was 
the inward-open facing crystal form reproduced, as discussed in Chapter 
4.2.3-4. The outcomes of these crystallisation trials highlight the fact that 
structural studies of proteins and their dynamics using X-ray crystallography 
can sometimes be limited by crystal packing effects. In order to study 
conformations that can not be accommodated by a crystal lattice, solution-
based structural techniques are necessary. 
An alternative structural technique to study protein structure in solution is 
small-angle X-ray scattering (SAXS). The main challenge associated with 
using SAXS to study membrane proteins solubilised in detergent, is that the 
resulting mixture of the protein-detergent-complex (PDC) and empty micelles 
in the sample (Figure 1.9) is known to make buffer subtraction difficult to 
achieve. The central challenge in the study of detergent-solubilised 
membrane proteins is, therefore, to collect data that will allow accurate 
buffer subtraction by accounting for the presence of empty micelles, and 
thus allow deconvolution of the PDC and micelle signals.  
In Chapter 3, the preparation of Mhp1 solubilised in various detergents is 
described. In this Chapter, SAXS data collection from the various Mhp1 
PDCs is described. 
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Figure 6.1 Solubilisation of membrane proteins using detergents. 
The figure is replicated from Figure 1.9. The membrane protein (MP) can be 
extracted from the lipid bilayer by mixing with detergents. Above the CMC of the 
detergent, protein-detergent complexes (PDCs) will form, as well as protein-free 
detergent micelles. With the resulting mixture of PDCs and empty micelles still 
present in the buffer, it is difficult to achieve accurate buffer subtraction.  
 
6.2 Small-angle X-ray scattering theory 
6.2.1 Theory of X-ray scattering 
In X-ray crystallography, all macromolecules within the crystal are evenly 
spaced on a lattice, thus producing a discrete diffraction pattern when 
irradiated with X-rays. In contrast, a dilute solution of randomly oriented 
macromolecules will instead produce a radially isotropic scattering pattern 
around the incident beam. In equation 1, the scattering vector q of length q 
and direction Ω describes the position of the scattered beam with respect to 
the incident beam (Error! Reference source not found.). The intensity (I) 
of the scattered beam is proportional to the scattering amplitude (A) as a 
function of scattering vector  (q), averaged over all directions (Ω):  𝐼 𝑠 =  < 𝐴!(𝒒) >Ω      (1) 
A SAXS signal is therefore represented as a one-dimensional (1D) curve of 
the radially averaged intensity, I, vs. q. q is also called the magnitude of 
momentum  transfer and is defined by equation 2, in which 2θ is the 
scattering angle, and λ is the wavelength of the incident radiation (Error! 
Reference source not found.): 𝑞 = !!! 𝑠𝑖𝑛𝜃     (2) 
The scattering of the macromolecule of interest is obtained by subtracting 
the scattering of the buffer alone from the scattering of the macromolecule 
-70 
430 
930 
1430 
1930 
2430 
0 
50 
100 
150 
200 
250 
300 
350 
400 
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2 
A280!
I(0)!
Rg 
Elution volume (mL) 
Buffer scans  
for subtraction  
Averaged scans for the PDC 
Excess 
micelles 
PDC!
(a) (b) 
PDC 
Lipid bilayer MP 
Micelle 
Monomer 
- 137 - 
containing solution. Therefore, sample and reference buffer preparation is a 
crucial step for accurate data collection.  
Figure 6.2 Simplified illustration of a SAXS experimental setup. 
The scattered beam produces a radially averaged scattering pattern, where the 
length of the scattering vector q is defined as q=(4πsinθ)/λ with the scattering angle 
2θ. 
 
6.2.2 Obtainable information from SAXS data 
From the raw SAXS data, a number of basic physical parameters can be 
obtained, including radius of gyration (Rg), the hydrated particle volume (Vp) 
and maximum intramolecular distance (Dmax). It is recommended to collect 
and report data from several dilutions of the sample, and for the data to be 
considered reliable and suitable for modelling, these parameters should not 
vary with concentration (Jacques et al, 2012).  
Rg can be estimated from the so-called Guinier region at very low scattering 
angles, where the data is assumed to follow the Guinier approximation 
(Guinier, 1955). This states that the scattering curve is linear at very low 
angles and the slope provides a value of Rg. In addition, the Guinier region 
serves as a sample quality control, as any inter-particle interactions will 
break the linearity in that region. 
I(0) is used to calculate the hydrated particle volume Vp, or the Porod volume 
(Porod, 1982). For globular proteins ranging from 14-500 kDa, the molecular 
weight (Mw) has been found to roughly relate to the Porod volume by Vp/1.66 
(Petoukhov et al, 2012). 
A more accurate estimation of both I(0) and Rg can be obtained by indirect 
Fourier transformation of the scattering curve, taking the entire data range 
Sample 
q = Q1 - Q0 
Buffer 
2θ 
Q0 
Q1 
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into account. Fourier transformation of the scattering curve yields a distance 
distribution function P(r), which describes the probability distribution of 
distances r between scattering electrons within the macromolecule. From the 
distance distribution function, P(r)=0 directly provides the maximum particle 
dimension Dmax and the shape of the curve also gives an initial idea of the 
overall shape of the particle. Further shape information, in terms of the 
compactness of the particle, can be obtained from a Kratky plot (I*q2 vs. q). 
A curve which decays to zero at higher angles indicates a folded particle, 
while the absence of a decay indicates that the particle, or parts of it, are 
unfolded.  
Additionally, SAXS data can be used to generate ab initio models of 
biomolecules. The use of SAXS for low-resolution ab initio reconstructions 
began in the 1970s, initially by representing models as envelope functions 
based on spherical harmonics (Stuhrmann, 1970). This method was later 
superseded by reconstruction of dummy atom models (Chacón et al, 1998), 
allowing modelling of more complex structures (Volkov & Svergun, 2003). 
  
6.3 Initial SAXS data collection on Mhp1 solubilised in DDM 
6.3.1 Introduction 
SAXS data collection on detergent solubilised membrane proteins is not 
routinely performed, due to the difficulties associated with the detergent 
micelles present in the sample buffer. Matching buffer blanks have 
previously been prepared by, for example, extensive dialysis (Zimmer et al, 
2006).  
SAXS data collection was carried out on wild-type Mhp1 solubilised in DDM, 
which was purified as described in Chapter 3. Matched sample buffer blanks 
were created by subjecting the protein samples to several cycles of dilution 
and re-concentration in a spin concentrator.  
 
6.3.2 SAXS data collection of Mhp1 solubilised in DDM 
Initial SAXS data were collected at the Stanford Synchrotron Radiation 
Lightsource (beamline BL4-2) on Mhp1 solubilised in DDM (Figure 6.3). 
DDM micelles have been estimated to have a molecular weight of ~70 kDa 
(VanAken et al, 1986), meaning that buffer exchange by dilution and re-
concentration using a spin concentrator with a 100 kDa MWCO membrane 
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should eliminate excess micelles while retaining the Mhp1-DDM PDC. The 
concentration of DDM in the purified sample was approximately 5X the CMC 
of DDM, and samples for SAXS data collection were prepared by buffer 
exchange into a buffer with approximately 2X the CMC of DDM. The 
reduced DDM concentration was chosen in order to minimise the amount of 
free DDM monomers and micelles while still retaining a stable Mhp1-DDM 
PDC. The dilution series for the SAXS data measurements was then 
prepared using the dialysis buffer, ensuring that the same micelle 
concentration is present in all samples. 
The scattering curves obtained had a bimodal appearance, which is 
characteristic of a mixture of detergent micelles and PDCs (Berthaud et al, 
2012). The peak at around q ≈ 0.16 Å-1 is from the DDM micelles present in 
the samples, and is also seen in data from pure DDM micelles (Lipfert et al, 
2007). However, even after buffer subtraction, both the Kratky plot and 
distance distribution function show that the sample is not fully monodisperse. 
The sample consists of at least two components, which is especially evident 
from the Kratky plot with two distinct maxima (Figure 6.3). This may be due 
to inaccurate buffer subtraction due to varying detergent concentration. The 
obtained physical parameters Rg, Dmax as well as the estimated Mw are 
summarised in Table 6.1. 
The intra-molecular distances in Mhp1 are, approximated from the crystal 
structure of the outward-open form (2JLN) and measured using the Distance 
measure tool on Coot, ~75 Å (longest distance) and ~50 Å (parallell with the 
putative membrane normal) (see Figure 6.4). DDM micelles have previously 
been shown to adopt an oblate shape, with dimensions of 39.6-41.2 Å 
(vertical axis) and 68-71.6 Å (horizontal axis) (Lipfert et al, 2007) (see Table 
6.2 and Figure 6.5). Assuming that a detergent micelle would be oriented in 
a similar way as the membrane with its horizontal b-axis (Figure 6.5), 
parallel to the membrane normal (as illustrated in Figure 6.4), the diameter 
of the detergent micelle encapsulating the Mhp1 protein could be 
approximately ~118-121.6 Å (~50 + 68-71.6 Å), making this the largest 
estimated intra-molecular distance. 
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Figure 6.3 Initial SAXS data collection on Mhp1 solubilised in DDM. 
(a) The SAXS curves (log I(q) vs. q) are shown for a concentration series of Mhp1 
solubilised in DDM at 10 mg/ml (green), 5 mg/ml (purple), 3.75 mg/ml (blue), 2.5 
mg/ml (red), 1.25 mg/ml (black). The peak at q ≈ 0.16 Å-1 is due to the scattering 
from DDM micelles. (b) The Kratky plot (I*q2 vs. q) shows that there are two 
components present in the system, indicating that the buffer subtraction was not 
successful and did not fully account for the free micelles in the sample. (c) The 
distance distribution function (P(r) vs. r) also shows evidence of a non-
monodisperse solution, potentially with multiple populations of molecules. The 
Kratky and P(r) plots were generated from the lowest concentration SAXS curve 
(black in a).  
 
Table 6.1 Summary of the Rg, Dmax and estimated Mw from the initial 
SAXS data of Mhp1 solubilised in DDM. 
Concentration 
(mg/ml) 
Guinier Rg   
(Å) 
Dmax 
 (Å) 
Mw  (≈Vp/1.66) 
(kDa) 
10 39.6 110.8 74.75 
5 41.0 124.0 64.73 
3.75 41.1 124.0 61.49 
2.5 42.1 135.3 59.66 
1.25 44.6 156.6 47.54 
 
The suggested value for Dmax of ~118-121.6 Å value falls into the range of 
the experimental values obtained for Dmax from the SAXS (110-156 Å, Table 
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6.1). However, this range is relatively wide and could be accounted for by 
the fact that the dilution of the dialysed Mhp1 affected the stability of the 
Mhp1-DDM PDC and that the resulting buffer subtraction was not consistent 
throughout the concentration series. 
 
Figure 6.4 Illustration of the theoretical dimensions of the Mhp1 
protein. 
The Mhp1 protein (PDB 2JLN) is depicted in a cartoon representation (coral), 
positioned in its putative orientation in the cell membrane (grey rectangle). Using 
the Distance measurement tool in Coot, the longest distance is approximately 75 Å 
(dashed, black arrow) and the diameter in the direction that is parallel to the 
membrane is 50 Å (solid, black arrow). 
 
The Rg of a DDM micelle has previously been determined as 33 Å (Lipfert et 
al, 2007). The Rg obtained for the Mhp1-DDM PDC was in the range of 39.6-
44.6 Å, which also falls into a reasonable range, being slightly larger than 
DDM micelles alone, as expected. In conclusion, the dimensions obtained 
from the SAXS data collected from the Mhp1-DDM PDC, where the buffer 
has been exchanged by several rounds of dilution/re-concentration into a 
buffer containing ~2X the CMC of DDM, correspond to previously 
determined theoretical values of the dimensions of the Mhp1 protein and 
DDM micelles alone, and strongly indicate that Mhp1 does not exist as an 
oligomer in solution. Both the Dmax and Rg decrease with increasing protein 
concentration (Table 6.1), indicating that there are inter-molecular repulsive 
forces in the sample. Even though this does not affect the monodispersity of 
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the PDCs in the sample, the concentration dependence suggests that the 
protein concentration should be reduced to obtain data that is suitable for 
modelling. However, the estimated MW (Vp/1.66) ranges between 47.54-
74.75 kDa and is much smaller than expected, since the molecular weight 
for Mhp1 is 54 kDa and one DDM micelle is 70 kDa (and thus the theoretical 
Mw would be at least 124 kDa, as more than one micelle would be required 
to surround one Mhp1 molecule). The Porod volume is dependent on the 
scattering range of the data used to calculate it (Petoukhov et al, 2012). The 
Porod volumes here were calculated from the entire data range, meaning 
that noise at higher angles might have affected the obtained values. 
 
 
Figure 6.5 The model used for describing the previously reported sizes 
of detergent micelles. 
The illustrated model shows the parameter a, b and t used in Lipfert et al. (2007) 
and Oliver et al. (2013) for describing the reference values for detergent micelle 
dimensions.  
 
Table 6.2 Previously reported dimensions for DDM and DM micelles.  
The values a, b and t are based on the model illustrated in Figure 6.5. 
Detergent a (Å) b (Å) t  (Å) Rg  (Å) 
DDM 13.8-14.3 28.0-29.5 6.0-6.3 33 
DM 12.0-12.5 23.0-24.0 6.0-6.3 26 
 
6.3.3 Discussion  
Overall, the presence of detergent micelles complicates SAXS studies of 
Mhp1 and the buffer exchange method used here to remove excess micelles 
is not efficient. Even though the obtained experimental values match 
estimated theoretical values, from the crystal structure of Mhp1 and 
previously obtained values for maltoside detergent micelles, the data are 
a 
b 
t 
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inconsistent. The Rg and Dmax values displayed a concentration dependence, 
indicating that there were intermolecular interactions between the PDCs in 
the sample and hence that the buffer subtraction was not correct.  
In addition, the Kratky plot indicates that there were two species present in 
the sample, confirming that the buffer subtraction was not successful and 
there were micelles present that contributed to the overall signal. This 
complicates deconvolution of the respective signals as free detergent, 
micelles and protein-detergent-complexes will co-exist in a complex 
equilibrium. 
Therefore, reducing the detergent concentration and using a conventional 
method for buffer exchange may not be a reliable method for eliminating the 
signal from detergent micelles. An alternative strategy is therefore required 
in order to accurately account for the micelles present in the PDC solution.   
 
6.4 SEC-SAXS data collection on Mhp1 solubilised in 
various maltoside detergents 
6.4.1 Introduction 
In section 6.3, the difficulty of obtaining reliable SAXS data from detergent-
solubilised Mhp1 is clearly demonstrated. It was shown that when employing 
a standard buffer exchange method, a concentration dependence of the 
physical parameters Rg and Dmax as observed. In addition, the Kratky and 
P(r) plots indicated that the samples still contained free detergent micelles. 
In a recent study, size-exclusion coupled SAXS (SEC-SAXS) has been used 
to address the problem of inaccurate buffer subtraction in the study of DDM-
solubilised aquaporin-0 (Aqp0) (Berthaud et al, 2012). The idea behind SEC-
SAXS is that the PDC becomes diluted into the running buffer on the SEC 
column, with excess empty micelles becoming separated from the main PDC 
peak during the SEC run. A number of buffer scans at the start of the run 
can be averaged and used as a buffer blank for the PDC peak (Figure 6.6). 
These data enabled the modelling of a dummy-atom model of the detergent 
corona surrounding the Aqp0 protein. 
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Figure 6.6 Illustration of the principle behind SEC-SAXS of membrane 
proteins. 
Th figure illustrates a SEC-SAXS run of the Mhp1-DDM PDC, performed at the 
SSRL, beamline BL4-2. The absorbance at 280 nm (denoted A280, green line) is 
combined with the I(0) (green crosses) and Rg (grey dots). Using the SEC run, the 
PDC is diluted into the column running buffer and is separated from excess 
micelles. Accurate buffer subtraction is achieved by subtracting an average of a 
number of buffer scans and the beginning of the run from averaged scans from the 
main PDC peak. 
 
Previously, purification and crystallisation trials have demonstrated that 
Mhp1 is stable in DDM and NM. The fact that Mhp1 does not crystallise 
when solubilised in DDM, but crystallises readily when the detergent has 
been exchanged to NM (see section 4.2.2) could be because the shorter 
detergent exposes the solvent-accessible parts of the protein that are able to 
form crystal contacts with varying degrees, and PDCs with different solvent-
accessible regions might be able to give more structural information. 
Alternatively, the protein could be more structurally homogenous in one 
detergent than another. As suggested by the fluorescence quenching assays 
performed on the Mhp1 protein solubilised in maltoside detergents of varying 
detergents described in Chapter 3, the affinity the Mhp1 protein for L-BH 
appears to decrease when the protein is solubilised in a shorter detergent, 
which could be due to the fact that a smaller detergent micelle restricts the 
conformational flexibility of the protein and thus makes it a less efficient 
transporter. Therefore, SEC-SAXS experiments were performed on Mhp1 
solubilised in one of four maltoside detergents of varying length (illustrated in 
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Figure 6.7). In addition, since the SAXS data are collected during the course 
of a SEC run, exploring different length detergents (giving rise to different 
size micelles) might enable the establishment of conditions where the 
separation between the PDC and excess micelles peak are optimally 
separated. Ensuring that there is no overlap and residual mixture of the main 
PDC and excess micelle peaks will allow for accurate buffer subtraction.  
 
 
Figure 6.7 The structure of the maltoside detergents used in this 
project. 
The figure is a replication of Figure 3.12. The common maltoside head-group 
structure is illustrated for the four detergents used in this project (blue), with the 
length of each of the aliphatic hydrocarbon chains (red) indicated by the number of 
carbons in parentheses (nC). 
 
6.4.2 SEC-SAXS data collection  
SEC-SAXS data were collected at the SWING beamline at the French 
national synchrotron Soleil, using the dedicated SEC-SAXS set-up at the 
beamline. For the SEC-SAXS studies, Mhp1 solubilised in maltoside 
detergents of different length was investigated: n-dodecyl-β-D-
maltopyranoside (DDM), n-undecyl-β-D-maltopyranoside (UM), n-dodecyl-β-
D-maltopyranoside (DM) and n-nonyl-β-D-maltopyranoside (NM) (Figure 
6.7). As expected, the Rg and Dmax values decrease for Mhp1 solubilised in 
detergents of shorter length (Table 6.3). The Dmax values for Mhp1 
solubilised in UM and DM do however not follow this trend, which could be 
due to poor quality data or the PDCs being partially unstable under the 
experimental conditions.  
The previously determined Dmax value for the Mhp1-DDM PDC (section 
6.3.2) ranged between 110.8-156.6 Å, which includes almost the entire 
range of the values obtained from various PDCs using SEC-SAXS. This 
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demonstrates again that the initial SAXS data collected on the Mhp1-DDM 
PDC may not be of good enough quality to extract structural information 
about the PDC.  
 
Table 6.3 The Rg and Dmax values obtained for various Mhp1 PDCs.  
Detergent PDC Guinier Rg  (Å) Dmax (Å) 
DDM 41.3 122.8 
UM 38.5 117.0 
DM 37.3 117.4 
NM 35.7 109.0 
 
In this case the experimental Dmax value for the DDM-Mhp1 PDC matches 
closely the estimated value of ~118-121.6 Å. The fact that UM and DM did 
not completely follow the trend of decreasing experimental values for the Rg 
and Dmax with shorter detergent indicates that there might have been some 
problem with the samples, which is reflected in the data where the SAXS 
curves for all PDCs apart from the Mhp1-DDM PDC are considerably noisier 
(Figure 6.8). This could have been sample instabilisty due to the shipping 
and storage conditions, or this could be due to the fact that the PDC 
becomes more destabilised the shorter the surrounding detergent corona. In 
section 3.5.2, the tryptophan fluorescence quenching assay shows that 
Mhp1 reconstituted in shorter detergents becomes less efficient at binding L-
BH, which could imply that the integrity of the Mhp1 protein becomes 
comprimised in a shorter detergent. Other reasons could be the formation of 
transient oligomers, as more of the protein becomes exposed when 
embedded within a smaller detergent micelle. A third potential reason for the 
poor data quality from the Mhp1-UM, Mhp1-DM and Mhp1-NM PDCs is that 
these complexes were prepared by detergent exchange from DDM to the 
each one of the shorter detergents. This could have resulted in a mixed 
detergent corona that becomes destabilised in a buffer containing only one 
detergent. 
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Figure 6.8 SEC-SAXS data from Mhp1 solubilised in maltoside 
detergents of varying length. 
The illustration in (a) shows the chemical structure of each of the maltoside 
detergents used to create Mhp1-detergent PDCs. The colours indicated for each 
detergent corresponds to the SAXS curved displayed for the Mhp1-DDM (b), Mhp1-
UM (c), Mhp1-DM (d) and Mhp1-NM (e) PDCs. 
 
6.4.3 Discussion  
SEC-SAXS data collection was performed in order to address the problems 
associated with SAXS studies on detergent-solubilised membrane proteins. 
In section 6.3.2, standard SAXS data collection on the Mhp1-DDM PDC was 
described, and it was shown to greatly suffer from concentration dependent 
effects and inaccurate buffer subtraction. The Rg and Dmax values derived 
from these data varied greatly across the concentration range tested.  
The SEC-SAXS data did display improvements with respect to the initial 
SAXS data of the DDM-Mhp1 PDC, where the sizes between the various 
PDCs could be distinguished, based on the obtained Rg and Dmax values. 
The general trend was that the Rg and Dmax values decreased the shorter the 
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detergent was, which is as expected as a shorter detergent will give rise to a 
smaller micelle. Some of the PDCs fell outside the trend, which is most likely 
explained by poor sample quality as indicated by the noisy data obtained for 
smaller PDCs. The Mhp1-PDC samples could have been affected by the 
shipping and storage conditions prior to the experiments. Another aspect 
that might affect the sample quality is how the PDC samples are prepared. 
During the purification of Mhp1, the protein is initially solubilised in DDM, and 
bound to the Ni-NTA resin while solubilised in DDM. After washing the resin 
with DDM-containing buffer to remove any unbound material, the exchange 
to a shorter detergent is achieved by applying a second wash buffer 
containing the shorter detergent of interest. It is difficult to quantify the extent 
of the detergent exchange, and whether the resulting detergent corona 
consists of a mixture of DDM and the shorter detergent, and what 
proportions of respective detergent constitutes the detergent corona. It is, 
therefore, not unlikely that the PDCs with UM, DM and NM consist of 
mixtures of each respective detergent and DDM. Since each elution was 
performed in a buffer containing only one detergent, the mixed detergent 
corona could be destabilised when diluted into the SEC running buffer, as 
the dilution might affect the effective concentrations of each detergent in the 
detergent corona. This suggests that a more rigorous detergent exchange 
protocol must be applied, involving for example solubilisation directly in the 
detergent of interest and/or followed by dialysis in the SEC buffer in order to 
ensure a homogeneous micelle. These results also indicate that the binding 
parameters obtained from tryptophan fluorescence quenching studies for 
Mhp1 in UM, DM and NM are for Mhp1 reconstituted into mixed detergent 
coronas. 
The decrease in the experimentally obtained Rg values from the SEC-SAXS 
data, where the least amount of noise is observed still shows that a smaller 
PDC is obtained with a shorter detergent. When relating the experimentally 
obtained values for Rg and Dmax for the Mhp1-DDM PDC to previous 
reference values for micelles alone, as well as estimated intermolecular 
distances of the Mhp1 protein from its crystal structure, they match closely. 
The estimated value for the largest intermolecular distance in the Mhp1-
DDM PDC is ~118-121.6 Å, while the Dmax for this PDC was determined to 
be 122.8 Å. Despite the close match of these values, it must be kept in mind 
that the estimated intra-molecular distances from the crystal structure of 
Mhp1 and previously obtained values for the detergent micelles are based 
on many assumptions.  
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Nevertheless, the comparison between experimental and estimated Dmax 
values demostrate that collecting SAXS data coupled to SEC enables the 
differentiation between PDCs of varying size and is therefore a more 
effective technique to study detergent-solubilised membrane proteins than 
standard SAXS. The data of the highest quality was obtained for the Mhp1-
DDM PDC, where the obtained experimental values fall into a reasonable 
range when considering the dimensions of the protein and micelles alone. 
6.5 Modelling of the detergent corona around the Mhp1 
protein 
6.5.1 Introduction 
Usually, SAXS data from biomolecules is used to generate low-resolution ab 
initio models of the biomolecule in solution (Svergun, 1999; Putnam et al, 
2007). These methods are, however, not applicable for detergent-solubilised 
proteins, as the resulting PDCs consist of components of varying electron 
densities. In order to enable the modelling of the detergent corona around 
the protein from SEC-SAXS data, the program MEMPROT has been 
developed (Perez & Koutsioubas, 2015). In MEMPROT the protein part of 
the PDC is modelled as an all atom model, while the detergent corona is 
modelled as a coarse-grained  elliptical corona consisting of dummy atoms, 
with electron densities defined for the hydrophobic interior as well as the 
hydrophilic exterior of the corona model based on previously determined 
values (Lipfert et al, 2007). The theoretical scattering from the PDC model is 
calculated using CRYSOL from the ATSAS suite (Svergun et al, 1995), and 
is then compared to the experimental SAXS curve. The fit of the theoretical 
scattering from the generated model vs. the experimental data is quantified 
by the value of χ (chi), defined by equation (3). For a perfect fit, the χ value 
approaches 1. 𝜒 =  !! [!!"# 𝒒𝒊 !!!"# 𝒒𝒊 ]!!!!! !/!    (3) 
 
The dimensions of the detergent corona are described by a set of 
parameters, describing the ellipticity and the thickness of the hydrophobic as 
well as the hydrophilic part. During a MEMPROT run, extreme values for 
these parameters are assigned at the start, which are then refined and 
assessed using the χ value. Previously, the detergent corona was 
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successfully modelled around the Aqp0 protein from SEC-SAXS data 
(Berthaud et al, 2012; Perez & Koutsioubas, 2015).  
 
6.5.2 Modelling of the Mhp1-DDM PDC 
Using the highest quality SEC-SAXS data, from the Mhp1-DDM PDC, 
modelling of the DDM detergent corona was attempted. Comparing the 
Kratky plot and the P(r) function of the SEC-SAXS data (Figure 6.9b and c, 
respectively) to those from the original data collection on DDM-solubilised 
Mhp1 (Figure 6.3) suggests that the buffer subtraction was successful and 
that the data represents one homogeneous species. The Kratky plot has one 
clear maximum, indicating that there is one well-folded species present in 
the sample, while the plot exhibited two maxima from the original data. The 
P(r) also appears to be smoother, suggesting that a more homogeneous 
sample is obtained by subjecting it to SEC. The small shoulder at 
approximately 0-20Å is still present, suggesting that it is a feature of the 
PDC, probably stemming from interatomic distances within the detergent 
corona. 
The crystal structure of the Mhp1 protein, in an outward-open conformation 
(PDB 2JLN, Weyand et al, 2008) was used as the protein model. In order to 
place the Mhp1 protein on the same grid as the detergent corona dummy-
atom model, the 2JLN structure was oriented to overlay with the crystal 
structure of the Aqp0. The advantage of the Aqp0 protein is that it is a 
tetramer, making the placement of this protein in the middle of the detergent 
corona straight forward. For the 2JLN structure, however, it was difficult to 
determine the unambiguous orientation of the protein molecule relative to 
the central axis of the detergent corona.  
A wide range of the dimensional parameters of the detergent corona were 
defined in the calculation of the detergent corona model. The lowest χ value 
obtained in this modelling attempt was 1.8, while previously χ values have 
fallen in the range of ~1.3-1.5 (Perez et al, 2013; Berthaud et al, 2012). The 
fit of the theoretical scattering curve does indeed deviate from the 
experimental data at higher angles, as well as around the signal minimum 
before the detergent micelle peak at q ≈ 0.16 Å-1 (Figure 6.9a). However, the 
dimensions of the resulting detergent corona match previously reported 
values for a DDM micelle alone, as summarised in Table 6.4. The 
dimensions a, b and c quoted for the detergent corona surrounding the 
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Mhp1 protein in Figure 6.9d correspond to the same dimensions of free 
micelles as illustrated in Figure 6.5. 
The resulting modelled DDM corona surrounding the Mhp1 protein matches 
the previously reported values for DDM micelles alone (Lipfert et al, 2007), 
suggesting that the buffer subtraction of the data for the Mhp1-DDM PDC 
was successful by coupling the SAXS data collection with SEC. The 
relatively high χ value for the theoretical scattering of the model against the 
experimental data could be a result of inappropriate orientation of the Mhp1 
in the model of the detergent corona, as this was done arbitrarily in order to 
place the Mhp1 molecule in line with the central axis of the detergent model. 
 
 
 
Figure 6.9 A model of the Mhp1-DDM PDC modelled from SEC-SAXS 
data, and the fit of the model against experimental data. 
The experimental data (blue) and the fit of the Mhp1-DDM PDC model (red) are 
shown (a), alongisde the Kratky plot (b) and the P(r) function (c) from the 
experimental data. The resulting model (d) is comprised of the Mhp1 protein (PDB 
2JLN, shown in a cartoon representation coral), with the surrounding detergent 
corona illustrated as a belt of spheres. The grey spheres correspond to the 
hydrophobic interior of the detergent corona, while the green spheres correspond to 
the hydrophilic head group dummy atoms of the detergent corona model. The 
parameters a, b and t correspond to those in Figure 6.5. The coordinate system for 
the detergent corona, as defined in the modelling program, is indicated by the grey 
arrows denoting the directions for the x-, y- and z-axes. 
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Modelling of the 2JLN crystal structure in different orientations all gave rise 
to considerably higher χ values and poor fits of the theoretical scattering of 
the model to the experimental data. The same was obtained when the 
detergent corona was modelled around crystal structures of the Mhp1 
protein in other conformational states, indicating that this methodology could 
be used to distinguish between preferred conformational states of the protein 
in various detergents. 
 
Table 6.4 The dimensions of the Mhp1-DDM PDC detergent corona 
model compared to previously reported dimensions for empty 
DDM micelles.  
The values a, b and t are based on the model illustrated in Figure 6.5, and quoted 
in Lipfert et al. (2007)*. 
DDM corona a (Å) b (Å) t  (Å) 
Model 13.5 31.0 6.0 
Reference* 13.8-14.3 28.0-29.5 6.0-6.3 
 
6.5.3 Discussion  
The modelling of the Mhp1-DDM PDC is described in this section, using the 
recently developed program MEMPROT. The data for the PDC obtained by 
SEC-SAXS data collection were used to model the PDC with an all-atom 
representation of the protein using a dummy-atom model of the surrounding 
detergent corona. The resulting dimensions of the DDM detergent corona 
surrounding the Mhp1 protein matched the experimental values previously 
obtained for DDM micelles alone. This supports the conclusion that the 
buffer subtraction in the SEC-SAXS data collection was successful.  
Even though the model appeared to match previously obtained values well, 
the χ value of the fit of the theoretical scattering form the PDC model against 
the experimental data was high, relative to previously obtained values for 
similar models (Perez & Koutsioubas, 2015). This could be explained by the 
fact that several assumptions are introduced during the course of preparing 
and performing the modelling procedure. Firstly, a crystal structure is used to 
represent the protein part of the PDC. This is a static structure and would 
thus not account for any conformational flexibility in the actual PDC sample. 
For the model generated here, the protein in an outward-open form was 
used as the protein model. When different crystal structures were tested (by 
superposing them onto the 2JLN position in the best model obtained here), 
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significantly higher χ values were obtained for the models, giving rise to a 
poor fit of the theoretical scattering to the experimental data. It is not unlikely 
that Mhp1 samples several conformations in solution (Kazmier et al, 2014), 
which makes the assumption that the protein remains static in the PDC 
model a limitation in the modelling approach.   
Secondly, the orientation of the Mhp1 molecule within the detergent belt may 
not be representative of the true orientation of the protein within the 
detergent micelles. In the case of Aqp0, its four-fold symmetry ensured a 
relatively reliable placement in the xy-plane, where adjustments could be 
made using the rotation parameter. In the direction of the z-axis, the 
placement was guided by the hydrophobic belt and the relatively large  
solvent-exposed tail regions. The monomeric Mhp1 does not possess any 
symmetry elements that could guide the placement within a theoretical 
detergent micelle, and the placement of the Mhp1 protein was initially done 
arbitrarily onto the central axis of the detergent micelle. 
A third assumption is imposed by the modelling program, where the 
detergent corona is assumed to adopt an elliptical shape. While this could be 
true for the case of Aqp0, for which the resulting PDC models gave rise to 
relatively low χ values, this is not necessarily the case for Mhp1. The Aqp0 
associates as a tetramer into the detergent corona, and being bigger and 
having a different shape of the hydrophobic belt, it could be imposing 
different constraints on the curvature of the detergent corona.  
Suggested improvements to the MEMPROT program in order to improve its 
applicability to all kinds of systems are to introduce further parameters that 
could help to systematically sample more orientations of the protein within 
the detergent corona. For example, an additional parameter could be the tilt 
of the detergent corona with respect to the central axis. Alternatively, the 
detergent corona belt modelling could also be attempted in an ab initio 
fashion, as applied in the reconstruction of low-resolution models from SAXS 
data (Svergun, 1999). Rather than defining parameter extremes that are 
scanned though to find the model with the best fit between the theoretical 
and experimental scattering data, doing an ab initio model of the corona 
could account for any shape distortions imposed on the detergent belt by the 
protein, any altered orientation of the protein in the belt and also save 
computational power.  
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6.6 General discussion and conclusions  
In this Chapter, different approaches for SAXS data collection of Mhp1 
PDCs in maltoside detergents of varying length are described. SAXS data 
collection on the Mhp1-DDM PDC using a conventional buffer exchange 
method did not give rise to reliable data, as the Rg and Dmax values exhibited 
a concentration dependence, possibly due to the procedure for the 
preparation of the dilution series and resulting inconsistent buffer 
subtraction.  
This problem was overcome by performing SEC-SAXS studies of Mhp1 
PDCs, with maltoside detergents of varying length. The resulting studies 
showed that SEC-SAXS data can successfully be collected on Mhp1 PDCs, 
where the decreasing size of the PDC with shorter detergent length was 
reflected in the resulting Rg and Dmax values. In the case of SEC-SAXS data 
collection, there were problems associated with the sample quality. For the 
detergents UM, DM and NM, the data were very noisy. This could be 
explained by the purification procedure used to prepare these PDCs, which 
could give rise to a mixed detergent corona (consisting of DDM and the 
detergent the PDC has been exchanged into). Therefore, the PDCs 
containing UM, DM and NM may have been destabilised by being diluted 
into buffer containing each respective detergent. This suggests that 
alternative sample preparation protocols need to be employed in order to 
study these PDCs.  
Nevertheless, the SEC-SAXS data obtained from the Mhp1-DDM PDC could 
be used to create a model of the PDC with the protein molecules as an all-
atom model and the surrounding detergent belt represented as a dummy-
atom model. The dimensions of the detergent belt in the resulting PDC 
model match previously obtained values for DDM micelles alone, indicating 
that the buffer subtraction and SEC-SAXS data collection was successful for 
the Mhp1-DDM PDC. The data for the other PDCs suggests that, in order to 
study these, further optimisation of the purification and/or the sample 
preparation is required.  
In conclusion, these experiments serve as a proof-of-principle that the 
suggested SEC-SAXS data collection and detergent corona modelling can 
be applied to a monomeric secondary-active transporter. For the case of 
Mhp1, additional optimisation of the sample preparation procedure is 
required, as well as potential adjustments of the MEMPROT software used 
for the modelling of the detergent corona.  
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The SEC-SAXS data, despite the potential associated problems with the 
sample quality, show that shorter detergents do give rise to a smaller PDC. 
In terms of the crystallisability of Mhp1 in various detergents, this is 
consistent with the previous suggestion that a smaller detergent micelle 
surrounding the protein results in the exposure of parts of the protein that 
participate in crystal contacts. The resulting model for the PDC gives another 
insight into the crystal packing of Mhp1 molecules. From the modelled 
Mhp1-DDM PDC, it is evident that the detergent creates a significantly bulky 
belt around the Mhp1 protein. 
From previously obtained values for detergent micelles alone (Table 6.2), 
the thickness of a DDM micelle in its horizontal axis is suggested to be 34-
35.8 Å (b+t = 28.0-29.5 + 6.0-6.3 Å), while the thickness of a DM micelle is 
29-30.3 Å (b+t is 23.0-24.0 + 6.0-6.3 Å). If extrapolating these values, the 
thickness of an NM micelle could be approximately 27.5 Å. The distance 
between NM solubilised Mhp1 molecules in the lattice of the crystals 
obtained as part of this Thesis is approximately 40 Å (see Figure 4.10), 
suggesting that the detergent phase is potentially highly crowded within the 
crystal lattice. The fact that DDM solubilised Mhp1 protein does not 
crystallise could be due to the fact that the detergent corona simply does not 
allow the formation of crystal contacts due to steric hindrance.   
This suggests that the crystallisability of the Mhp1 protein in various 
detergents could depend more on crowding of detergent belts rather than 
different degrees of solvent-exposed regions being able to participate in 
crystal contacts. Even in the case of NM, the detergent phase is probably 
highly crowded, which could account for the fragility of the crystals and the 
low quality of the resulting diffraction data. 
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Chapter 7: Conclusions and future directions 
 
Membrane proteins are very important targets for structural studies and 
subsequent drug design, however, they are very challenging to study due to 
their hydrophobic nature. An important class of membrane transport proteins 
are the secondary-active transport proteins which are responsible for the 
transport of ions, metabolites, vitamins and signal substances across cell 
membranes.  
The focus of this Thesis is the secondary-active, bacterial sodium-hydantoin 
transporter Mhp1. In an effort to gain more knowledge about the transport 
mechanism of Mhp1, serving as a model system for related eukaryotic 
transport proteins, the Mhp1 protein was studied using a combination of X-
ray crystallography and small-angle X-ray scattering.  
The transport mechanism of Mhp1 was probed using a series of single-point 
mutants, which had previously been identified to have altered ligand binding 
behaviour. Mutants of Mhp1 have been successfully produced and 
characterised (Chapter 3) for subsequent structural studies. The Mhp1 
mutants were subjected to crystallisation trials, using previously published 
crystallisation conditions as a starting point (Weyand et al, 2008; Shimamura 
et al, 2010). Crystals of Mhp1 mutants were successfully produced, and after 
considerable optimisation, reproducibly well-diffracting crystals (<4Å) were 
reproducibly obtained (Chapter 4). This was achieved by a combination of 
applying modifications to the crystallisation droplet morphology, controlled 
dehydration and contact-less harvesting. The crystals were of various Mhp1 
mutants in complex with various hydantoin ligands, and gave rise to a series 
of crystal structures of novel mutant-ligand complexes (Chapter 5).   
The resulting structures gave some mechanistic insights into the transport 
mechanism, but no conformational state other than those previously 
observed in published crystal structures of the Mhp1 protein was obtained. 
The structures indicated that the crystal lattice and crystallisation conditions 
may play a significant role in the conformational state adopted by the Mhp1 
protein in the crystal. Therefore, investigating the applicability of small-angle 
X-ray scattering to study the Mhp1 protein was a suitable route to obtain 
further structural information about the protein, as the measurements are 
carried out in solution without any restrictions imposed by the crystal lattice. 
As with crystallographic studies, membrane proteins are challenging targets 
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to study using SAXS, and the problems associated with detergents present 
in the sample buffer were addressed (Chapter 6).  
The mutant-ligand structures described in Chapter 5 are of single-point 
mutants with locations of the mutations in three different areas of the Mhp1 
protein: the ligand binding site, the sodium binding site and the interface 
between the so-called bundle- and hash-motifs, which undergo a rotation 
relative to one another upon the transition from the ligand-bound occluded 
form to the inward-open form. The Mhp1 mutants crystallised in the 
presence of various hydantoin ligands.  
However, no additional conformational state was obtained for the Mhp1 
protein, other than those previously observed. At the working resolution of 
the crystal structures of the mutant-ligand complexes presented in this 
Thesis, small alterations to the conformation and/or changes of single 
residues of the Mhp1 protein are likely to go undetected. In order to gain 
insight into these finer alterations to the structure due to single-point 
mutations, higher resolution crystal structures would be required.  
The results indicate that the crystallisation conditions used, and the resulting 
crystal packing, may also be a limiting factor to what parts of the 
conformational landscape of the transport mechanism of Mhp1 can be 
investigated. It appears that the P212121 crystal form is highly favoured for 
Mhp1 crystals and previously published crystal structures, along with the 
crystal structures presented as part of this Thesis, indicate that this crystal 
form accommodates and/or drives the conformation of the Mhp1 protein into 
an outward-open or occluded form. This could be a result of the 
conformational equilibrium of Mhp1 being sampled in the solution, where the 
inward-open form may be a short-lived intermediate, that does not exist for 
long enough to form protein crystal nuclei. The crystal lattice could also be 
acting as a scaffold for Mhp1, forcing the protein into a conformational state 
that fits in the crystal lattice.  
Apart from attempting to crystallise a different crystal form using single-point 
mutants of the Mhp1 protein, reproducing the crystal structure of the inward-
open form of seleno-L-methionine derivatised Mhp1 was also attempted, 
which has previously crystallised in a different crystal form (in space group 
P61). Crystals were obtained of seleno-L-methionine derivatised Mhp1 under 
different crystallisation conditions, but not of the expected crystal 
morphology and the resulting crystals were not of good enough quality to 
harvest for diffraction screening and the crystal form could thus not be 
assessed. A possible reason for the fact that the expected crystal form of 
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crystals of seleno-L-methionine derivatised Mhp1 were not obtained was the 
absence of a expression and/or purification batch specific ligand that may 
have been altering the conformational equilibrium of the protein to stabilise 
the inward-open form and thus, promote the crystallisation of the inward-
open conformation.  
At the current stage, remaining question about the structure and transport 
mechanism of the Mhp1 protein are: what are the conformations of the apo 
form of the single-point mutants; what is the structure of the inward-open 
form of native Mhp1; and what intermediate conformational states does the 
Mhp1 protein adopts between the transitions between outward-open " 
occluded " inward-open state? 
The next step in order to investigate these question and access a greater 
portion of the conformations adopted by Mhp1 during its transport 
mechanism is to perform broad re-screening for crystallisation conditions for 
the single-point mutants described here.  Identifying alternative 
crystallisation conditions could allow the crystallisation and exploration of 
alternative conformations of the protein. In addition, the library of mutants 
could also be expanded to include further single-point mutants, as well as 
Mhp1 variants containing combinations of mutations. In addition, low-sodium 
conditions for the orthorhombic crystals could also be explored for other 
mutants, as done for the Gln42Asn mutant in complex with L-BH, which was 
crystallised in the presence of a high potassium concentration.  
An alternative avenue to obtain a new crystal form and obtain higher-
resolution crystal structures is to move to lipid based crystallisation methods, 
screening for conditions in, for example, lipidic cubic or lipid sponge phase 
(Caffrey & Cherezov, 2009; Wöhri et al, 2008). This would most likely give 
rise to type I protein crystals, in which the packing of the hydrophobic parts 
of the protein molecules could allow a more stable crystal lattice, giving rise 
to higher resolution diffraction data. These crystals would also have no 
detergent present, which has been demonstrated to potentially limit the 
diffraction quality that can be obtained from crystals of detergent-solubilised 
Mhp1. In the studies carried out as part of this Thesis, attempts were made 
in order to improve the resolution of the Mhp1 crystals by investigating 
alternative cryo-cooling and harvesting approaches, out of which controlled 
dehydration and contact-less harvesting by photo-ablation proved to be the 
most sucecssful strategies. However, despite the fact that the techniques 
showed potential in improving the data, the resolution limit of 3.5-4 Å was 
never exceeded. This is likely to be due to the presence of the surrounding 
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detergent corona around the Mhp1 proteins, which is of a finite size and 
thus, has a limit to how much it can be contracted in order to achieve a 
tighter and more well-diffracting lattice. Therefore, changing the environment 
of the protein molecules in the crystal lattice, either by using shorter 
detergents or by moving onto lipid-based crystallisation methods, is most 
likely a better strategy in the future of the structural studies of the Mhp1 
protein and secondary-active transport proteins. 
Nevertheless, controlled dehydration using the HC1 device, as well as 
contact-less harvesting by photo-ablation have been presented as 
successful strategies to improve the crystal quality. The studies performed 
as part of this Thesis have highlighted that the hydration level is important 
for detergent-solubilised membrane protein crystals, and that various 
dehydration protocols should be explored in the process of optimising 
membrane protein diffraction. 
The crystallographic work presented in this Thesis has demonstrated the 
challenges and limitations that can be encountered with membrane proteins, 
it has shown that the crystal lattice may have a profound effect on the 
structural information that can be obtained using X-ray crystallography. 
Therefore, the investigation of SAXS as a complementary technique was a 
suitable complement to the crystallographic studies. There are several 
different solution based techniques that can be used to gain complementary 
functional and dynamics information about proteins, for example, EPR 
(Kazmier et al, 2014) and FRET (Zhao et al, 2010), which have previously 
been carried out on Mhp1 and related proteins. The advantage of SAXS lies 
in the fact that structural information can be directly extracted. With the 
recent improvements in the data collection and modelling from SAXS data of 
membrane proteins, this is a very interesting technique to investigate.  
In this Thesis, SEC-SAXS studies were performed on PDCs of the Mhp1 
protein and maltoside detergents of varying length. Even though the studies 
indicated that there are potential issues with the sample preparation 
procedure of these PDCs, they allowed for the data collection from the 
Mhp1-DDM PDC that allowed the modelling of the surrounding DDM corona 
around the Mhp1 protein. These studies served as a proof-of-principle that 
the method is applicable to the study of secondary-active transporters, 
highlighting necessary improvements and optimisation of the sample 
preparation and modelling procedure.  
In the current modelling approach of the PDC from SEC-SAXS data involves 
assuming the protein conformation is static. Future directions of the 
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modelling from SEC-SAXS data could be to assume the detergent corona as 
the static part of the system, while allowing the ab initio modelling of  the 
protein conformation. This approach would require substantial extracellular 
domains, that would protrude from the detergent corona and undergo 
conformational changes that are significant enough to be modelled from the 
SEC-SAXS data. The extracellular domains of, for example, Mhp1 are not 
very large and it is difficult to estimate whether the subtle movements of the 
helices upon ligand binding and release could be modelled from SEC-SAXS 
data. Nevertheless, introducing conformational markers, could be a strategy 
to make it possible to study the conformational changes of the Mhp1 protein 
and related secondary-active transporters. If the conformational markers 
could be compatible with protein crystallisation trials such as, for example,   
maltose binding proteins (Smyth et al, 2003; Moon et al, 2010), this could be 
a future approach for complementary studies of membrane proteins.  
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Appendix A 
SDS-PAGE gels (a) and corresponding Western blots (b) of samples from 
the purification of Mhp1 mutants used to make Figure 3.8. 
In all gels, apart from the gels of the purification of Asn318G*, the lanes 
correspond to 1) solubilisation mixture before ultracentrifugation, 2) soluble 
fraction containing solubilised Mhp1 protein after ultracentrifugation, 3) pellet 
after ultracentrifugation, 4) unbound material in the flow-through after binding 
to the Ni-NTA resin, 5) wash buffer of the Ni-NTA resin, 6) eluted sample 
from the Ni-NTA resin using 200 mM imidazole. The arrows indicate the 
position of the migration of Mhp1.  
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Lys110Leu 
 
 
In the gel of the purification of Asn318G*, the lanes correspond to 1) soluble 
fraction containing solubilised Mhp1 protein after ultracentrifugation, 2) pellet 
after ultracentrifugation, 3) unbound material in the flow-through after binding 
to the Ni-NTA resin, 4) wash buffer of the Ni-NTA resin, 5) eluted sample 
from the Ni-NTA resin using 200 mM imidazole. 
 
 
 
 
 
 
kDa 
52 
 
38 
17 
24 
kDa 
66.0 
45.0 
36.0 
29.0 
24.0 
20.1 
(b) (a) 1 2 3 4 5 6 7 1 2 3 4 5 6 7
kDa 
66.0 
45.0 
36.0 
29.0 
24.0 
20.1 
38 
17 
24 
kDa 
52 
(b) (a) 1 2 3 4 5 6 7 1 2 3 4 5 6 7
- 175 - 
 
Asn318Gly* 
 
 
kDa 
52 
 
38 
17 
2 3 4 5 62 3 4 5 6
kDa 
66.0 
45.0 
36.0 
29.0 
24.0 
20.1 
(b) (a) 1 1
- 176 - 
Appendix B 
The lanes in the SDS-PAGE gel (a) and corresponding Western blot (b) for 
batch 1, used for the purification of wild-type Mhp1 solubilised in DDM and 
NM, contain 1) molecular weight standard, 2) the solubilisation mixture with 
DDM, 3) the soluble fraction containing Mhp1 after ultracentrifugation, 4) the 
pellet after ultracentrifugation, 5) flow-through from the Ni-NTA resin prior to 
dividing the resin into two parts, 6) the wash buffer containing DDM, 7) the 
wash buffer containing NM, 8) eluted Mhp1 protein solubilised in DDM, 9) 
eluted Mhp1 protein solubilised in NM. 
The lanes in the SDS-PAGE gel (c) and corresponding Western blot (d) for 
batch 2, used for the purification of wild-type Mhp1 solubilised in UM and 
DM, contain 1) molecular weight standard, 2) the soluble fraction containing 
Mhp1 after ultracentrifugation, 3) the pellet after ultracentrifugation, 4-5) 
flow-through from the Ni-NTA resin prior to dividing the resin into two parts, 
6) the wash buffer containing UM, 7) the wash buffer containing DM, 8) 
eluted Mhp1 protein solubilised in UM, 9) eluted Mhp1 protein solubilised in 
DM. 
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Appendix C 
CD graphs and thermal melts used to determine the melting points in section 
3.3.2. 
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